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Abstract  
The introduction of Antiretroviral (ARV) treatment has allowed for many children living with 
human immunodeficiency virus (HIV) to survive to adolescence. However for this to be a reality 
adherence to treatment is important. Many studies suggest that during adolescence adherence can 
be very challenging. However not much research has been done within the South African context 
to understand what HIV positive adolescents are experiencing, particularly in relation to ARV 
adherence. The aim of this research study was to explore the experiences of adolescents on 
antiretroviral therapy (ART) in order to understand what helps them to adhere to their medication 
and the challenges that they may have with adherence. This was achieved by carrying out 5 
semi-structured in-depth interviews with HIV positive adolescents on ARVS at a shelter for HIV 
positive women and children in Johannesburg. A thematic content analysis was used to analyse 
the transcribed interviews. The results indicated several factors that both assist with adherence 
and those that challenge adherence. The participants reflected on the importance of full 
disclosure which increases their understanding of the importance of adherence, having people 
they trust whom they can confide in and who also support them to take and adhere to the ARVs, 
and having a positive experience at the hospital when they go for their regular checkups. Certain 
defence mechanisms adopted by the adolescents to help them cope with living with HIV and 
having to take medication every single day of their lives were also identified. The fact that 
acceptance is a process was also suggested by the research findings. The challenges the 
adolescents face were those of stigma and a fear of being rejected, bad experiences associated 
with taking medication, such as the negative side effects and the disruption of their leisure time, 
and negative experiences from going to the hospital. This study yielded some rich information 
that may aid in understanding what adolescents are experiencing and facing which may inform 
future research studies on this topic and policies which may assist with an increase in adherence.  
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Chapter 1: Introduction & Overview 
 
1.1. Introduction  
The research study described within this document aimed to explore and report the experiences 
of adolescents on antiretroviral therapy (ART) in the South African population, in order to 
understand what helps them to adhere to their medication and the challenges that they may have 
with adherence. This research was conducted by carrying out semi-structured in-depth interviews 
with adolescents at a shelter in Johannesburg. A thematic content analysis was used to analyse 
the transcribed interviews. There is a wealth of literature that engages with the Human 
Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) pandemic 
and the importance of ART and adherence. The majority of literature in South Africa on ART 
adherence is focused on adults and children, and not much has been done on adolescents’ 
experiences of ART adherence, particularly not research of a qualitative nature.  
 
1.2. Rationale  
Modern medicine has brought about significant breakthroughs in the HIV epidemic. A major 
breakthrough is the introduction of ART and its increasing availability worldwide. In fact, 
between 2003 and 2008 access to antiretroviral medication in low and middle income countries 
rose 10-fold (WHO, 2009). The AIDS Epidemic Update (2009) reports that South Africa has the 
largest ART programme in the world, the consequence of which is significant public health 
benefits and improved access to treatment for HIV positive people. With the increase of ART 
availability more babies, children and adolescents are on antiretroviral treatment. Also, due to 
ART more babies and children born with HIV are surviving into adolescence. Studies also show 
that there is a high HIV prevalence within this adolescent demographic as they make up a 
significant percentage of new infections (Gray, 2010).  However, despite the medical advances, 
adolescents are still a very vulnerable group. A recent study has shown that adolescents in 
Southern Africa are less adherent to ART compared to adults (Chaisson, Cotton, Dowdy, Hisiop, 
Maartens, Nachega, Nguyen, & Regensberg, 2009). This is a major concern as non-adherence on 
ART can increase the risk of drug resistance and morbidity. Very few qualitative studies have 
been done on the ART adherence of adolescents in Southern Africa. However there are related 
studies in Africa, such as an Ethiopian study looking at barriers and facilitators of adherence 
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among children (Chiunguzeni, Makwiza, Nyirenda, Phiri, Theobald & Weigel, 2009); and a 
mixed methods study done in Malawi assessing caregivers’ knowledge, perception and attitudes 
towards their children’s Antiretroviral (ARV) treatment (Amberbir, Biadgilign, Deribe & 
Deribew, 2009). Another major concern is that not much research has been done in South Africa 
to explore and understand the reasons that adolescents are not adhering well to ART. Several 
researchers have highlighted the importance of doing research on adolescence and ART 
adherence so that interventions can be initiated (Amberbir, Deribe, Getachew, Girma, 
Woldemichael, 2008; Abreu, de Oliveira, Evangelista, Filho, Hofer, Machado & Nogueira, 2008; 
Belzer, Durako, Moussa, Muenz, Murphy & Wilson 2005). Taking a qualitative approach to the 
study was vital for two reasons: the first reason was that no qualitative studies have been done in 
this context with this age group; and the second reason was that a qualitative study allowed for a 
more in-depth understanding of these adolescents’ experience. The significance of the study lies 
in its therapeutic applications, as with a better understanding of South African adolescents’ 
experience with ART and adherence, appropriate interventions and programmes could be set up 
to support adolescents living with HIV and could also encourage more in-depth research to be 
done in order to fully understand adolescents’ experiences of living with HIV and taking ARVs.  
 
1.3 Methodology  
In order to gain a more in-depth understanding of the experiences of adolescents on ART, a 
qualitative design was adopted. This allowed for the opportunity to effectively explore and gain 
some insight into HIV positive adolescents’ experiences with ART adherence. The study aimed, 
in particular, to explore what helps adolescents adhere to their ARV medication and the 
challenges they experience in adhering to their ARV medication. Due to time constraints and 
practical reasons this research study had a small sample size of 5 participants, which consisted of 
both males and females from a shelter in Johannesburg. However, the interviews were long and 
in-depth; hence it was felt that rich data was gained. Once consent and assent were attained the 
participants were interviewed and a semi structured interview schedule was used. A thematic 
content analysis was used to analyse the data.  The results of the study present a detailed 
exploration of various aspects of the research topic.  
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1.4. Conclusion  
This chapter included an overview of, and an introduction to, the research study presented in this 
document. Chapter 2 provides an overview of the literature pertaining to the history of HIV and 
ART in South Africa, ART adherence and the factors affecting and facilitating ART adherence 
in adolescents. This chapter contextualises the study and highlights some of the literature which 
has focused on adherence and adolescents’ experiences with ART adherence. Chapter 3 provides 
a review of the literature which informed the theoretical understanding of this research study. 
Chapter 4 describes the methodology adopted and includes descriptions of the research design 
and the participants, the process of data collection, data analysis and the ethical considerations 
made when conducting the study. Chapter 5 reveals themes related to the participants’ 
experiences living with HIV and taking ARVs. The adolescents’ relationships to their ARVs; the 
integration of the ARVs into their identities; and the process of acceptance around ARTs were 
the predominant themes that emerged. In Chapter 6 broader reflections have been noted in 
relation to the research findings. Chapter 7 is the conclusion, which includes a summary of the 
research findings and the limitations of the research study. This chapter then concludes with 
recommendations and opportunities for future research. 
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Chapter 2: Literature Review 
 
2.1. Introduction  
The literature review covers significant content areas related to the key research interests. The 
literature particularly reflects an overview of the history of HIV and ART in South Africa, ART 
adherence and the factors affecting and facilitating ART adherence in adolescents. This assists in 
contextualising the study and importantly highlights some of the literature which has focused on 
adherence and adolescents’ experiences with ART adherence across the world.  
 
2.2. HIV and AIDS in South Africa 
South Africa has one of the highest HIV prevalence rates in the world. Smit (2007) states that 
“the AIDS epidemic is one of the most important factors shaping social existence in South 
Africa” (p. 161).  Statistics South Africa (2011) estimated that by 2010 there would be 5.6 
million people living with HIV in South Africa. They also estimated that 10. 5% of the total 
population in South Africa is HIV positive and that one fifth of women in the reproductive stage 
are HIV positive. This also shows that South Africa’s epidemic remains the largest in the world 
(WHO, 2010). However there also seems to be a slowing of HIV incidences and signs that safer 
sex practices are being used among young people in South Africa (WHO, 2010). Statistics 
generated from antenatal clinics also show that from 2008 to 2009 there was a slight decrease in 
HIV prevalence among young women aged 15-19 years and an increase in prevalence among 
those aged 30-34 (Avert, 2010).  HIV incidence among 18-year olds declined sharply from 1.8% 
in 2005 to 0.8% in 2008, and among women 15–24 years old it dropped from 5.5% in 2003–
2005 to 2.2% in 2005–2008 (WHO, 2010). South Africa has achieved almost 90 % coverage to 
prevent mother to child transmission, and due to this the transmission of HIV to infants has been 
reduced (WHO, 2010). This means that fewer children are born HIV positive. However it has 
also been found that AIDS is the largest cause of maternal mortality and also accounts for 35% 
of deaths in children younger than five years (WHO, 2010)). There were an estimated 330,000 
under-15s living with HIV in 2009 (Avert, 2010). It was also estimated that by 2010, 1.99 
million children had been orphaned by HIV (Statistics South Africa, 2011). AIDS accounted for 
43% of deaths in 2010 (Statistics South Africa, 2011).  It was estimated that by 2010 
approximately 1. 6 million people would be in need of ART (Statistics South Africa, 2011). But 
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South Africa has less than 40% coverage of eligible adults receiving ART (WHO, 2010). The 
HIV and AIDS epidemic has affected South Africa significantly on both a macro and a micro 
level. An overview as to how HIV and AIDS has affected and impacted on the South African 
context on both these levels follows. 
 
Starting at a macro level, it is important to look at how the government handled and is handling 
this epidemic. “The National response to the HIV epidemic was different to other countries like 
Uganda, as it has a history of contestation and often even denial of the link between HIV and 
AIDS” (Lush & Parkhurst, 2004, p. 1916).  Systematic factors within the government played an 
important role in both facilitating and hindering the implementation of HIV and AIDS initiatives 
(Lush & Parkhurst, 2004). Starting from the time Nelson Mandela was president to when Thabo 
Mbeki came into power there was a lot of contestation and disagreement on the issue of HIV and 
AIDS and it was in fact kept out of the National Agenda (Lush & Parkhurst, 2004). In 2000 
Mbeki expressed his doubt that HIV was an exclusive cause of AIDS and he argued for a 
consideration of socioeconomic causes (Fassin & Schneider, 2002).  Schneider (2002) states that, 
“Mbeki’s statements seem bizarre but they have a clearer logic when seen as part of an ongoing 
struggle between various players in South Africa” (p. 145). There were a lot of public 
disagreements and non-accommodation between senior African National Congress (ANC) 
politicians and a range of non-governmental actors in South Africa about AIDS policies 
(Schneider, 2002). This time was marked with disagreement on the value of ARVs and 
government’s stalling to roll out nevirapine to prevent mother to child transmission of HIV 
(Fassin & Schneider, 2002). There was a lot of denial about AIDS and its effects within the 
government and this fed into the public’s beliefs about the epidemic. On a community level the 
belief of conspiracy theories about HIV and AIDS was prevalent and this hindered positive 
behaviour change (Lush & Parkhurst, 2004). In July 2002, the Constitutional Court made a 
judgement ordering the government to make nevirapine available to all pregnant women with 
HIV, and this was followed by a cabinet statement supporting wider access to ARVs (Fassin & 
Schneider, 2002). This brought about a new era in South Africa. These HIV and AIDS debates 
brought about awareness about health inequalities and helped in mobilising people to stand up 
and fight for their social rights around obtaining health care (Fassin & Schneider, 2002). Political 
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leadership played and still plays an integral part in addressing the challenge of HIV and AIDS. 
South Africa now actually has the largest ART programme in the world (Avert, 2010). 
 
HIV and AIDS in South Africa are both affected by society and affect society. Social factors 
such as social inequalities in income and employment status are seen as powerful predictors of 
infection, placing the lower socio-economic South African population at a higher risk of 
infection (Fassin & Scheinder, 2002). Due to a lack of income and unemployment people have a 
greater exposure to risky sexual experiences, lack of access to health information and prevention 
programmes, higher frequency of exposure to sexually transmitted infection and absent or 
delayed diagnosis and treatment  (Fassin & Scheinder, 2002). HIV and AIDS also affect the 
economy and society on the micro as well as the macro-levels (Booysen, Geldenhuys & 
Marinkov, 2010). In 2004, the Bureau of Market Research (2004) predicted that HIV and AIDS 
would significantly impact household income and expenditure, and the national income in South 
Africa during the period 2004 to 2015.  In 2004 it was estimated that a third of South African 
households are infected and/or affected by HIV/AIDS and that this would have a significant 
impact on households in South Africa and consequently on the national economy (Bureau 
Market Research, 2004). Collins and Murray’s (2008) survey on HIV’s impact on households 
found that 80% of the sample would lose more than half their per capita income with the death of 
the highest income earner and this has also changed the shape of the distribution of South 
Africa’s prime age working population. Due to high HIV and AIDS mortality rates companies 
are losing labourers, especially unskilled and semi-skilled labourers, resulting in a decline in 
productivity and this has a direct impact on the economy as a whole (Booysen, Geldenhuys & 
Marinkov, 2010). The economy is also impacted through the socio-economic costs of high HIV 
adult mortality which includes the grave burden placed on the welfare and health care systems 
(Smit, 2007).  
 
HIV has also hugely impacted society at a micro level. Smit (2007) states that the family, as a 
basic social unit, mainly feels the grave impact of HIV and AIDS in the society. The WHO 
report (2010) states that even with the decline of HIV prevalence among adults and increasing 
availability of ARVs in South Africa there has been no decline of children, aged 0-17 years, 
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orphaned due to HIV. The families are not only affected on an emotional level but also on a 
financial and social level. Family dynamics have been drastically changed as more and more 
single parent headed households result as spouses have either deserted the family or been killed 
by AIDs; grandparents are having to parent their grandchildren whose parents have died from 
AIDS; an increase of child headed households is being found as parents have passed away due to 
AIDS; and there is a shift away from the nuclear family as families are relying more on the 
extended family to care for them when they are ill and, or take their children in when they die 
(Smit, 2010).  “However one of the key obstacles to communities’ capacity to care has been the 
stigmatisation of the infected; a defence mechanism used by the community... which can lead to 
the social quarantine of the potential contaminant” (Barolsky, 2003, p. 25). This is a major 
problem for families as they are shunned by their own neighbours and community instead of 
getting support from them. However stigma is also found within the family. A South African 
study found that children were afraid to disclose their status to their own parents as they worried 
they would be stigmatised by them (Campbell, Foulis, Maimane & Sibiya, 2005). This study also 
found that some families hide away sick relatives, depriving them of health care and support, or 
they disown dead relatives and refuse to go to claim their bodies at the mortuary. Even sick 
relatives do not ever talk about having AIDS. Stigma is a real problem in the South African 
community and it often prevents people living with HIV and AIDS from being tested and/or 
accessing treatment. 
 
HIV and AIDS pose great challenges to the futures of South African children. They have to take 
on adult household responsibilities, such as taking care of the ill and dying and finding work to 
support the family, which often results in them missing out on an education leaving them at risk 
of destitution (Booysen & Arntz, 2002). Studies such as this also show that due to HIV, more 
and more children are being left orphaned and as a result they are ‘bounced’ from one family 
member to another (Smit, 2010). Due to this, the extended family, such as grandparents, have 
had to play a significant role in taking care of these orphaned children. This has positively 
influenced the government to roll out an initiative of child support grants to more households, to 
roll-out home-based care to more affected households, to develop alternative and innovative 
models of community-based orphan care, and to increase awareness and protection of the rights 
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of women and children (Booysen & Arntz, 2002). The AIDS epidemic has had a significant 
impact on the South African society at a national, community and individual level. HIV and 
AIDS has also left a great many South African children vulnerable and at risk.  
 
2.3. Antiretroviral Therapy Adherence 
The introduction of ART has brought about significant change in extending the lifespan and the 
quality of life of people living with HIV or AIDS (Amberbir et al., 2008, Abreu et al., 2008). 
Research shows that ART has and is considerably improving the lives of children in Africa; 
however excellent adherence is mandatory for treatment success (Boulle, Davies, Eley, Fafir & 
Nuttall, 2008). ART adherence is one of the major concerns in the public health sector. Highly 
Active Anti-Retroviral Therapy (HAART) is very important as it can lead to the suppression of 
HIV virus type 1plasma viremia to undetectable levels for more than three years or more (Belzer, 
et al., 2005). ART is clearly very important for people living with HIV or AIDS; however, for it 
to be effective one has to adhere to the medication. 
 
ART and adherence go hand in hand for optimal results. The definition of adherence is the extent 
to which a patient takes their ART as prescribed and required by their medical practitioner or 
health care provider (Belzer et al., 2005). However adherence is far more than taking medication, 
it is more of a lifestyle. Adherence is a treatment process and a patient has to be an active 
member in that process; health care providers believe that it is more than taking one’s 
medication, but is also about following a diet, and or executing lifestyle changes (WHO, 2003). 
ART treatment is a long term treatment plan of HIV/ AIDS and requires the patient to have at 
least 95% adherence to prevent the emergence of drug resistance (Belzer et al., 2005). High 
levels of adherence are essential for optimal benefit of ART. Several researchers have 
highlighted issues of poor adherence and non- adherence, which is when a patient is not taking 
their medication as advised by their health care provider (Farley, Kammerer, Malee, 
Montepiedra, Nichols, Sirois, Storm & Williams, 2006). ARV medication has to be taken every 
single day at the same time for the rest of the patient’s life for the simple fact that the disease 
process is chronic and ARVs manage and suppress the virus (WHO, 2010).  
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There are several methods used to measure if a patient is adhering to their ARV medication. 
Researchers use different indicators to measure adherence. The first is that adherence can be 
measured by counting if the patient has missed a dose of medication or skipped a day of 
medication, and also whether the patient has missed medical appointments (Bell, Bell, Camacho, 
Henry-Reid, Martinez, Rodriguez & Watson, 2000). Other methods to monitor adherence are 
through measuring the patient’s HIV-1 RNA viral load, through using a medication event 
monitoring system (MEMS), and through monitoring behavioural factors associated with ART 
adherence (Belzer et al., 2005) such as: re-fulfilment of medication and dietary requirements 
associated with ART (WHO, 2003). There are also many factors that are used to predict 
adherence and some are considered unreliable. Patient report is considered unreliable as patients 
tend to overestimate their adherence levels so other tools are used in conjunction with this such 
as pill re-fulfilment as a way of predicting adherence (Boulle et al., 2008). However pill re-
fulfilment is also unreliable because even if a patient has refilled their treatment it does not 
guarantee that they are taking their medication (Boulle et al., 2008). It is suggested that using 
questionnaires that ask about specific behaviours relating to treatment recommendations (e.g. 
dietary and nutritional patterns, healthy living and management of weight) may be better 
predictors of adherence behaviour (WHO, 2003). Pill counting is another strategy that is used but 
it is also not reliable as this cannot measure whether a patient is following time schedule 
requirements; hence, a medication electronic monitoring (MEMS) device was invented, which 
records the time and date when a medication container was opened, therefore better monitoring 
the way patients take their medications (WHO, 2003). This innovation is essential and could 
make a difference with adherence measurement, but unfortunately it is expensive and therefore is 
not widely available. Another innovation used to measure adherence is non-toxic biological 
markers that are put into the medication and then their presence is tested in blood or urine, which 
will inform the practitioner if medication is being taken. Unfortunately this too is not adequate as 
the findings can be influenced by a number of factors such as diet, absorption and rate of 
excretion (WHO, 2003).  It is clear that there are several methods used by both practitioners and 
researchers with varying levels of reliability and cost-effectiveness. However if multiple 
approaches are used then adherence measurements could possibly produce more accurate 
adherence levels. As mentioned earlier adherence to ART is one of the greatest challenges in the 
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public health sector with the management of HIV and AIDS; and it is very costly as a large 
amount of the treatment goes to waste (Belzer et al., 2005, WHO, 2003). It is reported that in 
developed countries, adherence to long-term therapies in the general population is around 50% 
and is much lower in developing countries (WHO, 2003).   
 
There are numerous reasons why adherence is such a concern and these will be reviewed next. 
Excellent adherence is one of the most important factors in achieving ARV treatment success 
and preventing drug resistance to drug regimes (combination of ARV medication) (Boulle et al, 
2008). There is a major concern for the public health sector that non- adherence to drug regimes 
may advance the emergence of drug resistant strains of HIV, which will consequently aggravate 
treatment for adults, children and adolescents living with HIV or AIDS (Bell et al., 2000). Drug 
resistance is a major concern in relation to the AIDS epidemic for the following reason: if a 
patient does not take their ARVs as they should, this results in there being low levels of 
medication in the body which cannot suppress the virus; once the virus is not suppressed it builds 
strength and it is able to adapt to the workings of the ARVS resulting in the virus becoming 
resistant to the ARVs, making them ineffective. If a drug resistant strain of HIV emerges there 
may be a spread of HIV that is not susceptible to ARV treatment. Non-adherence can also result 
in morbidity and mortality which is another major issue for both patients and the health sector 
(Bell et al., 2000). If the treatment fails then the patient has few options, and if there is nothing to 
suppress the virus the patient is at risk of developing AIDS which could eventually kill him or 
her. 
 
There are a significant number of adolescents in Southern Africa who acquired HIV prenatally, 
and evidence shows that they contribute significantly to hospital admissions and in-hospital 
deaths (Gray, 2009; Ferrand et al., 2010). Statistics show that 85 % of 2.5 million HIV- infected 
children under the age of 15 years worldwide are from the sub-Saharan African region (Boulle et 
al., 2008). The other issue is that the availability of second-line and antiretroviral therapy 
regimens in sub-Saharan Africa is limited and maintaining the first line of ART is crucial, more 
so for adolescents who are expected to live longer due to ARV treatment (Chaisson et al., 2009). 
This clearly shows that there is still an urgent need to provide access to services and increase the 
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availability of ART and support for adolescents living with HIV. Adolescents are considered to 
be the most likely to benefit from ART and if they are not adhering well as studies show, this 
could be a major crisis. There are gaps in the research in relation to adolescents and ART 
adherence in South Africa; very few studies have been done to understand the experience of 
these adolescents and their understandings of ART adherence.  However, before one can explore 
what they are experiencing it is vital to understand their developmental stage as a whole. This 
will be explored in the next chapter. 
 
2.4. Factors affecting and facilitating Adolescents and ART Adherence 
Despite the medical advances that are being seen, there are still some social aspects that are 
affecting the wellbeing of adolescents living with HIV. Studies are clearly showing that this age 
group is not adhering to ARV medication and this is of major concern as non-adherence to ART 
can increase the risk of drug resistance and morbidity (Gray, 2009). As mentioned above, 
adolescence is generally a difficult stage of development and being HIV positive and having to 
be on a long term treatment adds to the burden (Chaisson et al., 2009). A longitudinal study from 
thirteen states in the USA identified that factors associated with poor adherence among 
adolescents included depression, pill burden, advanced HIV status, alcohol use, dropping out of 
school, side effects and complications of day-to-day routine (Belzer et al., 2005). Belzer et al. 
(2005) suggest that the reason these adolescents could not adhere effectively during the late 
stages of the disease is most likely due to the fact that they are possibly more affected physically, 
thus being less able to tolerate the adverse effects of medication, or it could be owing to their 
depression over disease progression and lowered outcome expectations that the medication can 
be helpful to them. Ridder, Geenen, Kuijer and Van Middendorp's (2008) review also found that 
with chronic illnesses the malaise imposed by physiological processes of the illness has an effect 
on adjustment to living with a chronic illness.  
 
A qualitative study in Uganda found structural factors like poverty and stigma as barriers to ART 
(Atuyambe, Kasasa, Neema, Otolok-Tanga, Wabwire-Mangen & Wamuyu-Maina, 2009); 
internalised stigma is identified as being associated with important health outcomes such as 
delays in pharmacy refills and medical care (Chirwa, Dlamini, Greeff, Holzemer Kohi, Makoae, 
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Mullan, Naidoo, Uys & Wantland, 2008).  According to these findings, if a patient perceives that 
they will be discriminated against due to their status, they avoid getting medical care. Studies 
also found that the most common issues associated to poor adherence were psychosocial 
problems, and lack of help for these issues, erratic drug taking, and lack of disclosure of HIV 
status (Amberbir, Biadgilign, Deribew & Deribe, 2008; Ferrand et al., 2009; Farley et al., 2006). 
The psychosocial problems for adolescents in these studies were stigma, delayed disclosure, 
difficulty in identifying with HIV- negative peers and a desire to conform, anxiety about sexual 
relationships and future planning, and low self-esteem and feelings of hopelessness; which were 
compounded by the adolescent having to head a family, and having to take care of ill relatives 
and siblings (Chiunguzeni et al., 2009; Ferrand et al., 2009). The issue of stigma is linked to 
various issues, such as when the main caregiver is away there is fear of disclosure and some 
caregivers face difficult decisions about whom to ask to support drug adherence for their child in 
their absence; or the death of a caregiver, leaving no one to administer ARV treatment to the 
child; or even the child being away visiting relatives could cause problems in adherence to drugs, 
as the responsibility is then left to the child (Chi et al., 2009; Chiunguzeni et al., 2009).   
 
There is much debate on whether socioeconomic status (SES) has an effect on ART adherence 
(Amberbir et al., 2008).  Orrell et al. (2003) found that low SES was not a predictor of adherence 
for patients getting their  therapy for free; which was shown in this particular study by adherence 
in developing countries being at least as good as adherence in developed countries.  However 
several studies show that components of SES play a role in poor adherence. Fennell, Leitz and 
Fantauzzi (2012) indentified that education, poverty and living with a chronic illness are 
intertwined as children are at a higher risk of absenteeism and some drop out due to their own or 
a family member’s chronic illness. They miss out on too much foundational knowledge which is 
overwhelming, frustrating and difficult to catch up and/or understand (Fennell, Leitz & 
Fantauzzi, 2012). Lack of education is identified as a major cause of a lifetime of poverty and 
poor health (Fennell, Leitz & Fantauzzi, 2012). This also indicated the importance of educational 
institutions addressing the lack of standardised protocols and policies to accommodate 
chronically ill students and their families, in order to contribute toward their long-term economic 
security and health (Fennell, Leitz & Fantauzzi, 2012). The absenteeism at school can be due to 
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doctors and medication appointments or even the illness itself such as relapsing. Issues 
associated with SES that were found to impact on adherence were the inability to afford transport 
fares and food, which resulted in missed medical appointments and malnutrition (Amberbir et al., 
2008; Ferrand et al., 2009).  In the USA, studies show that adolescent’s living situations can 
impact on adherence.  These challenges included: their family structure; homelessness; being 
marginally housed; having unstable lives; needing help with basic daily living skills such as 
income generating, planning and eating nutritious meals; finding a regular place to sleep and 
live; and their parents or guardians struggling to care for themselves and sometimes even their 
own children, circumstances in which medical treatment and adherence is often the last thing on 
their minds (Bell et al., 2000; Farley et al., 2006). Farley et al. (2006) identified that older 
adolescents have an increased likelihood of non-adherence, and caregivers must be careful with 
giving the adolescents too much responsibility; as this may be premature for some, given that 
some adolescents with HIV infection may have cognitive or emotional difficulties that influence 
their ability to function independently, unlike their HIV negative peers. At the same time, they 
are facing the normal challenges of adolescence that may affect their willingness and, or ability 
to assume important health maintenance behaviour, such as medication adherence (Farley et al., 
2006). Chronic illness has been found to have an effect on behavioural, cognitive, and emotional 
challenges of disease and also coping with these physiologically-induced symptoms (Ridder, 
Geenen, Kuijer & Van Middendorp, 2008), making it necessary to always take note of this 
particularly with adolescents.  
 
The other factors that studies have identified as affecting adherence are as follows: in Brazil 
patients would not carry extra doses of medication while out of the house and therefore would 
miss a dose (Abreu et al., 2008); the other association to adherence was the relationship patients 
had with their health care provider and level of education and understanding of ART and 
unhealthy lifestyles (Abreu et al., 2008). Some patients reported skipping doses because of 
simply forgetting; feeling sick or ill (sometimes due to side effects of medication); being busy 
and running out of medication; and also due to a lack of social support (Amberbir et al., 2008; 
Abreu et al., 2008). Research across the world has shown that it is very clear that there are a 
range of reasons why adolescents are failing to adhere to treatment.  Adolescents living with HIV 
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are becoming a booming population and they are a major concern in the world and more so in 
Southern Africa. Unfortunately, insufficient research has been done in South Africa to explore 
what HIV positive adolescents are experiencing with ART adherence, especially from a 
qualitative approach. This is the area that this study will cover; exploring the adolescents’ 
experiences and trying to discover what they understand about ART adherence and also the 
challenges they experience with ART adherence; because only until  their experiences and 
challenges are understood can appropriate initiatives and interventions to support and address 
adolescents’ needs be established.  
  
As highlighted above there are several factors that challenge ARV adherence, however, research 
shows that there are also factors that facilitate ARV adherence (Dahab et al., 2008; Watt et al., 
2009; & Nachega et al., 2004).  A study conducted in Los Angeles identified that making a 
commitment, routinising, health beliefs, social support, and professional support facilitate ARV 
adherence (Roberts, 2000). This research found that medi-sets (pill cases compartmentalised into 
days of the week and, or doses during the day), alarm clocks, written notes and day planners 
remove the burden of having to remember complex medication schedules which is common to 
ARV regimens (Roberts, 2000). Medi-sets were also found to reduce medication mistakes such 
as double dosing or missing a dose which can happen when using the normal pill bottles. 
However it was also identified that some people were concerned that there may be some stigma 
associated with using the medi-sets (Roberts, 2000). People worry about what other people will 
say or think if they take out their medi-sets in public areas and this can result in one missing their 
doses. However medi-sets clearly assist with when and how one should take their medication. It 
was also found that one’s mindset, self discipline and commitment to taking their ARVs are 
helpful to adherence (Roberts, 2000). Research has also found that good adjustment predicts 
increased participation in self-management and vice versa (Ridder, Geenen, Kuijer & Van 
Middendorp, 2008). So if one can adjust or come to terms with living with HIV then they engage   
in more self care behaviour which befits them on a physiological and psychological level. 
Another facilitator that assists with commitment to ones ARV medication is routinisation of the 
medication schedule. Routinisation is when the person incorporates their medication taking 
behaviours into their day-to-day routine (Roberts, 2000). A way of doing this would be for a 
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person to incorporate taking their medication into activities they generally would be doing like 
waking up, eating breakfast, going to school or work and dinner time. Research also shows that 
if one believes that the medication is working and making a positive change in their health, they 
become more invested and motivated in taking the medication (Mills et al., 2006). In relation to 
this; people were also motivated to adhere to their ARVs when witnessing their friends or family 
members getting sick or dying, as they did not want the same thing to happen to them (Roberts, 
2000). One’s attitude also tends to have an influence on adherence. These included acceptance of 
HIV status, having faith in the treatment, high self-worth, self-efficacy and a desire to live (Mills 
et al., 2006). Another important influence on psychological adjustment to and the self-
management of a chronic illness is psychiatric conditions such as mood disorders (Ridder, 
Geenen, Kuijer & Van Middendorp, 2008). Thus it is important for clinicians to keep an eye on 
this and manage these disorders if they are present, as they can affect ones attitude, behaviour 
and cognitive processes to living with HIV. Social support is also identified as being a strong 
motivator for adherence. Family and friends that facilitated with adherence were also found to be 
helpful.  This support included: reminding them to take their medication, refilling their 
prescriptions, and helping to provide and cook the appropriate meals to take with medication 
(Murphy, Marelich, Hoffman & Steers, 2004). Roberts’ (2000) study also found that some 
patients would borrow medication from their friends or family when they did not have any with 
them. Research also found that people who had a good relationship and were able to 
communicate with their health care provider were more likely to adhere to their ARVs (Murphy, 
Marelich, Hoffman & Steers, 2004). The more they trusted and believed in what their health care 
provider was saying, the higher the chance that they would listen to their healthcare provider and 
adhere to their medication. 
 
Within children’s experiences of living with HIV and adherence to ARVs, disclosure seems to 
play a very significant role as well. Informing a child or adolescent of their HIV status is a 
difficult task, however, the time always comes when disclosure has to be done. It has been 
reported that there are both negative and positive social, psychological, and behavioural impacts 
to disclosing to a child their status. One of the impacts includes improved adherence (Vaz, Eng, 
Maman, Tshikandu & Behets, 2010). This study showed how parents worry that if they disclose 
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to the child, the child will react negatively and some worried their child would harm him or 
herself after disclosure. The most common motivators for full disclosure to the child are due to 
medication reasons; either because they were not taking their medication properly or because 
they were about to start their regime, to prevent siblings from getting infected and the child’s 
will to know their illness (Vaz et al., 2010; Azondekon et al., 2005). Writing about terminal 
illness, Kubler-Ross (1970) writes that the question should not be “should we disclose?” but 
rather “how should we disclose”. She further adds that when disclosure is done properly by a 
physician then the patient will not feel fear isolation, deceit and rejection but will rather have 
confidence in the honesty of his physician and also have the hope that if there is anything to be 
done it will be done. Abadia-Barrero and Larusso (2006) conducted a study in Brazil and they 
also found that lack of communication about HIV and AIDS creates a context of confusion and 
mistrust, and that self-stigma is detrimental to psychosocial development and coping, 
compromises disease knowledge, and increases vulnerability to risky behavior. It seems that a 
lack of disclosure causes more harm than good. The American Academy of Paediatrics (1999) 
report that children who know their status have a higher self esteem and better coping skills to 
those who are unaware of their status, but are ill or on medication. They also report that not 
disclosing to the child can have the negative consequence of them developing inappropriate 
negative fantasies about their illness and may also isolate them from potential sources of support. 
With children and adolescents it is important for the family and the heath care provider to 
collaborate in how to disclose to the child (Vaz et al., 2010).  Studies show that disclosure may 
have an initial negative response but on a long term basis it seems to benefit the child and 
adolescent. Disclosure allows for them to take up a more active role in their health such as 
adhering to the medication, and it also opens up the space for communication and them seeking 
the support that they need to be able to process, come to a place of acceptance and manage and 
cope with their illness.  
 
Several studies have also been done in developing countries on barriers and facilitators of 
adherence and these include Brazil, Tanzania, Peru, Ethiopia and South Africa. A study 
identified adherence as being higher in developing countries than in developed countries and it is 
vital to explore why that is (Watt et al., 2009). This however is contradictory to other studies 
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mentioned previously, such as that conducted by Orell et al. (2003).  These contradictory 
findings serve to illustrate the need for further research to be done in this area. A study done in 
Tanzania identified five main factors that facilitate ARV adherence (Watt et al., 2009). The first 
factor was the people’s confidence in ARVs after experiencing improvements in their health 
(Watt et al., 2009). The second factor was people’s perceptions of their responsibility to their 
family, for example, parents wanting to live to take care of their children and also being around 
to see them grow up (Watt et al., 2009). The third factor was material support; such as food and 
money, and emotional support from family, friends and counsellors from their health centre 
(Watt et al., 2009). The fourth factor that Watt et al. (2009) found was strategies used to 
remember to take pills, such as routinising pill-taking by linking it with day to day activities or 
events as was discussed earlier. The last facilitator identified in this study was a person’s 
relationship and trust in the advice of health care providers (Watt et al., 2009). A study done in 
Ethiopia focused on the facilitators of adherence in children and they found these to be: mobiles 
or wall alarms, ongoing counselling to caregivers on adherence, improved health and quality of 
life in the child, child friendly ART clinic setups, and disclosure of HIV to children (Amberbir, 
Biadgilign, Deribe & Deribew, 2009). Facilitators for adherence in children are closely linked to 
the child’s caregivers as they are responsible for making sure ART is adhered to, but also for 
making the child aware and involved in adherence.  
 
Studies have also been done in the South African context. A qualitative study done on a 
workplace program in South Africa found that disclosure, having social support and a strong 
belief in the value of treatment facilitated adherence (Dahab et al., 2008). Another study 
conducted in KwaZulu-Natal found that people with higher CD4 counts and better perceptions of 
their health had increased adherence. More positive attitudes about life and fewer worries about 
dying; higher social support scores and experiencing less discrimination were also found to be 
predictors of adherence (Anderson, Peltzer, Preez & Ramlagan, 2010). A study done on adults in 
Soweto showed that they had excellent adherence and it also found that affordability of 
medication and HIV and AIDS education programs that help to decrease disease stigmatization 
maximise adherence (Nachega et al., 2004). Another factor highlighted in a review of 
psychological adjustment to chronic illness identified that for some benefit finding once 
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diagnosed with a chronic illness can help with psychological adjustment and living with chronic 
illness (Ridder, Geenen, Kuijer & Van Middendorp, 2008). It is however also important to assess 
that the benefit finding is not being used as a defence mechanism which can hinder the process 
of psychological adjust and acceptance of one's illness. As highlighted in this section, facilitators 
of adherence are an integration of social and personal factors. It is clear that adherence is 
possible and can be achieved. However most of these studies focused more on adults or children 
and it is vital to also look at what helps adolescents to adhere to their ARTs in our community. 
 
2.5. Conclusion 
HIV and AIDS is a vast topic with various foci and thus there is a vast array of literature on HIV 
and AIDS. This literature review chapter started off on a broad level by trying to better 
conceptualise the issue of HIV and AIDS in South Africa. To accomplish this HIV was discussed 
in relation to the progression of the political, social and economic impact of HIV and AIDS in 
South Africa. The next focus was to highlight and discuss the issue of antiretroviral therapy 
adherence which is a part of the focus of this study. This chapter then highlighted some literature 
on factors affecting and facilitating adolescents’ ART adherence, particularly the factors that 
inhibit appropriate adherence and what assists adolescents with good adherence. There was not 
much research that was found on adolescents ARV adherence in South Africa, hence the 
motivation for this inquiry.  
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Chapter 3: Theoretical Framework 
 
3.1. Introduction  
The theoretical framework includes a review of the literature which informed the theoretical 
understanding of this research study. The literature includes some theories of the development of 
adolescents, theories on identity formation, which is also an important area of development in 
adolescence, and lastly the chapter provides literature on a variety of defence mechnisms and 
ways in which people cope with and come to terms with living with a chronic or terminal illness 
as this can be highly challenging for HIV positive adolescents.  
 
3.2. Adolescence  
To understand the stage of adolescence it is vital to look at theories on development. There are 
diverse theories which take different approaches to understanding adolescence as a 
developmental stage. These theories provide us with a deeper understanding of how adolescents 
act, why they act in a certain way, and how this affects the way they develop. Hall (as cited in 
Balk, 1995) stated the stage of adolescence as a time of storm and stress; and psychoanalysts 
kept this view alive, and in this section there will be discussion on some theories on the 
development of adolescents. 
 
Sigmund Freud developed three concepts: the unconscious, defence mechanisms and the stages 
of psychosexual development. The unconscious is made up of three mental processes: the id (its 
purpose is to achieve pleasure and the individuals purpose is to keep it under control); the ego 
(its purpose is to develop mental processes that allow an individual to be able to simultaneously 
meet the demands of the id and the expectations of the external world); and the superego (this 
develops between age 5 and 6 and its purpose is to internalise the expectations of parents or 
caregivers; in other words the individual develops a conscience) (Balk, 1995). Freud believed 
that the id, ego and superego are fundamental to how an individual develops and interacts with 
the self, others, and the world (Balk, 1995). The second concept Freud developed is defence 
mechanisms; also known as operations of the ego to prevent an intrusion of the id. There are ten 
examples of defence mechanisms and some of them are repression, intellectualization and 
projection (Balk, 1995). The purpose of the defence mechanisms is to assist the ego to cope with 
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anxiety, frustration, and unacceptable impulses and help relieve tension and inner conflicts 
(Lemma, 2003). The third concept is Freud’s stages of psychosexual development. Freud 
suggested that there are five psychosexual stages: oral, anal, phallic, latency and genital (Naidoo, 
Townsend & Carolissen, 2008). Rather than discussing all five stages, this paper will only be 
looking at the genital stage as that is the stage relevant to adolescence. Freud believed that this 
stage begins with puberty, which marks the start of adolescence (Lerner, 2002). He believed that 
during puberty males become more interested in sexual intercourse and seminal discharge, where 
as females experience a strengthening of sexual inhibitions. A South African study identified that 
almost two-thirds of both rural and urban adolescents have had sexual intercourse (Peltzer, 
2006). This study also showed that urban female adolescents take more initiative at first sexual 
intercourse than rural female adolescents (Peltzer, 2006). Another study in South Africa showed 
how gender influences developmental changes among the youth by inhibiting their self-
confidence, access to information, and opportunities to acquire skills; differences between male 
and female determine the power dynamics that influence the way girls and boys experience 
intimacy, sexuality and reproduction (Maluleke, 2007).  This particularly poses some difficulty 
with HIV positive adolescents as they have to worry about issues of disclosure of their status to 
their partners and safety measures required during sexual exploration and intercourse. Freud’s 
view is that turmoil and turbulence mark adolescence because unconscious prohibitions are 
raised against releasing tensions brought about by puberty (Balk, 1995). He also believed that 
adolescents are narcissistic; meaning that an adolescent is infatuated with the self.  This 
narcissism is said to strengthen the adolescent’s egos attachment to ideals; meaning that they 
eventually go beyond selfish interests in immediate gratification and form ego ideals which 
include social institutions like the family (Balk, 1995). HIV positive adolescents all across the 
world often are the ones left in charge of taking care of their parents and their families, so 
moving beyond one’s selfish needs has to occur whether they are ready for it or not.  
 
Anna Freud believed that adolescence is a time of developmental disturbance and a period of 
turmoil (Lerner, 2002). She believed during the latency stage an individual’s development is 
stormy and stressful (Lerner, 2002) as the balance between the id, ego, and superego that was 
achieved previously is discarded during puberty, leading an individual to a new internal 
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adjustment. According to Anna Freud this upheaval is necessary for an adolescent to be able to 
incorporate a mature sexual identity into his or her personality (Balk, 1995). She felt that if an 
adolescent did not go through this upheaval then they were not making the necessary internal 
adjustments; therefore they were not developing in an appropriate manner. Anna Freud actually 
viewed this stage as an abnormal time in one’s life. 
 
Blos (as cited in Balk, 1995) used Freud’s concepts of the id, ego, superego, Oedipus complex, 
defence mechanisms, and the five psychosexual stages, and also wrote about the stage of 
adolescence as a time of turmoil and stress. He believed that with regards to a person’s 
psychological development, maturity can only be attained through conflict (Blos in Balk, 1995). 
Blos (as cited in Balk, 1995) also described adolescence as a time of vulnerability, ambivalence, 
and conflict.  He suggested that there are four phases of adolescent development: 
preadolescence, early adolescence, adolescence proper (middle adolescence) and late 
adolescence. The preadolescence phase is the period before the onset of puberty. According to 
Blos (as cited in Balk, 1995), during this time the adolescent is experiencing psychic imbalances 
because their instinctual demands (the id) are revived and are confronted with disapproval from 
the ego and superego. Due to this conflict the adolescent then regresses to their earlier forms of 
development (Balk, 1995). Blos (as cited in Balk, 1995) stresses that this stage is crucial for all 
of the adolescence process as it sets the stage for resolving the developmental challenges that 
materialize later in adolescence. Early adolescence is marked with a lessened identification with 
parents, increased identification with peers, intense involvement with causes, infatuations with 
an opposite-sex peer. Blos says that adolescents try to form new ego ideals that are separate from 
dependency on parents, form more heterosexual relationships and develop a mature identity; 
failure to achieve ego ideal results in a permanent barrier to maturity (Balk, 1995). This can be 
particularly hard for adolescents living with HIV because as well as trying to cope with the 
normal challenge of identity formation in adolescence; they are also trying to find ways to cope 
with an HIV-positive identity. The adolescence proper phase is coupled with detachment from 
the parents, and development of a distinctive, and mature identity. A study in South Africa 
showed that adolescents’ perceptions of sexuality included developing trust in themselves, and at 
the same time seeing parents and other adults as backwards and old-fashioned people (Maluleke, 
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2007). This supports Blos’s theory that adolescents move away from their parents to try and form 
their own identities. In this phase the adolescent is also trying to resolve the Oedipus complex 
which according to Blos is the second individualisation process. He states that during this period 
the superego is altered substantially. He also states that during this phase adolescents regress; as 
they revert to earlier forms of coping. Blos however did not view this regression as a negative 
thing but rather that it was normal and necessary for the adolescent to mature (Balk, 1995). This 
regression is therefore needed for development. Late adolescence is when an adolescent realises 
that striving towards the ego ideal is a never ending process which is necessary and important for 
their development. The end of this phase is also the emergence of a stable character formation 
which can be achieved by meeting distinct developmental challenges; dealing and coping with 
traumatic experiences; being able to accept ones past and being able to move forward and have a 
future (this can be difficult if defence mechanisms prohibit that). The last developmental 
challenge is the emergence of the sexual identity (Balk, 1995). Beginning to negotiate one’s 
sexual identity and relationships can be difficult for any adolescent, more so for those living with 
HIV as they have to worry about issues of disclosure, stigma and taking extra precautions if they 
want to engage in sexual intercourse. Blos agrees with Anna Freud that adolescence is a time of 
conflict and turmoil, but differs with her in considering adolescence an abnormal time in life 
(Balk, 1995). He considers the turmoil normative and takes the stance that this conflict and 
turmoil is important for increasing maturity, individuality and independence.   
 
Erik Erikson took a different approach to the above three theorists. He developed the 
psychosocial model. The psychosocial model proposes that psychological development occurs 
because the individual must adapt to society’s demands and expectations (Lerner, 2002). This 
model proposes that psychological growth occurs because of conflicts that are specific to the 
human species. Erikson believed that there are eight stages of development, known as Erikson’s 
eight ages of man and that in each of these stages there is a crisis that society expects one to 
master (Balk, 1995).  Erikson’s eight ages of man are: Infancy, Early Childhood, Play Age, 
School Age, Adolescence, Young Adulthood, Adulthood and Old age. This section will only 
cover the stage of Adolescence. Erikson states that “during adolescence the crisis is between 
developing a sense of identity (e.g. knowing one’s role in society, and knowing what one 
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believes) versus role confusion or role diffusion (e.g. not knowing what one can do with oneself  
in society, and what one believes in)” (Lerner, 2002, p. 45).  He believed that during adolescence 
the major challenge is for one to achieve fidelity in one’s commitments while retaining diversity 
at the same time. Basically the adolescent would have to find a balance between fidelity and 
diversity. Erikson states that during this stage there is rapid physical development causing the 
adolescent to be self conscious (Balk, 1995). They worry more about what other people think 
about them than self evaluation. Erikson like Blos believed that during this stage there is an 
emergence of a new ego identity, but unlike Blos he also thought there was an integration taking 
place in the form of a new ego identity (Balk, 1995). Gibson and Rohleder (2005) state that the 
‘self’ is continuously shaped through the prevailing social discourses and construction of 
meaning. Therefore, for an HIV positive person, whatever negative meanings or beliefs are 
adopted by their communities about HIV may be integrated into the construction of their self 
identity (Gibson & Rohleder, 2005). HIV positive adolescents’ identity formation may be 
particularly difficult as they are subject to societal stigma and discrimination that surround HIV 
and AIDS which may impact on the development of their identity.  
 
The psychosocial approach basically stipulates that there are five main sets of developmental 
issues during adolescence: identity, autonomy, intimacy, sexuality and achievement (Steinberg, 
2005). Erikson went as far as stating that the greatest threat to an adolescent achieving resolution 
of the developmental crisis of adolescence is the inability to choose and settle on an occupation 
(Balk, 1995). He believed that the need to find an occupation went beyond a desire for lots of 
money, achievement or approval from society, but rather they would be victims to role confusion 
if they did not settle on an occupation (Balk, 1995).  Blos and Erikson have more posit ive views 
of adolescent development in that they believed that this was a time for self discovery and 
finding a purpose and interest in life which is a natural process, where as Sigmund Freud and 
Anna Freud thought adolescence was a time of turmoil and psychopathology (Balk, 1995). All 
adolescents even those who are living with HIV, face difficulties of a personal nature, such as 
self-awareness, defining their identity, building their peer group, making plans for the future, and 
dealing with their sexuality (WHO, 2009). This is a stage where they are taking the step from 
childhood into adulthood and this is hard in a variety of ways and causes inner conflicts such as 
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stress, confusion, and an identity crisis. As mentioned earlier, adolescents strive for autonomy 
and independence but adopting conventional theories of how adolescents develop is not always 
applicable for HIV positive adolescents as they do not always develop like their HIV negative 
peers and they have many stresses and burdens that affect their development both physically and 
psychologically. 
 
3.3. Identity Formation   
This section will be looking at the issue of identity formation as this process is also quite critical 
during adolescence. Coupled with this is also the challenge of trying to integrate being HIV 
positive into the process of identity formation. Identity formation involves a process of crisis/ 
exploration and commitment to sexual orientation, an ideological stance, and a vocational 
direction which occurs more gradually and unconsciously (Marcia, 1968). Marcia (1966) 
referred to “crisis/exploration as the period when the adolescent actively examines 
developmental opportunities and identity issues. Commitment pertains to the degree that the 
adolescent  is personally involved in, and expresses allegiance to, self-chosen aspirations, goals, 
values, beliefs, and occupation” (as cited in Hosek, Harper & Robinson, 2002 . p. 355). An 
important issue during adolescence is when adolescents are trying to figure out their identity; a 
process of exploration where they try to discover who and what they might be. This process of 
exploration and commitment to an identity and the consolidation of this process is what underlies 
the formation of an identity (Berman, Schwartz, Kurtines & Berman, 2001). Marcia (1968) 
viewed:  
Identity as a self-structure; an internal, self-constructed, dynamic organisation of drives, 
abilities, beliefs, and individual history. He further writes that the better developed this 
structure is the more aware individuals appear to be of their own uniqueness, similarity 
to others and their own strengths and weaknesses in making their way in the world. The 
less developed this structure is the more confused individuals seem about their own 
distinctiveness from others and the more they have to rely on external sources to 
evaluate themselves (p. 159).  
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Erick Erickson (1968) believed that identity issues could be present at any stage of one’s life; 
however, he saw identity formation as the critical developmental task of adolescence. Marcia 
(1968) also writes that:  
Adolescence is a period more crucial for change in structural form; a period of transition 
in approach to cognitive (from concrete to formal operations); in approach to moral 
issues (from law-and-order (duty) reasoning to transcendent human values); in approach 
to psychosocial concerns (from others' expectations and directives to one's own unique 
organisation of one's history, skills, shortcomings, and goals) (p. 160).  
 
This process that characterises adolescence and which makes up the formation of one’s identity 
appears to involve a number of tasks. Adolescents have to relinquish their parents for larger 
psychosocial concerns; and move from others' expectations and directives to their own unique 
organization, based upon their own histories, skills, shortcomings, and goals. For some 
adolescents achieving identity is difficult as it is hard for them to let go of the past which is 
known and delve into the unknown, uncertain future (Marcia, 1968). In other words identity 
formation is a process of self discovery where the adolescent is trying to determine who they are 
and who they want to be, in a process of trying to gain their independence, and this can be a 
difficult and scary as it demands going into the unknown.  
 
Marcia (1968) conceptualised the four identity status theory, intended for characterising an 
individual’s exploration and commitment in the development toward a mature identity. 
Elaborating Erikson’s psychosocial stage of identity achievement vs. identity diffusion, the four 
statuses are: Identity achievement, Moratoriums, Foreclosure, and Identity Diffusion.   This 
allowed for Erikson's theoretical notions about identity to be subjected to empirical study 
(Marcia, 1968).  
Identity achievement describes someone who has experienced a decision-making period 
and are pursuing self-chosen occupation and ideological goals (crisis and commitment 
are present). Moratoriums describe people who are currently struggling with 
occupational and, or ideological issues (they are in an identity crisis with vague 
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commitment). Foreclosures describe people who are committed to occupational and 
ideological positions. But these have been parentally chosen rather than self-chosen 
(they show little or no evidence of crisis and commitment is present). Identity diffusion 
describes young people who have no set occupational or ideological direction, 
regardless of whether or not they may have experienced a decision-making period 
(crisis present or absent and commitment absent) (Marcia, 1968 .p. 161).  
 
These statuses provide us with a variety of identity styles which allow for a broader 
understanding of the process of identity formulation. The statuses also highlight the presence of 
an identity crisis and explore how committed individuals are in the process of consolidating an 
identity. Disability or chronic illness can complicate identity formation and may cause a feeling 
of flawed identity in an adolescent (Chigier, 1992; as cited by Hosek, Harper & Robinson, 2002). 
It is thus important to then look at whether the experience of living with HIV and taking ARVs 
may have an effect on the adolescent’s process of identity formation. Hosek, Harper and 
Robinson (2002) conducted a qualitative study which explored the issues of adolescent 
development, particularly identity development, and how this process may be affected by the 
presence of HIV. They found that all the participants fell into either Diffusion or Achievement 
identity statuses, which in turn impacted their response to having HIV. The two identity statuses 
represented here fall on the opposite ends. This might indicate that for some, the HIV diagnosis 
helped to facilitate and further the identity development process, while for others the opposite 
occurred and the possibility that their life is limited, and fear of setting goals that might not be 
achieved, inhibited exploration of identity issues and promoted the avoidance of commitment 
(Hosek, Harper & Robinson, 2002). There is not much research that has been done of the effects 
of HIV on adolescence identity formation, but these studies, however, have shown that having a 
terminal or chronic illness has some impact on this process and it is vital for this area to be 
adequately researched.  
 
3.4. Defences and coping with a chronic or terminal illness   
An HIV diagnosis can be experienced as a loss and as a trauma, as one has to grapple with the 
reality of having a chronic or terminal illness and possibly premature death. This section will 
highlight some of the literature which looks at how people manage the reality of possible death. 
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Kubler-Ross (1970) writes that death has always been distasteful to man and will always be and 
this is because to the unconscious mind, death is never possible in regard to ourselves. However 
when it comes to a chronic or terminal illness the possibility of death has to be faced, which is a 
very difficult reality to be confronted with and one that often evokes activation of intrapsychic 
defences. “Defences are an unconscious function of the ego in where they falsify, negate or 
distort reality so to avoid anxiety provoking situations, through denial, avoidance or transforming 
ideas and their associated affect” (Lemma, 2003, p. 206). Ridder, Geenen, Kuijer and Van 
Middendorp’s (2008) review also identified consequences of chronic illnesses which is a new 
experience to patients and challenges their habitual coping strategies which forces them to come 
up with new ways of coping with the adjustment. This process of adjustment and coming to 
terms with one's illness can be a 1ong process. Having to face and accept possible death and 
living with a chronic illness can be challenging and Kubler-Ross (1970) put forward the five 
stages of bereavement which she observed in patients who were told they had a terminal illness. 
However this process can also apply to chronic illness also as it is a loss and bereavement of 
one’s old life and having to adjust and come to terms with a new life.   
 
The five stages are Denial and isolation; Anger, Bargaining, Depression and Acceptance. The 
first stage, Denial and Isolation, is the initial reaction to awareness of a chronic or terminal 
illness. This stage is when a person does not acknowledge the weight of their diagnosis and the 
looming possibility of death. This stage of denial is said to be temporary and also a healthy way 
of dealing with the more difficult and painful feelings surrounding their situation, as it acts as a 
buffer to the shock and allows the patient to collect him/herself, and with time mobilise less 
radical defence mechanisms (Kubler-Ross, 1970). The initial experience of finding out one’s 
status can be very overwhelming and denial counteracts this, but with partial acceptance then the 
need for denial is not as strong as it is initially. The second stage is Anger. Once the denial 
cannot be maintained any longer then feelings of anger, rage, envy and resentment towards God 
and or other people emerge, where the person asks him/herself questions like: “Why me”? 
(Kubler-Ross, 1970). This is usually a difficult time for the family as anger is displaced and 
projected into the environment and into them. The third stage is that of Bargaining. This stage is 
an attempt to postpone, it usually has to include a prize for good behaviour, it also sets a self 
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imposed deadline, and it includes an implicit promise that the patient will not ask for more if this 
one postponement is granted (Kubler-Ross, 1970). An example would be making a deal with 
God that if they are good then he grants them back their life. Kubler-Ross (1970) suggests that 
what is happening psychologically while a patient is bargaining and making promises may be 
associated with quiet guilt and it would therefore be helpful for others to acknowledge these 
remarks. This implies that it is important to offer these patients a listening space so they may be 
able to share their unconscious feelings of guilt and fears of punishment. The fourth stage is that 
of Depression. Once the patient can no longer deny their illness, when the numbness, anger and 
rage get replaced with a sense of great loss, then depression sets in (Kubler-Ross, 1970). The 
final and fifth stage is Acceptance. If the patient has had enough time and help in working 
through the previous stages then he or she will not harbour any anger nor depression but rather 
they are almost void of emotion about their fate (Kubler-Ross, 1970). In other words only once 
one has worked through and dealt with their difficult feelings around the tragic news can they 
begin to accept their situation and make meaning of what this means for their future. The time 
taken for the five stages to be processed is unique for each individual: they can follow one after 
the other or coincide (Kubler-Ross, 1970). These five stages show what people generally go 
through once confronted with traumatic news such as finding out their HIV positive status. These 
stages describe the defence mechanisms and coping strategies adopted in order to allow a person 
to process the trauma such as finding out ones HIV positive status. Kubler-Ross (1970) adds that 
the last thing that exists in all five of these stages is hope, in which one feels that all that they are 
experiencing has meaning. Part of this could be benefit finding where one finds positive meaning 
as to why they got the illness and engaging with benefits to their life now that they have been 
diagnosed such as living healthier and finding more meaning in life (Ridder, Geenen, Kuijer & 
Van Middendorp, 2008). Although Kubler-Ross’ stages are helpful with regard to understanding 
the common experiences of individuals diagnosed with terminal illnesses, an HIV diagnosis is 
different, in that death is not imminent.  For individuals diagnosed with HIV, they need to find a 
way to continue living after the stage of Acceptance. This needs to be borne in mind with regard 
to the experiences of the adolescents in this study. 
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Coping with a chronic illness like HIV as highlighted above can be quite a traumatic experience 
and defences are employed to cope with the difficult emotions evoked by such a trauma. Klein 
(as cited by Lemma, 2003) wrote that the ego identifies danger situations which gives rise to 
anxiety and therefore organises defences to protect itself. An HIV diagnosis can be viewed as 
such a danger, as death can be seen as quite real and imminent. The initial stages of finding out 
one’s HIV status can provoke great anxiety and lead one to institute primitive defences to protect 
the ego. Living with HIV can provoke a fear of annihilation which for these individuals is a fear 
of dying. This kind of anxiety is said to be in the paranoid schizoid position, which is 
characterised by persecutory anxieties, where the individual is dominated by extreme fear that 
agencies outside the self want to harm them and this contributes to certain defences mechanisms 
(Klein, 1946). Contracting and living with HIV and the stigma that accompanies it can possibly 
evoke fears and anxieties of persecution. The defences deployed in the paranoid schizoid 
position are mechanisms of splitting internal and external objects, emotions and the ego (Klein, 
1946). Coping with a chronic or terminal diagnosis can lead one to go into a paranoid schizoid 
way of functioning in which primitive defences, such as denial of inner and outer reality, stifling 
of emotions, splitting and projecting are also activated. One of the schizoid mechanisms is 
violent splitting off and destroying of one part of the personality under the pressure of anxiety 
and guilt (Klein, 1946).  Another primitive schizoid defence mechanism that is used is projection 
which helps the ego overcome anxiety by forcefully evacuating danger, badness and unbearable 
feelings (Lemma, 2003). The anxieties of living with HIV can be traumatic enough to lead one to 
regress into the schizoid defence mechanisms, such as those of splitting and projecting as a 
means to cope with the anxiety and difficult emotions. Primitive defences have been discussed 
above; however, it is also important to acknowledge that neurotic defences can also be used as a 
way of coping with a chronic illness. Pedersen and Elklit (1995) found that in their study their 
participants relied more on neurotic defences than primitive defences, particularly in relation to 
anxiety. However they did find that primitive defences were positively associated with avoidance 
in the traumatisation scale. One could thus assume that depending on where one is in trying to 
process their illness will depend on what defences they employ to help them cope with the  more 
difficult emotions and come to terms with their illness.  
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The process of living with a chronic illness is being able to come to terms with the illness; 
moving from a place of fear of death to a place of hope for a longer healthy life. An important 
part of acceptance of one’s status and living a longer healthier life is adhering to ARVs.  Ridder, 
Geenen, Kuijer and Van Middendorp's (2008) review indentified that there are at least five keys 
for adjustment to chronic illness. The first key they identified was successful performance of 
adaptive tasks such as an adjustment to disability, maintained emotional balance and 
preservation of healthy relationships (Ridder, Geenen, Kuijer & Van Middendorp, 2008).  The 
second key identified was the absence of psychological disorders (Ridder, Geenen, Kuijer & Van 
Middendorp, 2008). As discussed earlier this must be carefully assessed for by clinicians as it 
can hinder the process of acceptance and being able to live a healthy balanced life. The third key 
was presence of low negative affect and high positive affect (Ridder, Geenen, Kuijer & Van 
Middendorp, 2008). The forth key is keeping an adequate functional status (Ridder, Geenen, 
Kuijer & Van Middendorp, 2008); with adolescents this would include being able to attend 
school and being able to function well at school. The fifth key was having satisfaction and 
wellbeing in various domains in one’s life. Research shows the importance for clinician to have 
ongoing exploratory discussions with adolescents on their perceptions of the illness, how they 
cope with it and treatment, and how they could improve their adherence (Michaud, Surisa, 
Thomasa, Gnehmb, Cheseauxc & MoCHiV, 2010). There were also various models that were 
proposed for achieving these five key factors to adjustment and coming to terms with living with 
a chronic illness such as HIV. The modals included aspects of cognitive adaption which 
emphasises illness acceptance and perceptions of control over illness; ones personality such as 
optimism verses neuroticism; how one copes with stress and self-regulates such as how one deals 
with adaptive tasks imposed by the illness (Ridder, Geenen, Kuijer & Van Middendorp, 2008). 
These demands and changes have to happen on a cognitive, behavioural and emotional level for 
psychological adjustment, hope for a longer healthy life and coming to terms with living with 
HIV. A study on adolescence found that adequate psychological adjustment and effective coping 
mechanisms was linked with high adherence (Michaud, Surisa, Thomasa, Gnehmb, Cheseauxc & 
MoCHiV, 2010). Coming to terms with living with a chronic illness is a process that can take 
time as one has to adjust to the life changes however it is possible when one can recognise the 
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long term demands needed for adjustment and good adherence. This also indicates the 
importance of insight for adolescents adhering to ARVs and living with HIV. 
 
3.5. Conclusion 
This chapter aimed to provide a theoretical framework for this research. As this study is 
concerned with adolescents it was vital to provide a theoretical understanding of theories focused 
on the developmental stage of adolescence. As highlighted above, adolescence is quite a 
challenging developmental stage. An important part of the developmental process of adolescence 
is the process of identity formation; hence a brief overview of the process of identity formation 
was discussed. This chapter also discussed research that has looked at how HIV affects the 
process of identity formation. HIV seems to affect the process of identity formation in both a 
positive and a negative way. Living with HIV; a chronic illness and accepting and living with 
HIV can be challenging. Due to this, defences and strategies for coping with HIV are employed. 
Thus a theoretical understanding of defence mechanisms and coping mechanisms that are 
employed to cope with living with a chronic or terminal illness were also discussed.  Within this 
scope, the five stages of the grief process (including Denial and isolation; Anger, Bargaining, 
Depression and Acceptance) were discussed and also ways in which one comes to terms with 
living with a chronic illness such as HIV.  
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Chapter 4: Methodology 
 
4.1. Introduction  
The chapter provides a full explanation of the methodology adopted during the research study. 
This includes detailed descriptions of the research design and the participants, the process of data 
collection, data analysis and the ethical considerations made when conducting the study. 
 
4.2. Research Approach 
The proposed research adopted a qualitative design. Qualitative research allows researchers to 
explore, describe and explain people’s experiences, behaviours, interactions and social contexts 
(Fossey, Harvey, McDermott, & Davidson, 2002). The aim of this research was to explore the 
experiences of adolescents living with HIV and going through ART and therefore a qualitative 
approach was necessary as it allowed for interpretation of the participants’ narratives around 
these topics, affording the opportunity to develop and understand the meanings and experiences 
of these individuals (Fossey et al., 2002). Through transcribed in-depth interviews that explored 
what they think and feel about having to take ARV medication, an understanding of the 
adolescents’ perceptions and life experiences began to emerge. Analysis and interpretation of the 
interviews was conducted through the use of Braun and Clarke’s (2006) thematic content 
analysis. This method of analysis allowed the researcher to gain thematic information on how the 
participants experience living with HIV, taking ARVs and adherence, through a process of 
outlining the major and more minor, but important themes that emerged from the transcribed 
interviews.  
 
4.3. Participants 
The participants consisted of 5 adolescents between the ages of 13 and 18 years living with HIV 
and on ART. The participants were recruited from a shelter for HIV positive women and children 
in Johannesburg, and participants were involved in the study on a voluntary basis. The shelter 
was chosen for the study as a number of HIV positive women and children live there, including a 
number of adolescents. However, after an initial meeting held by the researcher with the 
adolescents at the shelter, with the permission of the shelter’s Therapy Director, it became 
33 
 
evident that a lot of the adolescents did not want to talk to the researcher or be part of the study. 
This was particularly evident amongst the females. They seemed to be quite uncomfortable with 
the idea of being involved in the study and this was evident in their disinterest in the study when 
initially introduced to them by the researcher.  Their unwillingness to participate was confirmed 
through feedback from two of the caregivers, including the shelter manager, who are in charge of 
making sure that the children at the shelter are taking their ARVs. This study had a limited 
sample due to practical and time constraints and also due to the challenges experienced while 
recruiting adolescents to take part in the study.  The interviews consisted of 3 male participants 
and 2 female participants. The following table describes the demographic characteristics of the 
participants. It also illustrates when their status was disclosed to them and also the age at which 
they started taking their ARVs. Pseudonyms have been used to protect the participants’ true 
identities. 
 
Participant Sex  Age  Status Disclosed 
to adolescent   
Started ARVs 
Tebogo Male  16 7 years old Around age 6 
Sipho Male  17 5 years old  13 years old  
Tshepo Male 15 13 years old  Last year 
Masego Female  15 11-12 years old 11- 12 years old 
Pule  Female  14 This Year This year 
 
Table 1: Participant Demographic Characteristics  
This was a purposive sample which was chosen due to time constraints. As these participants are 
living in an institutionalised setting this may limit the generalisability of the findings to the 
broader population of HIV positive adolescents within the South African context, however the 
study generated in-depth data on these participants’ experiences. The participants did not live 
with their mothers, as most have lost their mothers (to AIDS and some are from broken homes) 
and as a result are living at a shelter. So consent was obtained from the manager of the shelter 
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who is acting in ‘loco parentis’ for the adolescents. It was also a necessity that the participants 
sign an assent form themselves. 
 
The aim of the research and permission to conduct the research at both the shelter’s homes was 
obtained from the Therapy Director of the shelter. Once permission was attained, a meeting was 
set up to meet the shelter managers and adolescents at the shelters. At this meeting the researcher 
explained the aims of the research and the inclusion criteria of participants. The shelter managers 
at both the shelters homes were met first and the researcher explained the aims of the study and 
invited them to allow the adolescents living in their shelters to participate in the study. The 
researcher explained that she was looking to meet with HIV positive adolescents who are taking 
ARVs. Once permission was obtained from both the shelter managers at the shelters and it was 
ascertained that some of the adolescents living at the shelter are HIV positive and aware of their 
own and each others’ positive statuses, the managers gathered the adolescents together. The 
researcher then met with the adolescents and an open invitation to participate in the study was 
offered to them.  The researcher introduced herself and participants were informed that the 
researcher was conducting a research study on the experiences of HIV positive adolescents on 
ARVs. The adolescents were further informed that taking part in the study would mean they 
would be interviewed about their personal experience, understanding and feelings around being 
on ART and what adhering to treatment was like. They were also informed that the interviews 
would be audio recorded. It was also made clear that their agreeing to be a part of the research 
was voluntary and even if they decided to be a part the research they could pull out at any time. 
This information is further elaborated in the Participant Information Sheet in Appendix B. 
Participants were then informed that they could approach either the researcher or the residence 
manager at the shelters if they were interested in participating. The researcher availed herself at 
the shelter so that the adolescents could approach her directly if they preferred. This also allowed 
them the chance to come to the researcher privately if they had any questions regarding the 
study. The participants who were interested approached their shelter managers, who then 
contacted the researcher with the list. The researcher negotiated a time for the interviews with the 
shelter managers that would suit the participants. Upon the next visit at the shelters the 
researcher obtained the consent forms signed by the shelter managers acting in ‘loco parentis’. 
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The assent forms signed by the participants were also obtained before the interviews 
commenced.  The recruitment of participants commenced only once ethics approval for the study 
had been attained from the University of the Witwatersrand’s Ethics Committee.   
 
It is important to note that due to disinterest from a number of adolescents at the first shelter, the 
researcher had to also get permission to recruit more participants from the other shelter that 
formed part of the same organisation. They were included in the five interviews conducted. It 
was also then decided that the sample was sufficient as this was an exploratory study on these 
adolescents’ experiences, which was evident as themes began to repeat in all the individuals' life 
experiences.  The director put the researcher in contact with the shelter manager at the second 
shelter. The manager informed the adolescents fitting the criteria about the study and two 
participants whom were interested informed their shelter manager. The manager then informed 
the researcher who then set a time to come to the centre. The researcher then went to the second 
shelter to meet with the shelter manager and the potential participants. The research was 
thoroughly explained to the participants and both consent and assent forms were signed. The 
explanation and signing of the forms allowed a good opportunity to build some rapport with the 
participants and answer any questions and concerns they had. The assent forms (both for 
participation and permission to audio-record) were signed before the interviews commenced.  
 
4.4. Data Collection 
After the recruitment process and signing of the assent and consent forms was completed; five 
semi-structured, in-depth interviews were conducted and a voice recorder was used to record the 
interviews. This interview style allowed the researcher to be able to open up the interview in 
order to elicit the aspects of the adolescents’ experiences that were most pertinent to them and 
then to focus the interview more specifically on the adolescents’ experiences and understandings 
of ART adherence instead of getting too broad a story. The focusing of the interview occurred 
through the use of a pre-designed interview schedule.  The questions were constructed focusing 
on particular themes that hoped to elicit the participants personal experience, understanding and 
feelings around being on ART and adhering. The themes that were explored were around the 
participant’s experiences of disclosure of their status by their guardians or parents; experience of 
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disclosure to others; disclosure of why they are taking ARVs; experience of taking ARVs, what 
they think and how they feel about this; and adherence and identity issues related to living with 
HIV. These themes were informed by the literature that was read on this related topic. The 
themes are further illustrated in the interview schedule which can be found in Appendix H. The 
semi-structured interview design was suitable for obtaining in-depth information and it does not 
restrict the interviewer to a prescribed interview schedule, yet gives the interviewer the 
opportunity to ask the same questions to all the participants (Sommer & Sommer, 1997). A semi-
structured interview was appropriate for this study as it allowed for a more focused exploration 
of a specific topic (Fossey et al., 2002). This also allowed the researcher to be aware of non 
verbal cues which was valuable for interpreting the participants’ feelings towards certain 
questions and around the various responses they gave. 
 
The five Individual interviews were conducted privately in offices provided by the shelter 
managers. The interviews were 45 minutes to an hour long and were mostly conducted in 
English, as all the adolescents at the shelter attend English-medium high schools. However there 
were moments within the interviews where questions had to be translated into the participants’ 
various home languages and the adolescents also sometimes responded in their various home 
languages. The researcher was able to translate questions and answers when needed into the 
vernacular language which was known by the researcher. A translator was not needed in this 
research as the participants were for the most part fluent in English and the interviewer could 
speak a few African languages. These interviews were face to face, which provided an excellent 
opportunity to explore the feelings and attitudes that the participants have towards ART and 
adherence, which, as the interviews progressed, the participants felt comfortable enough to 
express. Face to face interviews also allowed the researcher an opportunity to observe other 
valuable factors: such as general appearance, overall health, personality, non-verbal behaviour 
and other individual traits (Sommer & Sommer, 1997). Audi-recording the interviews allowed 
for the researcher to concentrate and pay full attention to the interviews and learn about the 
participants and their life experiences, without having to take detailed notes.  Immediately after 
each individual interview was complete the researcher made detailed notes of her observations 
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during the interviews, such as how participants responded and reacted to the questions asked and 
themes explored.  
 
4.5. Data analysis 
The recorded data between the researcher and participant (adolescent) was transcribed to attain 
the data content. The transcribed data was anonymised to protect the identity of the participants. 
A thematic content analysis was used to analyse the data. The thematic content analysis 
permitted the researcher to indentify, analyse and report patterns (themes) within the data that 
was obtained from the adolescents (Braun & Clarke, 2006). Using this approach helped to 
describe the data in detail and also allowed for exploration of the various aspects of the research 
topic (Braun & Clarke, 2006). It was important for the researcher to be flexible especially when 
analysing the data and establishing what should count as a theme and what should not. The 
researcher was flexible in the sense that she was able to allocate sections of the data to different 
themes when they were better described by a different theme and also in the changing around 
and, or re-naming of themes if they did not quite capture the findings. The aim of this research 
was to provide a rich thematic description of the entire data. The thematic content analysis that 
was conducted outlined the major and minor, but important themes that emerged from the data 
(Braun & Clarke, 2006). Inductive analysis allowed for themes to be identified which were not 
prescribed by the researcher’s theoretical interest but rather determined by the transcribed data. 
This was done through analysing the transcribed interviews and analysing the meaning of each 
quote and working out what the participant was communicating to the researcher. This approach 
allowed for rich descriptions of the data obtained, which are presented in the chapter outlining 
the results of the study. The data analysis method utilised in this study followed Braun and 
Clarke’s (2006) six phases of thematic analysis, which were: becoming familiar with the data, 
generating initial codes, searching for themes, reviewing themes, defining and naming themes, 
and producing the research report. The researcher transcribed most of the interviews and the rest 
of the interviews were transcribed by an independent transcriber. The independent transcriber 
signed a confidentiality clause that she would not disclose any of the information in the 
interviews. Once all the interviews were transcribed the researcher read through the 
transcriptions to generate the initial codes. This was done by using different coloured pens to 
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colour code the various themes which emerged. The initial themes which were generated were 
understanding and awareness of HIV status, process of acceptance, not knowing and the need to 
know how they were infected with HIV, identity issues (being different and belonging), fear of 
what others will think, need to keep secrets, death and life, bad medication, bad hospital, non-
adherence (defaulting), good medication, good hospital, trusted other and defences to manage. 
These categories/ sub-themes were generated through an interpretation of what the participants 
were communicating in each of their quotes. Once this was completed, the researcher grouped 
the various sub-themes under more overarching themes into a Word Document and then re-read 
the interview transcriptions, copying and pasting the various quotes into the respective themes 
generated in the analysis. The overarching themes were understanding, bad medication 
experiences, challenges and facilitators. Some of the quotes in the various sub-themes needed to 
be shuffled around to more appropriate themes. Once this stage was completed some of the 
themes were renamed to better capture the themes elicited by the participants’ shared 
experiences. The overarching themes were edited to the following categories: Relationship to the 
ARVS (consisting of the sub-themes: understandings of the medication; ‘Bad’ meds,‘bad’ 
hospital and defaulting; and Help (good meds and trusted others)); Integration of ARVS into 
their identities (consisting of the sub-themes: experienced identities; not knowing and needing to 
know how they got HIV; secrets and fear of rejection; challenges; life and death;  and defences) 
and the last predominant theme was the Process of acceptance. These themes are further 
elaborated in chapter 5 of this research document. In the discussion found in chapter 6 there were 
some further adaptions made with different groupings and renaming of sub-themes which 
provided a better understanding and structural flow of the information provided by the 
participants on their experiences of living with HIV and adhering to ARVs. The following main 
headings in the discussion complemented the research questions and included: HIV positive 
adolescents’ experiences with ART adherence (consisting of the sub-themes: the importance of 
disclosure; the struggle to develop an identity and choosing to live); The challenges adolescents 
experience in adhering to their ARV medication (consisting of the sub-themes: the 
inconvenience of ARVs; the stigma and fear of ARVs;  depression and loss and ARVs;  and 
ARVs complicating normal adolescent developmental challenges); and the last heading was The 
factors that help adolescents adhere to their antiretroviral (ARV) medication (consisting of the 
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sub-themes: understanding and awareness; support; practical strategies; emotional defence 
mechanisms; and the process of acceptance). 
 
4.6. Ethics 
Ethical considerations are paramount in all research. The participants in this research study were 
a vulnerable group and the research was sensitive to this fact. Therefore a number of steps were 
followed in order to ensure that the rights of participants’ were protected. The first step was to 
obtain permission from the Director of the shelter to conduct the research at their centre, which 
was attained. Ethical clearance for the study was also obtained from the Ethics Committee at the 
University of Witwatersrand (ethics clearance number: H1 10224).  Once the list of participants 
was generated, the managers from both the homes forming part of the shelter, who are the 
guardians at the shelter, were met for the researcher to explain the aims of the study and invite 
them to allow their adolescents to participate in the study.  After thorough explanation of the 
study and what participation would entail was provided for those interested in participating in the 
study, informed consent from the guardians and informed assent from the adolescents was 
obtained.  
 
In order to ensure confidentiality all names have been changed and the name of the shelter has 
been omitted from the final report. All participants were offered full confidentiality at all stages 
of the research project, with the exception of a self-harm clause. Due to the high risks linked to 
non-adherence on ARV medication, it was decided that if during the interview it came to light 
that any adolescent was not adhering to their medication, steps would have to be taken to ensure 
that this was addressed. It was decided that if a participant shares that they are not taking their 
medication that there would have to be a debriefing session where the researcher would discuss 
the concerns that came up and the need to tell a caretaker at the centre or the adolescent’s 
guardian. Before each interview the participants were informed that if they disclose that they are 
currently harming themselves or intend to harm themselves, that the researcher would be obliged 
to break confidentiality in order to access help or assistance for them. However, participants 
were informed that if this situation arose, that this would be discussed with them and then they 
would be given the opportunity to choose the person at the shelter they would like the researcher 
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to tell, so that the adolescent’s safety could be ensured.  When issues arose this was discussed 
with the participants to ensure whether they were getting counselling and free counselling was 
suggested to them where the participants could get further assistance and support. With the 
agreement of the participants, the researcher also spoke to the shelter manager who was aware of 
the adherence problems and who told the researcher about the ways in which they attempt to 
manage these issues and difficulties experienced by the participants.  
 
It was explained to both the adolescents and their guardians that participation in the study is 
voluntary and if at any point they wanted to drop out of the study they would be free to do so 
without any consequences. All the participants’ identifying information was removed from the 
transcripts and the research report and pseudonyms were used.  
 
Participants were informed that the recordings and the transcripts of their interviews would be 
kept securely locked by password on the researcher’s computer for 2 years if the research is 
published in a journal, or kept for 6 years if it is not published, before it can be destroyed. They 
were also informed that if they wished to see the results of the study, that general feedback 
would be given in the form of a letter to the participants. However the participants did not 
request feedback. The participants were also informed that the Director of the shelter would also 
receive a letter summarising the findings of the study.  It was also made clear to all the 
participants and their guardians that the finished report and any articles generated from it would 
be seen by the public. 
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Chapter 5: Research Findings 
 
5.1. Introduction 
A thematic content analysis was conducted in order to discover themes that might provide an 
overview of the adolescents’ experiences. The following chapter will discuss the results of this 
study in relation to three predominant themes which were identified as:  the adolescents’ 
relationship to the ARVs; the integration of ARVs into identity; and the process of acceptance. 
Although these three predominant themes are written about separately in this section, many of 
the subthemes are interrelated and certain subthemes may appear throughout the chapter. This 
chapter will also include the researchers self reflection of doing this study.  
 
5.2. Relationship to the ARVS: 
A large part of the interviews explored the adolescents' feelings towards their medication, how 
they understand the medication and the purpose of the medication. What arose from the 
interviews was a love-hate relationship with their medication which has been discussed under the 
following sub-themes: ‘Bad’ medication, Defaulting, ‘Bad’ hospital and Help (‘good’ meds and 
trusted others).   
 
5.2.1. Understandings of the medication  
Understanding and awareness seems to have played an important role in how the participants 
began to acknowledge their HIV positive statuses. Many described a process in which they 
began trying to make sense of this for themselves. The disclosure of their status was generally 
followed by an awareness of why they need to take their ARVs.  Many of the participants shared 
how they had managed to make sense of this and apply this new understanding and awareness to 
their daily lives. Tebogo explained that finding out about his HIV positive status came with the 
realisation that he will be living with the illness all his life:  
 
I learnt my HIV status and stuff, ah begin to learn about it more, it was in 2002 or 1. 
That’s when I got aware that actually I’m HIV positive, why I’m taking this medication 
right now... First time I thought ah, it was nothing. It was like those other diseases like 
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flu and stuff and stuff but when I learnt more about it, found out that I’m going to live 
with it for the rest of my life. 
 
Tebogo also spoke about how at first he had thought that his ARVs were the same as the sweet 
medication (most likely vitamins) that he had to take when he was younger but then he became 
aware and realised that these tablets were different, and learnt that they were ARVs. He said: 
“Yes, cause I was like, I thought that like, cause over here they use like give us ah, tab, those 
sweet tablets to drink, so I thought that it was the same stuff but in a familiar way, so like... like, 
like in other way, like they not the same colour stuff and taste and stuff”. 
Many of the participants stated that they had felt an array of strong feelings upon finding out 
about their HIV positive status.  Tshepo described feeling shocked and surprised, while Sipho 
describes initially thinking that his sister was joking with him, but becoming really sad when he 
realised that she was telling the truth:  
 
Eh, I wasn’t thinking that is a serious thing... Yes, my sister told me, I take it, as ah, 
they are playing ... I was feeling so sad, because my sister explained to me that what is 
HIV positive ... My sister told me that I’ve got something in my body. The thing that I 
have, I found it in my mother’s breast. Eh before my mother passed away, I found it 
through my mother’s breast.  
 
Pule described a sense of disbelief upon being told about her status by a nurse: “Yes but the other 
time was sleeping there at my bed at hospital, the other sister she’s talking she say do you know 
how is your sickness is for what? I say that I don’t know, I started thinking if she just kept 
quiet... It’s for what, yes I didn’t think about can be HIV positive”.  Thus, disclosure of their 
being HIV positive evoked different reactions, such as surprise, disbelief and even feelings of 
sadness. This was also a process for them of trying to figure out what it means to be HIV positive 
through the understanding of their status. Some of the participants were already on ARVs when 
they were told about their status, but describe not having had an awareness as to why they were 
taking ARVs and what the purpose of these were. Not having an awareness as to why she was 
taking the tablets led to Masego wondering when she could stop taking the medication.  She 
stated: “I was, I was just thinking about when am I going to finish my ARVS, I just thought that I 
can’t, I don’t feel like drinking this anymore than before”. Pule, when asked about what she 
thought the purpose of the ARVs was, explained that initially she had not known this, but had 
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been told: “I didn’t understand it. Yes. See actually they told me if not taking it then you can 
die...” It appeared that for most of these adolescents, their first experiences of taking ARVs 
occurred without a full understanding or acknowledgement as to why they were taking them. 
However it seemed that with time they began to understand and contemplate more about what it 
meant for them to be on ARVs and they also became aware of the issue of adherence or what 
they referred to as ‘defaulting’.  Tebogo explained his understanding of the importance of 
adherence:  
 
You do make a mistake it’s alright, it’s alright but before 4 hours you must have drink 
your medication... They won’t work cause if work after four hours, you got to wait 
cause you got to still drink at night, it won’t go by six- six, it will go by that time... Nah, 
if you miss the 4 hours you have to wait for that night, that evening four hours... Then 
you have missed out, like you didn’t drink anything... Mmm, defaulting... Um, my 
guardians he told me, they, they usually know much about my medications. 
 
Sipho also explained how he was taught the importance of taking the right medication in the 
right order: “Eh. She say that I’m jumping my pills; I’m not taking them in order... If I don’t take 
them in order, they tell me that I must take them in order...They was teaching me step by step so 
that I must understand”. Tebogo also shared how he learnt from another child the importance of 
also eating well so you do not get sick. He said: 
 
Like okay, I use, I use to wonder like, when ever like us we’re sick with like flu and stuff. 
You might be sick, for the, for the next three days, okay come back. But like she was 
always, she was always, she was always healthy. She ate fruits and stuff so I was like 
wondering, ain’t that, ain’t that pos, ain’t that possible okay. It is possible if, you can take 
fruits and if you live in a rich family and stuff if you eat well there’s food and stuff and 
stuff.  
 
Being told about their HIV status, understanding what it means to be HIV positive, 
understanding the reasons they are taking ARVs, and how to keep healthy and the importance of 
this, all appear to be factors that have allowed them to begin to process what it means for their 
lives to be infected with HIV, what it means to be on ARVs and the importance of adherence or 
what the adolescents referred to as ‘not defaulting’.  
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5.2.2. ‘Bad’ meds, ‘bad’ hospital and defaulting 
A number of factors were highlighted by the participants which appeared to play a role in some 
of their negative experiences around taking ARVs and how some of these factors may result in 
them or their friends not adhering to their medication. Tebogo described how frustrating it is for 
him to wake up every day to take his ARVs and also how much he hates the taste of his 
medication:  
 
Sometimes it is annoying because you have to wake up early in the morning, that’s what I 
hate waking up early. I don’t like waking up and if you don’t up early in the morning 
they come and drag you up, wake up, wake up... My meds ah, my medication, yah they 
pretty much ugly when they taste through. When they come pass the tongue when u 
swallow them or get stuck over here (touching throat) argh, on your throat, tasteless and 
stuff...I once told my doctor that this medication are not good cause when I drink them I 
often want, also want to take them out , vomit or something... That’s an everyday thing 
like sometimes when I drink them I ask myself ah, I don’t want to continue my life but, 
yah, yah, yah, so disgusting but I have to drink them in order to live.  So I have no 
choice.  
 
While Tebogo’s dislike of his medication seemed to be linked to the side effect of nausea that he 
experienced, his comment also suggested that his wish to ‘vomit’ the medication out may be 
linked to a wish to not have to take them or perhaps a wish to ‘vomit’ out his HIV.  Sipho also 
shared his bad experience of taking his ARVs such as the negative side effects when he first 
started his ARVs: 
 
Ah, I was getting sick the time I was starting to take them, and I grow up, I grow up. 
They told me this is the pills that you have to drink them until you die... They find that 
the medication that I was taking them first, they are not ok to me. After I sleep, they say, 
we are going to, you are going to here, we are going to find another medication those you 
can take them until you get okay. 
 
In addition to unpleasant side-effects, the inconvenience of the medication was also cited as a 
reason that the medication was ‘bad’.  While Tebogo did not enjoy having to wake up early to 
take his ARVs, Tshepo expressed how angry he gets when he is enjoying doing something and 
he has to go take his medication. He shared that sometimes he gets so angry that he contemplates 
defaulting: 
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It’s like when I get angry, when they say “medication time”, maybe I’m watching 
something interesting, then I got their attention, when they say angry medication, I just 
stop, my mind can go backwards, feel like I can take the time back, then I get angry, 
pissed- off, I feel like I can say “stuff medication... then I just take them, but not happy 
inside, you know in the outside it can show that ah, probably this guy is not happy, damn 
he’s so angry. 
   
Masego shared how tired she gets because it feels like it never stops; that she has to keep on 
taking her medication.  She also felt that this frustration sometimes contributed towards her not 
wanting to take her ARVs:  
 
I went to the sick bay then I was like when are these pills getting finished then their like 
when you are older but since I was young I was drinking them how can they finish when 
I’m older? Then they are like there’s nothing you can do Masego you have to drink them. 
Then I’m like no I’m tired, I’m tired, I’m tired then like, Ah. 
 
Taking medication seemed to be a major challenge and from the extracts above it seemed that the 
taste of the medication made it difficult to get used to the medication. Some of the participants 
experienced severe side effects from their ARV regimes which resulted in hospitalisation and a 
need to change the regime. ARVs were also represented as a burden in the sense that there is a 
specific time in which they have to be taken and sometimes this disturbs sleep and other 
activities, which many of the adolescents found quite frustrating.  Adding to this frustration was 
the knowledge that they have to continue to take their medication for the rest of their lives, which 
is a burden for them.  
 
Along with the challenges of the actual medication there were also some challenges experienced 
in relation to their health care providers. Sipho stated that he does not like going to the hospital 
as he worries people will know he is HIV positive and he finds the process too long. He also 
feels sad when he is found out for not adhering to his ARVs which leads to a lecture of what not 
taking his ARVs could result in:  
 
I feel like, like I can get out of there and go back home... Because I see many people, I 
think that they are gonna know that I got HIV... I go to the hospital; I started to 
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Counsellors, after Counsellors, I go to the Doctor, Doctor check, after Doctor, I’m going 
to the Chemist, after Chemist I’m going home... If I getting there, they take my containers 
they count them, if I don’t drink ok, they told me “why are you not drinking ok, your 
medication?”; after they tell me if you not drinking your medication ok, you going to 
die... I’m getting, feel, I’m feeling so sad. 
 
Tshepo’s following statement seemed to reflect a process that would be overwhelming for 
anyone, let alone an adolescent.  He seemed to become confused by the amount of information 
he is given at the hospital: “there is like it’s cool, but sometimes they can explain too many 
things, they like ‘take this 2 times a day, take this’ they are doing it fast and like some people 
don’t understand them, and they will just do their own things”. He seemed to feel that the sense 
of being overwhelmed also contributed to defaulting on medication.  Masego spoke about hating 
having to miss school for her hospital checkups as she feels due to this she falls behind at school:  
 
Sometimes I just go during the week when I have to go to school then I just get angry 
mmm... I get angry cause I have to write something then I just ask them why today, then 
they like it’s your day. Then like you have to tell my teacher. Then they like okay I’ll tell 
the teachers. Okay cool ... Sometimes it’s boring and it’s quite obviously... I just get 
bored. 
 
The above extracts illustrated some of the negative experiences that the participants have 
experienced at the hospital. A number of issues were highlighted, including: people discovering 
they are HIV positive, which is linked to a fear of rejection; going to the hospital for checkups 
which results in them missing school and concerns around falling behind at school; and that 
going for checkups is a tedious process that is sometimes overwhelming. It also seemed that 
sometimes the information they were given felt too much to take in and was difficult to 
understand. At times, these bad experiences of taking medication seemed to strongly influence 
the participants and their friends, resulting, at times, in defaulting on their medication, as will be 
seen below.   
  
Sipho also spoke about how sometimes the pain of missing his mother gets so much that he does 
not feel like taking his medication, so he defaults: 
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Eh sometimes if I’m not taking them, if I don’t like to take them, I’m making like I’m 
sleeping, and I’m not sleeping, after they wake up me, I, I lied about I’m having a 
headache. They bring them to me, after bring them to me I don’t drink them, I throw 
them away... Coz I was feeling, I was think about my mother all the time, and this thing 
is not getting out of my heart... Another friend that has HIV asked me, “Sipho, why are 
you not going to drink your medication?” I say, I lied, I say I already drink them lot of 
time. 
 
This seemed to suggest that the adolescents’ moods influence adherence to their medication; 
when depressed or preoccupied with worry, the motivation to take their ARVs seemed to 
decrease.  Tshepo expressed how sometimes he just gets so sickened by taking his ARVs that he 
defaults. This statement also expressed his ambivalence around whether to take his ARVs or not 
and how sometimes he chooses not to take them: 
 
I like don’t wanna take them, you feel so disgusted when they say medication...for me, 
sometimes, I feel like, it says just run away or hide them under the bed because they 
won’t, and like, sometimes I want to but I just can’t. I need to take my medication... like I 
was feeling lazy to take them, so lazy because like I came back from a soccer practice, 
soccer practice; and they say, uhmm “come and take your medication nani nan.” I told 
them that uhm, like I’ll come back in 2 minutes, they say ok, then I just went, I didn’t 
come back and I’ll, like, I was sick that my eyes were red, lazy again, I don’t want food 
and stuff. 
 
It seemed that Tshepo being sickened by his medication may have been about his anger and hate 
towards being HIV positive and having to take medication and a wish to escape this, but 
realising that he cannot as there are consequences to this. Masego shared her observation of why 
and how some of her peers go about defaulting.  In this quote she implied that some of her peers 
feel like having HIV is overwhelming and they don’t want to engage with this. They need to 
avoid thinking about it and avoid anything that reminds them of it. This appeared to concern her, 
as for her taking ARVs means choosing life and she was afraid to lose her friends and was  
perhaps afraid of her own anger and resentment at having to take the pills: 
 
Like, it’s like um, they don’t want to take them anymore and some of them they do throw 
their medication and flush them or in the dustbin that’s why... Cause they don’t want to 
drink them, they like some of them they’re tired to drink their medication, that’s why 
they throw them away... I just feel like I, I ask myself why do they throw them cause like 
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it’s their life, they don’t know what’s going to happen tomorrow and I ask them why do 
you throw your medication, she like. No I don’t want to drink them anymore. Then was 
like there is nothing you can do, you have to, you have to. Then she’s like I don’t drink, I 
don’t want them anymore. 
 
All the participants were quite open about how sometimes they do contemplate defaulting and 
though some shared that often they do end up taking their medication despite not wanting to, 
some admitted that, at times, they do not take their ARVs and when asked by their caregivers, 
they lie about it. Some of the participants even shared that they are aware of some of their peers 
at the home who do not adhere to their medication, and how they lie about taking medication, 
and throw their medication away. There did however appear to be consequences to them 
defaulting, which the participants also openly shared. Sipho shared the trouble he gets into when 
his sister discovers that he has been defaulting. He said: “My sister, if I’m not drinking my 
tablets, sometimes she shout at me or beating me”. Tshepo spoke about the health consequence 
of not taking his medication and how this worries him which then leads him to taking his ARVs.  
He described how he feels if he hasn’t taken his ARVs for a while: 
 
I’m like exhausted, tired… like everything, and I’ll just want to sleep, and sleep, and just 
don’t do anything, just sleeping... sometime like it worries me I didn’t take them, I’d say, 
like at the night what if tomorrow I wake up dead or something from this medication, and 
I’m like, like ok pissed… and they when I didn’t take them about for 2 weeks, on maybe, 
Monday then I take them, I get my body back and I get that energy and then, yes ... for 
the first week, things were perfect, the second week things weren’t perfect...like I don’t 
want to eat anything.  
 
As illustrated above, some of the consequences of the participants not adhering included getting 
into trouble from their caregivers when it is discovered that they have been defaulting. The other 
consequences are those of a physical nature, such as their heath declining and major concerns of 
dying due to not taking their ARVs.  
 
5.2.3. Help (good meds and trusted others) 
Understanding what their ARVs are for and how they can help seemed to be very significant to 
these adolescents’ meaning making processes.  This awareness seemed to enable them to 
overcome the challenges they face with taking ARVs and in adhering to their ARVs. The 
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participants also noticed and identified the positive changes in their health since starting to take 
their ARVs, which seemed to facilitate the process of acceptance and adherence to their 
medication. It also seemed that having a good relationship with their doctors and a positive 
experience at the hospital also encouraged them to adhere to their ARVs. Tebogo expressed how 
important taking ARVs is for him as they keep him healthy, alive and away from hospital, and 
that they allow him to focus on attaining his goals: 
 
Okay, ah, taking medication, taking my meds is a big role in my life, cause without that 
medicine I’d me like okay, suffering and stuff in the hospitals, yah fighting for my life... 
What I understand is that they help you, they help you reach your goals, reach anywhere 
you want to be, because without life there is nothing. If you, instead, okay let me make an 
example: If they said okay, there is no more life in this world, there would be nothing, but 
my plans in the future is like is about curing AIDS and stuff  so that’s why I’m 
benefitting from doing and working hard and providing what I want in the future and 
doing stuff. 
 
Tebogo’s statement seemed to reflect a fantasy of being able to cure HIV and it seemed that the 
medication is linked in his mind to a sense of hope for the future. Sipho also felt that ARVs keep 
him alive and that they are his only hope for life: “I feel ok because they are saving my life... Ah 
medication… I take it as my life... Without it ah… nothing else is going for me, to going to make 
me alive, without medication”. Masego also expressed how ARVs have increased her life span 
so she can spend more time with her family and friends. She said: “Because I just want to live 
longer with my family and other people, that I actually know, even here, like that even when I 
am angry, but I do talk to them and sit with them”. Thus the meaning attributed to their ARVs 
was that it gives them a life, a future to be with their family and the opportunity to reach their 
goals. This hope for a future seemed to motivate them to take their ARVs. Tshepo shared how 
when he bumped into his old friend who is also HIV positive he realised how ARVs had helped 
him, which motivated him to take his ARVs and grow like his friend had: 
 
There’s a boy I used to go with, what’s his name, is it N? We went there I think in 1999. 
He was born  January, I was born July, and then he was like HIV, we were like so short 
then, we just grow up together and now he is fat and I’m like, “wow you have grown”, 
then he’ll tell me ‘you are taller; you are even taller than me’. Then I get motivated, like 
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he’s like medication can help, ne bra? And I’m like, yes it can, just taking them and 
growing day by day. 
 
Masego also shared how her ARVs have helped her to gain weight, have more energy and 
improved her health: “I just feel like... I just feel like I now, I’m now; I’m now picking up weight 
and all the stuff. I’m just feeling okay about them... They are building my body and like even 
when I’m sick I’m just drinking them. Then I just get some more energy than before then I just 
get better”.  Pule expressed how now, due to her ARVs, she is healthier and does not miss school 
as she did before: “For me what is easy, because it helps me every time. Yes I was thin, 
they...I’m getting better now. Yes... Because I’m I can go now to school I’m not sick”. The 
above quotes illustrated how the participants see their medication improving their health, their 
physical appearance and how people can notice the change in them. Their health improving and 
them not getting as sick as they used to seemed to mean that other areas of their lives also 
improved, such as not being sick all the time and not being absent from school as much. 
 
Having a good relationship with their doctor also seemed to be a contributing factor to a positive 
experience with taking ARVs. Tebogo described how he feels close to his doctor and that he is 
able to be open with his doctor, which facilitated a good working alliance and him adhering to 
his ARVs: 
  
Yah she is always telling me I must feel free to ask anything. That’s why, that’s why I’m 
always closer to her and stuff. I ask her things, okay, can you do this for me can you do 
this for me okay, she also asks can you meet me where, where, where and bring our files 
and stuff. Yes I’ll bring them... She often like asks me something, okay, I’ll do it and I’ll 
ask her and she’ll do it, like that. 
 
Tebogo seemed to be expressing how important it is to have someone trustworthy like his doctor, 
with whom he can be open and who is genuinely interested in his well being, which seemed to 
really motivate him to do what he says he will do. Tebogo also spoke about enjoying going to the 
hospital, as there is a support group with his peers that share and understand his experience, to 
whom he can talk and have fun with: “I found out there a group of children, a group of my age 
group talking about this; always having fun, nice things, always having fun, eating, having fun, 
drinking stuff. Mmm, doing activities, doing soccer”. Pule also expressed how she is encouraged 
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by going to the hospital as she is able to be with other children who are going through the same 
experience that she is. She also relayed having a positive relationship with her doctor that 
encourages her: “It’s like everyone is taking it just like me. Yes... It makes me feel better 
because I saw lots of people taking, fetch their ARVs. That’s why it make me better...It’s good 
because she’s always telling me that I’m going to be fine, yes. I must take my tablets all the 
time”. This quote reflected a sense that the doctor plays an important reassuring role. It seemed 
that having a doctor whom she trusts to tell her that she was going to be alright, allowed her to 
believe this could be true and then her anxiety could decrease. Thus, for these adolescents, a 
positive experience at the hospital seemed to facilitate a more positive experience around taking 
their ARVs. It also seemed that a good quality relationship with their doctor also helped because 
they were able to communicate with their doctors around their challenges and the doctor was 
able to advise and encourage them. There was also a sense that at the hospital they were able to 
meet their peers who are also taking ARVs and they seemed to experience a sense of comfort 
and hope in being able to relate to others in a similar position. 
 
Trusted others  
There were various ways in which the participants managed taking their medication, both at a 
personal level and also at a relational level. What came through strongly was the need for people 
whom they can trust and rely on to help to remind them to take their medication, who make sure 
that they have taken their medication and also protect them from getting infections as their 
immune systems are sensitive. Sipho described how pleased he is to have someone to care for 
him and makes sure he adheres to his ARVs: 
 
Ok, I’m getting happy because I got, I get, there’s a sister that is take care of me. She 
check every day that I am drinking my tablets... Sis B take care of me, take care of me 
every day, to drink my tablets every day... Eh they called, they call me before 6, they call 
me that “Sipho you did not take your medication. Go and drink your medication”... They 
sit with us; they see that we are drinking our medication right or wrong. If you are 
drinking wrong, they teach you that, no you are drinking wrong your medication, you 
have to drink your medication, like this, like this, like this. 
 
Tshepo expressed how he trusts the adults who help him take his ARVs: “Obviously they are 
adults, I trust them and they... Sis B gives us medication every day, and Mam’ Z makes sure, 
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makes sure that I get that medicine”. Masego also expressed how safe she feels, as the sisters at 
the home take care of and make sure she takes her ARVs properly and does not get sick: 
 
I’m okay with them. They’re kind and they’re responsible for me and others... Because 
they help me and they protect me from some diseases... Like, if like, isn’t it in sickbay 
there’s people who are sick, some of them they stay in the other room and so if I come 
and take my medication, I just go in the sitting room and drink there then I come out 
again. They don’t want that I must get infection from others... They waking, they are 
waking me every day at 6 o’clock. 
 
The above extracts illustrated how for most of the participants it is important for them to have 
someone whom they trust to remind them to take their medication, who makes sure that they take 
their medication, and who protects them from harm, such as keeping them from getting 
infections. The participants expressed how these trusted others are also able to explain and 
advise them on how to take their medication. Having these helpful and supportive caregivers 
seemed to make it easier for the participants to manage taking their ARVs, which helped to give 
them a good experience of taking their ARVs.  
  
As the participants live in a home with other adolescents who, like them, are also taking ARVs 
they tend to help each other. Pule spoke about how she goes with Masego and another child to go 
get their medication.  Tebogo shared how in his room there are others who take ARVs so they 
wake each other up in the morning, which helps: 
 
Okay, we like, like, we boys in our room and stuff, some of them, okay, okay, some the 
children medication, down there, neh, we like, we know each other, okay, we drink 
medication, the same medication and stuff, so when he wakes up, he also wakes others, 
we wake each other up, when we late, if I wake up early, I wake each other, each and 
everyone up who takes medication, then we all go and drink. 
 
It seemed evident that they help each other and that when it is time to drink their medication they 
are able to remind each other and go and get their medication together. This supportive 
environment seemed to help as then they do not feel so alone.  Feeling alone was a common 
experience for them, however, this will be discussed later in this chapter.  
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Most of the participants seemed to get a lot of support and assistance with taking their ARVs, 
however, they were also able to employ different ways in which to take responsibility themselves 
and manage taking medication on their own. Masego shared using her phone alarm to remind her 
when there is no one around to remind her. Tshepo spoke about how he pays attention to the time 
when he is at home so that he does not miss his medication time: “Like when I’m at home, I just 
look at the watch, at 6 I drink the medication, then I carry on with what I was doing, because like 
if I skip, night one, ah maybe I will default, then that’s a big problem... because of my status, and 
my... like uhm, like, HIV, I need to make sure that I don’t get AIDS”. Paying attention to the 
time or even using their phones to set their medication times illustrated them taking control and 
being responsible for their ARVs when their trusted others were not there.  
 
5.3. Integration of ARVS into their identities: 
The next predominant theme that the analysis highlighted was that of integrating ARVs into their 
identities which included the following sub-themes: Experienced identities; Not knowing and 
needing to know how they got HIV; Secrets and fear of rejection; Challenges; Life and death, 
and Defences. This section looks at how the participants adjusted their self concepts, particularly 
in relation to their HIV status and taking ARVs. Issues of being different from their HIV 
negative peers and fear of rejection were highlighted and thus they live a life full of secrets. This 
section also looks at the challenges they face and strong sub-themes emerged with regard to HIV 
and ARVs being associated with life or death, and the various defences the adolescents 
employed to manage these challenges.  
 
5.3.1. Experienced identities 
Another important area that was influenced by the participants learning about their HIV status 
and understanding why they have to take ARVs is how they perceive themselves, particularly in 
relation to their peers and also how their peers see them, both those peers who are HIV positive 
and those who are HIV negative. Tebogo shared his concern and anxieties around being the only 
one at camp taking ARVs and his relief when he discovered more children like him who were 
taking ARVs: “Last year, it was pretty much hard because I thought I might be the only one in 
that group who did drink medication, but others came out”.  Tebogo explained how at school he 
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had thought he was the only one who was HIV positive and expressed his delight to find out that 
he was not and wanting him and this girl to stick together as he felt a sense of belonging as they 
had a shared experience: 
 
But when I saw her coming with it, I was like, was like, I thought I was the only one and 
I was like, I went to her nicely, I asked, I didn’t like, I didn’t like jump to that topic are 
you HIV positive and stuff cause obviously she was gonna freak out and go tell her 
parents and stuff. So I just pulled her to the side okay I said okay, like those pills are the 
same as I, are the same as my medication, she’s like how, I took them out, she says how, 
you also on the treatment that I have. That’s when I started the topic, okay maybe we 
both HIV positive mmm, I’m also HIV positive, okay, let’s stick together, cause we the 
only two in the class, let’s keep this a secret okay, sharp. 
 
Sipho expressed how sometimes he does not feel like he is the same as his HIV negative peers, 
as he is not as healthy or physically fit as them which saddens him: “Sometimes I feel them, I’m 
one of them, those who are not taking the medication, sometimes I’m thinking, I’m thinking that 
this thing I’m thinking of ah, it’s wrong... eh if I’m playing with them I’m getting tired faster. If 
I’m not playing, I get flu, just like not, it’s hot or not, I get flu just like that... It feel bad”. Tshepo 
on the other hand felt that besides being HIV positive, he is not different to his HIV negative 
peers: “Other teenagers, my life and their life it’s the same, the difference is just that I have HIV 
but no one can see, they can hear it, not see it”. In the following extract Masego communicated 
her ambivalence around how she views herself in relation to her peers, as sometimes she does 
view herself as different from her HIV negative peers and sometimes she feels like they are no 
different: “I’m just ah fine like it’s not um rough for me cause some the teenagers they don’t 
have it and it’s only me and X that have yah ... Sometimes I do feel like different and sometimes 
I do feel like... me”. Pule expressed how painful it is to be sick, missing school and having to 
take medication when the other children do not have to: 
 
What’s hard; is you see your friends she doesn’t take them... only you take them and then 
your heart gets sore. Yes... Um, when I see my friends are not drinking and just sit there, 
me always I always, I getting... It has been sooo sore, yes. Because when you see your 
friends they don’t take tablets, yes... And I’m not going to school the other ones go to 
school, me I’m always sick. 
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In the extracts above it was suggested that for most of the participants there was a strong sense 
that they are different from their HIV negative peers and how emotionally difficult this can be 
for them. It seemed that there is a fear that they are the only ones taking ARVs; they feel they are 
not as fit as their HIV negative peers, and it is difficult to have to be the only ones having to take 
medication. Most of them explained feeling that their HIV negative peers do not have the same 
concerns that they have, like their health and having to worry about their ARVs. The issue of 
stigma and shame around having HIV also emerged strongly. Tshepo expressed that there was 
not much of a difference besides the fact that his peers are HIV negative. He seems to be able to 
identify more with his HIV negative peers and feels that there are more similarities than 
differences. Masego also did not seem to find it very difficult being different, though she 
mentioned that sometimes she does feel that she is different.  
 
On the more positive side another theme that emerged was a feeling of belonging with other 
adolescents who are HIV positive which is further highlighted below. Tebogo explained how at 
school he had thought he was the only one who was HIV positive and was delighted to find out 
that one of the girls in is class was also HIV positive. He expressed having wanted them to stick 
together as he felt a sense of belonging with her due to their shared experience: 
 
But when I saw her coming with it, I was like, was like, I thought I was the only one and 
I was like, I went to her nicely, I asked, I didn’t like, I didn’t like jump to that topic are 
you HIV positive and stuff cause obviously she was gonna freak out and go tell her 
parents and stuff. So I just pulled her to the side okay I said okay, like those pills are the 
same as I, are the same as my medication, she’s like how, I took them out, she says how, 
you also on the treatment that I have. That’s when I started the topic, okay maybe we 
both HIV positive mmm, I’m also HIV positive, okay, let’s stick together, cause we the 
only two in the class, let’s keep this a secret okay, sharp. 
 
Tshepo expressed how at the shelter where they live there are other children like him who are 
taking ARVs, so he does not feel like he is alone but rather feels a sense of belonging which 
helps: “Ah I feel like, ok, it’s not, uhm I’m not alone. I’m with someone who has the same thing 
that I drink, that we have and Ja... Ja it helps”.  
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The above extracts illustrated how some of the participants felt lonely at times like they are alone 
with their worries and struggles, the only ones with HIV, and therefore they felt comforted 
having others who they feel are like them. They seemed to have a feeling of ‘sameness’ with 
other adolescents who are HIV positive and on ARVs.  This experience of a shared identity 
seemed important to maintain as it helps them feel less different and instead makes them feel a 
sense of belonging and that they are not alone.  
 
5.3.2. Not knowing and needing to know how they got HIV 
Knowing their HIV positive status seemed to have motivated the participants to educate 
themselves around the illness.  Their wealth of knowledge of how one is infected with HIV was 
substantial and seemed to have resulted in them questioning how they were infected and seeking 
answers. The participants that did not know how they were infected seemed to have a strong 
preoccupation with finding out how they were infected. Some of the participants seemed really 
invested in gaining this information, as not knowing appeared to be difficult for them. Along 
with the need to know how they got HIV, the issue of who is to blame for their being HIV 
positive was also evident.  
Tebogo explained how frustrating it is for him not to get the answers he wants and his 
investment in knowing how he was infected is evident in his statement below: 
 
Ah I don’t know where, maybe I was born with the HIV disease and stuff, cause I don’t 
quite remember and stuff. Okay, I take it easy cause I been asking, asking, asking, from 
doctors from everyone who knows about me. And their busy telling me, I don’t know, he 
doesn’t know, go ask who, go ask the doctor, go ask someone. They don’t know. I just 
keep it cool okay... Mmm, sometimes I feel okay, if they don’t answer me I just feel like 
okay, why do I have it, Why (whispers). If no one knows why do I have it. How did they 
know that I have HIV positive, if I’m HIV positive I mean. How did they know. If they 
don’t know how, why did I have this. How did I have this I mean.  
 
While Tebogo’s comment reflected a strong wish to know how he was infected, it also suggested 
scepticism with regards to those who are telling him that they do not know how he was infected.  
His whispering also suggested a sense that he suspects that something may be being hidden from 
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him.  Tshepo shared how surprising and confusing it is for him and his family that he tested HIV 
positive as he was born HIV negative: 
 
And my granny, obviously, they told her, and she was surprised... like she knew that my 
mother and father didn’t have HIV, she was so confused about that...I think from when I 
was born...Yes they didn’t have it, and like my granny was so confused about that, I don’t 
know why, and even I was so confused why. When I ask my dad, he’s like we never had 
HIV, your mother was healthy, even me too I was healthy. Then I say ok, I’ll pass 
through this...  
 
Tshepo seemed to be expressing his need to know how he got HIV and it seemed that not 
knowing was difficult for him as he was confused about how he can be HIV positive when his 
parents are not. A part of him might feel that something was being concealed and that he may 
never know, so he has to find a way of moving on without the truth he wants. Pule also shared 
what a shock it was to find out that she is HIV positive as she had no idea how she got it and 
neither does her mother who hurts about this but tries not to show Pule her hurt so as to protect 
her: 
 
Cause but me I don’t know, I was born healthy, yes just I was sick, sick, sick. It’s the 
only thing that is getting my heart sore because I don’t know where this thing comes 
from... Mmm that was scary...  Because I didn’t know where this HIV come from. Yes. 
That’s the thing make me scared... And ah, at hospital their asking me. I’m not sleeping 
with the boys. I don’t have boyfriend even now... I’m not feeling well because I don’t 
know who’s this thing, where this thing comes from... Because the next thing it makes 
me shocked. I was born healthy now I was sick, sick for a long time. Yes so now it’s this, 
I’m taking my tablets... Mmm even my mother she wasn’t know it. You can see that she’s 
feeling pain but she doesn’t want to show me... Um, because... I’m also going to feel the 
pain.  
 
From the extracts above it could be seen that there is a need to know how they were infected. It 
was also evident that many of the adolescents had gone about inquiring from their families and 
health care providers but many of them felt that they had not received satisfactory responses. 
This seemed to have resulted in feelings of frustration, feelings of shock and confusion and also 
deep sadness.  The participants conveyed a sense that if they knew where the HIV in their bodies 
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had come from then they would better be able to deal with it.  The not knowing seemed to leave 
them stuck and struggling to fully process their HIV positive status.  
 
Tebogo explained how important it is for him to know as he would know whether it was 
something he did or that someone did to him and also how to protect himself:  
 
If I got HIV from sex I’ll always tell myself why did I, why did I have to do that and 
stuff. If I knew why did I have to do that, if I didn’t, okay, okay for example if I didn’t 
know that okay there is a disease called HIV positive, I could have made a mistake, okay 
that was my mistake, oops. It was my mistake, I did a mistake, I know I’m the one and 
stuff yah, I’ll just, I’ll just take the blame usually. But if I knew that it was something, 
needles and stuff, I’ll blame other people for not taking care of me, for the needles and 
stuff. You are not supposed to put needle near me and stuff, like needles and stuff. Yes... 
Yes. If I knew that I did it, okay, I’ll put the blame on me but if it was like needles like I 
said, yah I’ll put the blame on them... I’ll be aware, like when I found something, okay 
this is dangerous, like this is dangerous okay, go put it away, throw it away, do something 
with it... Yah, I’ll be, I’ll be prepared for anything. Like when this happens I’ll take 
action, okay this happens I’ll take action, when you alone, I’ll try stand up for you and 
stuff. Right now I’m trying to figure out for myself, if I, if I find a solution from where I 
get, okay, I’ll try understand and try to control it a little bit, when I’m okay I’ll start doing 
whatever I do. 
 
Tebogo’s statement above reflected a sense of wanting to feel more in control of his life, his 
status and his body.  His comments seemed to be in reaction to a helplessness that he feels with 
regards to how he became infected.  This can be seen through the slight irrationality in his 
statement, that if it was through his own ‘mistake’ that would be fine, but that if it was someone 
not taking care of him ‘properly’ then he would have someone to blame, and that if it was 
through ‘dangerous needles’, he could then know what to do and ‘take action’, he could ‘put 
them away’, however, none of this knowing, blaming or taking action would change his status.  
Thus, in his case ‘knowing how he became infected’ seemed to represent having greater control 
over his illness and his life.  Pule expressed how important it is for her to know so she can 
understand what happened to her:  
 
I want to know cause I don’t know which this thing come from and they saying my sister 
she was sick they say it’s then but I was staying with her. At this time I was not sick, I 
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was started sick that time... Yes, so I don’t know I didn’t find someone who’ll explain to 
me, yes. Also my mother she think that it’s my sister but she don’t know properly. 
 
There were lots of questions and a strong preoccupation and as illustrated above there seemed to 
be a sense that the not knowing makes them stuck and due to this they may struggle to fully 
accept their status, as there is this big piece of the puzzle missing which is “How did I get this”. 
The other thing that emerged strongly in the above extracts was a sense of who is to blame, who 
did this to me and how did they do it?  The wish to externalise the blame suggested a sense that 
the HIV is linked to a feeling of being persecuted and a struggle to integrate their HIV positive 
status into their identities. 
 
5.3.3. Secrets and fear of rejection 
Fear of what others will think 
There seemed to be a strong fear amongst most of the participants that their HIV negative friends 
and peers would abandon or ridicule them if they knew that they were HIV positive. While some 
of them seemed to imply that their friends would continue to accept them and be okay with it 
they still chose not to disclose their status to their friends. Tebogo shared how some people 
rejected him once they knew he is HIV positive. He also expressed his uncertainty around 
whether his friends would accept his status, but he tended to lean more towards a feeling that he 
would be rejected: 
 
Some other people can say okay, he is HIV positive ah, he is not my child and I don’t 
give anything okay, I’ll actually even dealt with it... Um, okay my friends are people that 
support each other and stuff, I think they are going to be okay, to accept it. Like ah, 
everyone is normal and stuff. They were going to accept it but things would change a 
little bit cause they would get familiar and stuff, that guy is so, so, so, and I have to get so 
so so, not me and him and stuff and stuff. They will think otherwise and stuff, so I would 
rather keep it to myself.  
 
Sipho described his fear to take his ARVs in front of his HIV negative peers as he fears that they 
will make fun of him: “ I’m scared to take the medication, eh, if my friends that doesn’t have 
HIV, I’m scared. Yes, because I don’t trust my friend... I was going to leave them... Because they 
gonna make me like I am a joke or something else”. He also expressed that he is comfortable 
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with those that do know his status but that they must keep it a secret: “I feel ok because I told 
them that they must not tell anyone that I have this thing”. Tshepo shared how he prefers that his 
friends do not know his status as then they cannot use it against him: “Ah for me ah, if they 
didn’t know it’s ok because, like, when I’m, one day I can fight with one of them, they will say 
everything, you know then I will feel like I can kill them”. Pule explained how if her friends 
knew she was taking ARVs they would not want to be her friend anymore so it is best not to tell 
them:  
  
Because they’re talking can’t be her friend, what, what, but actually one person knows, 
my friend is know R, even her brother take ARVs the small one she know it and her 
mother. Yes I tell her once and she understand but the other friends they don’t know. 
Yes... They will not play with me or they’ll laugh at me. Yes ...Yes, but only R she know 
it for my friends, but the other ones don’t know. 
 
Being HIV positive seemed to be something that is difficult for the participants to share with 
their peers. There seemed to be some ambivalence around whether to share their status with their 
peers, due to a difficulty trusting them with their status. This also seemed to be a difficult thing 
for the participants to discuss.  This could be seen in Tebogo’s tendency to contradict himself, 
the vagueness with which he speaks and the more pronounced dysfluency in his speech when 
discussing what it actually means to disclose his status to his friends. The topic seemed to evoke 
a lot of anxiety related to their fears around what their peers would do if they knew their status.  
This lack of trust is what seemed to influence their decisions not to disclose their HIV status. It 
seemed that they would like to trust their friends with their status but the risk seems too great, so 
instead they choose not to disclose to their friends. It appeared that living with this secret was felt 
to be safer for them than trusting and being rejected.   
  
Tebogo shared how difficult it is to trust his teachers with his status as he fears that they may use 
that information to humiliate him: 
 
Mmm, No, unlike, okay teachers that’s a big thing, teachers, teachers they might laugh at 
you make jokes with you okay, tell you you’re my favourite kid in the class and stuff but 
when it turns to that stuff, he doesn’t even care, he’ll even embarrass you in front of the 
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class, don’t talk you something, something, something taking medication and stuff, and 
worsely I can’t shut up, I can’t ... Yes, I don’t trust anyone, especially teachers.   
 
The above extracts indicated how some of the participants worry that if people knew or that 
those who already know their status may use it against them. This fear of rejection does not only 
include their peers and friends but there is also a sense that at school they have difficulty even 
trusting their teachers with their status. Trust seems to be difficult for them and this results in a 
need to protect themselves, as will be highlighted below. 
 
Secrets 
As indicated above most of the participants seemed to fear disclosing their status and being 
rejected and so secrets and telling lies seemed to be a way of keeping this part of their lives very 
private as a preventative measure against rejection, particularly from their friends and families. 
Pule shared how her status is kept from some of her siblings: “My mother yes and my family 
they don’t know that I know it, it’s my sister that one that she is staying at Soweto. My mother 
told her, my brother. The other one my sister and brothers they didn’t tell them”. This extract 
captured how even within the nuclear family, her HIV status is kept from other members of the 
family. Secrets seemed to be an everyday part of their lives, as it is difficult to trust what 
someone will do with that information.  This fear seemed to be linked to an awareness that HIV 
is associated with a stigma. Tebogo explained how some people have noticed him taking his 
ARVs but when they ask him he makes up a story to throw them off: 
 
Mmm, a few people know but some of them are asking why are you taking tablets, I just 
like ignore them or just tell them lies like I take tablets for mentally something and stuff, 
so that to keep them away from me... Um, I just feel comfortable cause they the ones who 
know not other people know like my friends and stuff, but I take it that easy cause they 
the only people who know and ah, that’s what I want, like not many people to know that I 
am HIV positive.  
 
Tebogo seemed to be highlighting here that he does not want too many people knowing about his 
status. It seemed that he would rather his friends and people think that there is something 
mentally wrong with him than for them to know the truth of his HIV status. Tshepo said that he 
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sometimes feels that he can ask his friends to wake him up, but that he will not reveal why or 
what he is doing:  
 
Like my friends would tell me it’s 6 o’ clock, and I’ll ask him in the morning, please 
wake me up at 6...  I just go outside and drink water. When I came back I slept; then he’ll 
ask “what’s going on with you?” I’m like no I just wanted to drink water at 6, I’m just 
lying to them... and I’ll like when you ask me, ‘no, you are asking the wrong guy, me I 
don’t take that, no ARV’, but inside my heart I know I take them... sometimes I feel like 
to tell them but, I just save it and just keep it in my heart and in my mind. 
 
The above extracts illustrated how some of their HIV negative peers have noticed or are aware of 
them taking their ARVs and how they have to come up with alternative explanations as to why 
they are taking medication. The issue of trust seems to be a strong factor and it seemed to create 
a push-pull internal tension, as to whether they should share their status with their friends. 
Tebogo shared how he noticed someone at school with the ARV bottle, whereas he prefers using 
the medication box which conceals the medication he is taking: 
 
Like this other, like girl when I was still attending at [name of school]... Like she use to 
take medication like each and every like meal time, 3 times a day. So in the morning at 
break time and after school, so every time I use to see like every time when he is about to 
take medication I use to see the paper, the same as mine the paper is the same one that I 
have. So I’m taking, I’m taking the same, so I’m taking ah the containers for not noticing 
okay these okay these are medications for ARVs. People are not like charging me and 
stuff, or I know that thing you took it from where, where, where, I just like know. But 
when their like, I don’t like coming with the paper and stuff, the whole packet, yah. I just 
like come with the tablets in the container. 
 
Tshepo expressed how he asked his friend who found out his status to keep this a secret from the 
other children: “Please don’t tell anyone, I want to keep this as a secret, and then he said yes, and 
he never told anyone”. He also expressed how his grandmother sometimes reveals in front of his 
friends that he is on medication, which is humiliating for him and how he makes up an 
alternative reason for taking medication:  
 
What I find difficult is that like my granny, what she does it’s, like when I go for a visit, 
she will, like, call me and like “it’s time for medication” in front of my friends, and they, 
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they will like “why are you taking medication?’, and I’ll be like “no it’s just for TB, it’s 
just TB and fever and they will understand, but I know inside that she did embarrass me. 
 
Being able to trust their family and friends about their status and why they take their medication 
seemed to also be very important to the participants, particularly as they have a strong fear of 
rejection. There also seemed to be a sense of shame and embarrassment around being HIV 
positive and taking ARVs. There were various ways in which the participants go about 
concealing their reason for taking ARVs: one way is coming up with alternative reasons as to 
why they take medication and the other way is to not carry their ARV prescriptions in their 
prescription bottles but rather keep them in a neutral pill container so that they can continue to 
keep their status private.  
 
5.3.4. Challenges 
The participants were also faced with other daily challenges, some of which were developmental 
and life challenges common to all adolescents, however, these challenges seemed to make it 
more difficult in relation to being HIV positive and taking ARVs.  The challenges that they were 
experiencing included: negative peer pressure, unstable family backgrounds and for some, 
mourning the loss of their mothers. Tebogo described his experience with negative peer pressure 
and his concern that he might give in to the pressure, and he felt that this would be bad: 
 
When like okay we go party with friends and stuff, party and stuff. I see them drinking 
and stuff, to make them, okay not, okay, fear okay, they might, they might, overcome 
you, say okay, drink, drink, everyone’s drinking you’re the one who’s not drinking, okay 
they tell, they tell you, they tell you. Never listen to that, okay, okay, I do it, I’m gonna 
drink, I’m gonna drink, I’m gonna drink next minute I’m not there, I’m not okay, okay 
when I don’t know the place, I must stay with them until, if they sleep over then I stay till 
next morning. When they get up okay we go all of us. If I know the place I hurry up and 
go cause end up in people like that, ay, it’s not a good thing. They might tell you okay 
drink, drink, sometimes I like, okay, I’ll tell myself it’s only a taste, it’s only a taste. 
Once you taste one more that’s why last time I, last time I didn’t want to even know, I 
didn’t want to even go to the party. I just went there and chilled... Yah but I’ve once 
tasted it, but ah, I’ve heard that is nice but yoh, I might end up like ruining my future. 
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While pressure to drink is a fairly common teenage experience, for adolescents with HIV, who 
have been counselled as to the health risks of drinking and smoking, this pressure seemed to feel 
more threatening. Tshepo also shared his experiences of negative peer pressure and what he does 
to avoid it such as focusing on his school work and sports: 
 
Like to be a teenager, you see too much pressure from your friends, like smoking, they 
will be like, “have you smoked before?” And you’ll be like “no”, then they’ll want you to 
do it. Me, I choose good friends because they used to call them nerds, they will be like 
quiet in class but talkative in the books... then like ok, let me choose good friends, when 
they are outside and we are just chilling, they will talk about school work, not girls, not 
smoking, not gambling, they were just talking about books. Then I started learning from 
them that gambling, smoking is not good. I never smoked before and I never drinked 
alcohol before ... even when I’m not playing with the kids, if I just get a soccer ball, I 
would say ‘everything behind me let me focus on this ball’, then I play soccer.    
 
These above extracts illustrated the challenges around peer pressure and once again issues 
around identity and trying to figure out for themselves where they belong and making choices 
with regard to what is right for them and what is not. There was a sense that to avoid being 
influenced by negative peer pressure, they have to avoid situations that would result them falling 
victim to negative peer pressure. Another idea that emerged from the above extract was that one 
should associate with friends that will not exert negative peer pressure.  Focussing on hobbies 
that keep one out of trouble was also regarded as a way of managing peer pressure. Learning to 
manage peer pressure seemed important to all the participants, most likely due to their worries 
around their health. 
 
Even normal teenage things like ‘sleeping in’ were represented as being dangerous. Tebogo 
expressed the challenge of missing his medication time in the morning as he sometimes battles to 
wake up and he over sleeps: 
 
Mmm, okay, yes, in the morning, cause sometimes my phone don’t wake me up, 
sometimes it’s flat, it’s off and stuff so I have to figure a way to wake up, I usually wake 
up early then the time, okay 3am in the morning and stuff but when I am, when I try to 
get hold of it, stay awake, I just fall asleep and wake up at 8 o’clock and stuff. But the 
doctor says it’s okay waking up late but you have to drink them before 4 hours, okay, so 
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I’m telling them ah, you can drink them anytime, but I must, I must get them in time. Not 
always I must make a mistake and oh, I’m late I must get them in 4 hours and stuff; I just 
get up at 7 o’clock or something. 
 
Tebogo also explained the stress of going to camp due to the fact that theft occurs there.  He 
worried that his pill box might be stolen, resulting in him defaulting: “Cause some pep, some 
other boys on camp they turn out crazy and stuff and steal your stuff and end up stealing your 
medication and stuff, and then you cannot drink and have to wait till you go back home, you’ll 
be defaulting and stuff, yes”.  
 
The fear of rejection due to being HIV positive was experienced alongside other fears around 
competence.  Sipho was moved around a lot after the death of his mother at age five and he 
discussed falling behind academically and how he was made fun of by his peers: “Even now I 
can’t write, I can talk English but I can’t write it... Is make me upset because others, my friends 
at school they laugh me every day if I’m doing the wrong thing”.  
 
Pule expressed her constant worry around her health, as before she was prescribed ARVs she 
was sick a lot, which resulted in her also falling behind at school, something with which she is 
still currently battling: “It was been hard a little bit, sometimes I getting worried, sometimes I 
getting well so um, now I have been taking my tablets, yes...Yes, and the school now I’m lating 
[missing school]. I didn’t get school well cause I was sick, sick... It makes me feel painful 
because I see the other ones getting the high [marks], my friends”.  
 
These extracts captured the daily challenges the participants face due to being HIV positive and 
the processes related to taking ARVs. There were issues around waking up too late to take your 
medication, as there are set times in which they have to take their medication. There was also the 
issue of their health fluctuating and also having to go for checkups which results in absenteeism 
at school and them possibly falling behind. For some this results in a fragile sense of self as they 
do not feel they fit in amongst their HIV negative peers. There was also the issue of their 
treatment regimen being changed just as they are getting used to it and this lack of stability 
seemed to be quite frustrating. While adolescence is normally associated with growing 
66 
 
independence, the need for medication and having to rely on others to make decisions around 
their medication was also frustrating for the participants.  Tshepo described the difficulty of 
getting used to his medication and then the frustration he feels when it gets changed without any 
suitable explanation as to why: 
 
When I’m getting used to it, they change it, then they put another one, and I don’t 
understand what’s going on... 3 times....they say, as reason then I was still healthy by that 
time, even now I’m still healthy, they said they will change them, and I asked my 
Counsellor, “Why are you changing them, the tablets?” and they say these tablets are for 
kids. They said it last year when I was 14... then they changed them this year January and 
again at July...  
 
Sipho talked about losing his mother at the age of 5 and how even today he still wonders about 
her and still experiences a deep pain from her loss and around the effect that this has had on his 
siblings and on him: 
 
Eh... about 5 years, I was busy upset and thinking about my mother, I was don’t know my 
mother, I ask my sister: “my sister, where is my mother?” she take me, he go with me to 
the room, he explained to me that our mother, she passed away the time I was 5 years 
old... I cried, cried. My brother comes, my brother comes, and he asks me ‘what are you 
crying for?’ I’m crying, my sister told her...him: he’s cry crying for mother, he want he’s 
mother back... so if I tell them that my brother, get so... so destructed about that I want 
my mother, and he start, he started to steal, to go to the jails and come back, go to jails 
and come back. Now, just now he’s in jail for nothing... I was 15, I cried until I bleed. 
 
Masego also shared her feelings of shock and anger after losing her mother: 
  
Like um, my mother was sick and she was having TB and the she went to hospital to see 
them um and after that, I went to go visit her and they told me that not for longer then I 
just stayed there then when I came back um, when I came here, when I came here then 
my other doctor then she showed me the video of my mother then she told me that it’s too 
late now my mother, my mother died. Then I was like how come it happened then she 
like I don’t know, I’m not always there she’s working in the other hospital... It was um 
sad but I was not controlling my temper, cause I usually have a short temper even when I 
am angry I do. 
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The issue of mourning and loss was illustrated above and it seemed that in addition to their 
worries around their health and their ARVs, many of the participants had also experienced loss 
of a parent due to HIV.  They appeared to be struggling with the bereavement process and for 
Sipho; the loss of his mother seemed to be so painful that it resulted in him sometimes defaulting 
with his medication. There also seemed to be a lot of anger around losing their mothers and 
struggling to manage this. These participants were living in a home and this suggested that most 
of them have had really difficult childhoods resulting in them staying at the home and therefore, 
there seemed to be a lot of emotional turmoil that they were trying to deal with in their lives.  
This turmoil seemed to be linked to their moods and as mentioned previously, their moods 
seemed to influence their levels of adherence.   
 
5.3.5. Life and death 
Living with HIV and understanding why they are taking ARVs and the importance of ARVs 
seemed also to be strongly linked to the sub-theme of life and death. It seemed that they are 
confronted with this issue of life and death every day of their lives as they take their medication. 
They seemed to have to ask themselves everyday to choose to live or to choose death, because 
that is what the choice of taking their ARVs means to them. Tebogo expressed his sadness 
related to his internal debate of choosing to take his medication and to live or not to: “I always 
feel, okay sometimes I feel sad, I ask myself should I live, should I don’t, should I, should I, 
okay I just come to a point where I stop. I drink my tablets in order to live, that’s it”. Sipho 
described his understanding that if he does not take his ARVs it means death: “They say, this 
thing, this medications, I have to drink them until I die. If I leave them, I am going to die... Eh, 
ARVs they said, if I leave them I’m going to die or I’m going to be thin. I say ok, they teach me 
about ARVs”. Pule shared how life was easier before she found out she was HIV positive as she 
did not have to constantly worry about death, as this is very scary for her: “Because when you 
take your tablets like that time you didn’t take it, it was better because you don’t think I’m going 
to die or something, yes... It feels scary too much scary. I’m asking myself... Why this thing 
about that, but my doctor did tell me I have to take my tablets all the time”. Death seems to be 
something with which they are preoccupied, as it has been linked to their meaning of ARVs. 
Taking their ARVs means life and not taking them means death.  Even when they contemplate 
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not taking their medication, the thought of life or death seemed to influence their decision to take 
their ARVs.  
 
Tebogo expressed that some of his peers want to or have given into death and have lost hope: 
 
Most of the teenagers could tell themselves ah, I’m done with life why should I drink 
medication, I won’t reach 20 years, I won’t see 20 years in the future, I won’t see this 
HIV in the future. If they hope in their selves, and believe in their selves they might reach 
there... Some teens they don’t tell themselves, okay I can make it. They always tell 
themselves negatively, no I won’t, I won’t reach there, that’s why many teenagers who 
are HIV positive kill themselves or do something, or smoke or do drugs, or drink, cause 
yah, cause they tell themselves I ain’t gonna reach there and if I don’t and nothing will 
stop me and stuff, ah, I will rather do this and that in order to not reach there. 
 
This theme of death was also linked to a sense of hopelessness and as the above extract 
illustrated, being HIV positive has led to some adolescents losing hope and giving up on their 
lives as they do not feel that they will live long. Therefore some give up but it seems that some 
choose life and for them that means taking their ARVs.  
 
5.3.6. Defences 
The defence mechanisms that help the participants to manage living with HIV and taking 
medication every day of their lives were quite clear during the interview. When asked certain 
questions, they were either quite vague or sometimes were inconsistent about their experiences 
particularly with how they feel about their status, having to take ARVs and around the issue of 
defaulting. Tebogo described his coping mechanism when dealing with the horrible taste of his 
ARVs.  He does this by telling himself his ARVs are sweets: 
 
No, I was a little bit surprised at first but as I carried on with the medication cause it was 
a little bit sweet and stuff I took it just like sugar, sweet and candy and stuff cause it had, 
it had that, that, sweetness inside it so I just every, every morning and night when they 
say medication I just remember sweets... 
 
This seems to help him to take his medication even though he finds the taste and the idea of his 
ARVs almost intolerable. Tebogo also shared a particular interaction pattern that he has with his 
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guardian where there is an avoidance of dealing with the seriousness of taking his ARVs: “Yah I 
feel safe because he is the only one who knows and stuff, he not gonna do like, okay, you gonna 
die by HIV and stuff. Okay we all make jokes, yah we all make jokes but you must drink your 
medication. I tell him why? It’s obvious you already know why you asking and we laugh and 
laugh and you drink”. This extract seemed to suggest some avoidance of talking about the more 
serious implications of not taking ARVs, but rather an engaging with the frustrations and worry 
in a more playful way, perhaps indicative of a degree of manic defence.   
 
In the following extract some splitting was highlighted, as minutes before Sipho expressed that 
sometimes he does not adhere to his medication, however, when I asked again, he contradicted 
himself and said he does not default. He said: “Eh I take it eh, everyday... everyday”. When 
asked how often he is found to be defaulting by his doctor he responded: “Aah, I don’t know”.  
This suggested some defensiveness around acknowledging his defaulting. These responses 
illustrated a splitting between the times when he is taking his medication as he should be and the 
times when he is not taking his medication as he should. He was aware that he should not be 
defaulting, and this knowledge appeared to make it difficult for him to engage with the topic of 
defaulting for too long.  This ‘not knowing’ seemed to help him manage.  Thus he separates in 
his mind the good him who takes his medication and the bad him that does not adhere.  
 
 Tshepo shared his denial when he was first told about his status: “I didn’t believe it”. This 
shows how finding out that he was HIV positive was such a shock that he initially went into a 
state of denial as a way of managing the difficulty of finding out his status. Masego illustrated 
her confusion in how she felt about taking ARVs: “They told me that the medicine was for HIV, 
I don’t know. I was HIV and then my mother was having TB, I don’t know. Okay fine I am 
proud of it cause I feel like I am going to be alive. I am proud of it”. This also seemed to indicate 
some denial of hers and her mother’s status when her status was first disclosed to her and a 
difficulty with it and how she even takes a more positive view of her status as a way of 
deflecting from the difficult feelings of what it really means for her to be HIV positive and take 
ARVs every day. Denial seems to a defence that was and is strongly adopted as a way of dealing 
with the difficulty of being HIV positive.  
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Sipho’s extracts are indicative of how when it came to talking about him not adhering it was 
difficult for him to engage with it for long therefore he splits off or avoids it and this was 
indicated by some inconsistencies with his responses to the questions. Tshepo’s extracts show 
how difficult it was for him to find out about his status and when he was asked how he felt he 
describes being in disbelief and possibly indicating an initial process of denial which allowed 
him to manage how difficult it was to accept his status. There was also a process of denial with 
Masego as she seemed to be very vague, unsure and inconsistent about how she felt about 
finding out her status and why she was taking ARVs. Being HIV positive and taking ARVs 
brings a lot of challenges and difficulties and as a way to cope or manage the participants seem 
to be spitting at times, avoidant, vague, inconsistent or denying their thoughts and feelings about 
their status.   
 
5.4. Process of acceptance: 
This sub-theme examined how the participants go about trying to make sense of being HIV 
positive and having to take ARVs every day for the rest of their lives. It particularly captured 
their process of accepting their HIV status and having to take ARVs. Tebogo described his 
experience of not knowing how he got HIV and how he goes about trying to find a way to move 
on without knowing:  
 
I get angry but not that angry, I’ll just say okay it’s my fault, I’ll tell that I’ll deal with it, 
cause it’s me no need, okay, when okay, who’s HIV positive, me not them, so whether I 
beat them or hurt them, what try to kill them or when I’m angry it won’t help nothing, I 
won’t gain anything it will just put the blame on me and that’s it... I usually like, yes, I 
usually like write down like how can you get HIV po...HIV disease. Like I count them 
then I like, I then I memorise what I can remember when I was a little kid. I memorise 
everything what I can remember... Mmm, right now I haven’t come up with anything 
cause I’ve been telling myself, okay, I HIV, okay I was born with it, that’s it cause I can’t 
find any solution so just say okay I was born with it now I will live the rest of my life 
with it. 
 
There are powerful emotions being illustrated in Tebogo’s quote around his struggle with 
processing and coming to terms with his status. While he was expressing his anger about not 
getting full disclosure from people around him, underlying that there was also a sense that he is 
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feeling deep sadness, helplessness and desperation, all of which are involved in him coming to 
terms with his HIV positive status. 
 
 Tshepo expressed his feeling of anger and confusion about his status and how watching the local 
series for children helped him to think about and begin to work on accepting his status: 
“Confused, angry, then shout, I wanted to say, say “stuff HIV!” ...and like I used to watch too 
much TV, then I will watch Soul Buddyz, then they’ll be talking about HIV, then I think about 
me, they say ‘you can live with it but don’t tell anyone’...that’s what I got from there, and then I 
just put it here in my heart, then I just say Ok, let me just accept it. Then I just go, pass through 
it, then I got used to ARVs”.  
 
The above extracts illustrated the process of accepting their HIV status and how initially there 
was anger and blame and a need to know how they got it. The issue of ‘how did I get HIV?’ was 
mentioned earlier and in this section the process that the adolescents move through is evident.  
Not knowing and trying to move forward without the answers seems very difficult. There is a 
process of reasoning and a need to let go of the focus on the how, and rather focus more on the 
present, which is that they will have to live with it for the rest of their lives.  There also appeared 
to be a process of accepting that it is not a death sentence and that they can live with HIV, 
particularly through taking their ARVs.  
 
Tebogo shared how he was able to accept taking ARVs by equating them to medication he had 
been taking before the ARVs.  Through thinking of the ARVs as he thought about the other 
tablets, he seemed better able to make the transition to ARVs:  
 
Ah, I was, I was, I wasn’t that surprised cause I was use to taking meds, I wasn’t that 
surprised I was like okay, I will carry on like each and every day  ... So I just prepare 
myself I say, okay If I want to live I should just drink them... So like I’m trying to go to 
school, I know I have a talent in this and that but I’m not quite sure if it might help me in 
the future. I want to be a scientist, that’s what I want to be, nothing will stop me being a 
scientist. 
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Tebogo’s quote above illustrates the importance of hope in the process of acceptance. Sipho 
described his process as taking time to accept his status and make a choice to start taking ARVs.  
He felt that one of the reasons that he was motivated to take his medication is so that he can take 
care of his sister.  This role and responsibility appeared to be important to him: 
 
Oh the time I was starting taking ARVs, eh, they test me and they ask me if I’m ready I 
must come to the hospital and tell them that I’m ready. I sit, eh, maybe 3 weeks; next, 
after 4 weeks I go to tell them that I’m ready now to take my ARVs. They give, they 
started me, they give a card and some medication, and I bring them in N.H... Ah like, if 
I’m take those pills, I’m taking not for me alone, for me and my sister to support my 
sister... Eh, because my sister loves me very much, to me, to me, he like, she’s like my 
mother or father. 
 
Tshepo described how sometimes he gets angry and does not want to take his medication but 
how at these times he is able to focus on the benefits, which motivates him to accept that he 
needs the medication and adhere to his treatment regime: “Nna, I’m used to it. I would say is 
very true to keep healthy, like uhm, to be active... Sometimes I feel angry, like I don’t wanna 
take it, I just wanna go away, but I think twice. If I run away... my medication, who’s going to 
help me, and who’s going to make sure that I stay healthy”.  This statement also highlighted the 
role of supportive others in managing being HIV positive and adhering to treatment.  Tshepo 
suggested that he chooses to stay so that he has people around to help and support him. 
 
Tshepo also described that with time he has been able to get used to and accept taking ARVs and 
that through this process he has managed to feel that he is no different to the children that do not 
take ARVs: “Ah for me, it perfect because I used to take them when I was 12, 13, 14; now I’m 
getting used to them, and like, ah let me see, I’m the same like the other teenager who doesn’t 
have HIV, who doesn’t take medication... I’m used to it now, I know this time it’s medication 
time, then I have to go and take medication”. Masego expressed the importance of not being 
ashamed as this is her reality which allows her to accept her status: “Some of my friends they do 
know, those that stay here they ask me yah, they ask me ‘are you proud of that?’ then I’m like 
‘yah I’m proud of it, there’s nothing I can do’”. Tebogo described the importance of being 
hopeful that there will be a cure and this helps him to accept the reality of having to take his 
ARVs until there is a cure: 
73 
 
 
I always, I always think okay, things will work out. I always think positively that things 
will work out, there will be one day okay a cure for AIDS, there’ll be one day, as long as 
I’m taking, but when I give up my hope is gone as well, like when people hope okay, like 
okay, let me do like this, okay, out of 100%, 75 % people hope that okay there is gonna 
be a cure for AIDS and others are making, like they trying to figure out that, um, 15% or 
25% is busy like figuring, like, okay, I don’t know how we gonna do the cure for AIDS 
and stuff... if we  believe it might be there but if we don’t believe if might kill, might kill 
other people. So I just put my belief in that, that there is gonna be a cure and I must keep 
on pushing. 
 
These extracts illustrated a process of meaning making.  It appeared to be a highly personal 
process, in which each participant had to make peace with their status and figure out on their 
own ways to manage the difficulties and challenges associated with being HIV positive and 
taking treatment.  The process seemed to involve taking into consideration all they have been 
told and their understandings of the purpose of them taking their ARVs. It seemed from the 
above extracts that this process involves constantly making a choice to take the ARVs.  Hope for 
the future, a feeling of belonging and purpose and a certain drive to reach certain goals seemed to 
motivate them to accept the importance of taking ARVs.  Struggling through the anger and 
helplessness also seemed to be important as it allowed for an acceptance that they cannot change 
how things are and that it seemed better to accept their reality. It also seemed that with time the 
participants have been able to work through the more difficult feelings and have developed 
coping mechanisms. Some of these included occasional avoidance and humour. Another 
important aspect of accepting the current situation was having hope and holding onto it. Holding 
onto hope that there will be a cure seemed to help the participants to accept, to some degree, their 
current reality of having to take ARVs every day. It also seemed that with time they are able to 
get used to the lifestyle of taking ARVs and some were even able to shift from a space of feeling 
alone and at risk of rejection, to being able to identify with their HIV negative counterparts.  
 
5.5. Self-Reflexive clinical impressions 
The following section is a first-person written account of the researcher’s experiences conducting 
the study in order to explore her own assumptions and influences on the study. Reflexivity is an 
accepted tool that is used in qualitative research process (See end of Ortlipp, 2008); in which 
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researchers are encouraged to reflect on their presumptions, choices experiences and actions 
during the research process (Mruck &Breuer as cited in Ortlipp, 2008) . It is thus for researchers 
to be cognisant of their emotions, assumptions, values and also how the participants may view 
him or her during the research process and this shall be reflected upon. The researcher was 
inspired to do this research study due to the work she used to do with HIV positive adolescents in 
Botswana. The experience gave her some insight into some of the challenges that adolescents 
experience and in particular to the challenges in ART adherence. This motivated her to do this 
research in order to really understand the adolescents’ experiences. The researcher’s experiences 
in conducting this research was both emotionally challenging yet enriching in understanding the 
adolescents' experience of ARV adherence. The research met her assumptions that adherence to 
ART is quite a challenge to a point that non-adherence is common for both the participants in 
this study and some of their peers.  
 
Upon the first visit to the shelter to meet the adolescents, most of them were still on their way 
back to the shelter from school so the researcher had to wait. The adolescents came in one by one 
and the researcher had to start and stop introducing herself and the research study. The researcher 
was able to do an introduction and after that only Sipho came up to her to say he wanted to do 
the study. The researcher felt quite discouraged as she was unable to reach more of the 
adolescents. Upon coming back to the home the researcher found out that none of the females at 
the one shelter wanted to be part of the study and with further inquiry from the guardians at the 
home, the researcher was informed that they possibly did not want to be part of the study as they 
tend to default (not adhering) and possibly did not want to be open about this. I felt such 
disappointment as I felt that they were the right people to talk to, as one of the main aims was to 
understand why the adolescents are defaulting.  However, it appeared that acknowledging the 
defaulting is difficult in this particular population.  
 
The researcher started the first interview with Tebogo who was quite open which allowed the 
interview to flow. However the researcher felt that at times Tebogo was not being authentic as 
though he was trying to present a positive picture and avoid his difficult emotions. He was 
guarded regarding talking about the more difficult feelings which were characterised by 
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avoidance of answering certain questions as he was vague and dysfluent in his responses. The 
second participant was Sipho, who had approached the researcher on her first visit to the shelter 
and informed her he was very interested in taking part in the research study and sharing his story. 
As much as Sipho was very interested in taking part in the study it was very clear during the 
interview that remembering and talking about his past and his experience of living with HIV was 
quite difficult for him. Sipho was very emotional during and after the interview. It was quite a 
difficult interview, as the researcher felt guilty about unearthing these difficult emotions; 
however, it seemed that he experiences these emotions regularly and that he needed that space to 
share his story instead of being quiet about it. The researcher also found that during certain 
points in the interview Sipho was open about not adhering while at times he would say the 
opposite to that effect. This indicated some push pull relationship with adhering and not adhering 
and how at times it seemed difficult to acknowledge non-adherence as he is aware that it is not 
good to default. Pula also had quite a difficult time talking about her experiences, particularly as 
she recently found out that she has HIV, unlike the other participants who have known their 
status for some years now. She worries about being rejected by her peers who are HIV negative 
and also because she does not know how she was infected. Pule was quite open during the 
interview but it was clear that out of all the participants in the study, her pain was still raw and 
she had not started her process of acceptance. The researcher felt a strong sense of wanting to be 
able to give Pule the answers as to how she got infected. It was clear that she was really 
struggling with the not knowing and it made me feel helpless. Tshepo seemed quite indifferent 
during the interview; he was very direct and tended to give short answers. The interview felt 
quite short and it seemed like Tshepo did not really want to take part or talk to the researcher 
about his experiences. This made the researcher feel anxious. However when the researcher went 
through the transcript she realised that the interview was rich with information and that Tshepo 
had in fact been able to tell his story. Masego was quite avoidant of her emotions as she 
struggled to express her affect and would say that everything is fine, but struggled to express 
what “fine” was to her. She, however, was quite open in talking about her experiences.  
 
Hearing the participants’ life experiences of living with HIV and having to take ARVs was 
emotionally difficult for the researcher, particularly when the participants themselves were 
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emotional. Hearing their stories brought feelings of sadness that these adolescents have to deal 
with all the difficult life challenges that they face. The thought that their childhood is not as free 
or carefree as their HIV negative peers was particularly sad.  It seemed a heavy responsibility for 
these teenagers to have to make “life-death” decisions every day, which seem to be such a 
burden physically, emotionally and socially.  
 
5.6. Conclusion 
In this chapter the results of the study were presented.  The predominant themes were: the 
adolescents’ relationship to the ARVs; the integration of ARVs into identity; and the process of 
acceptance. The participants’ quotes were used in the explanation of the themes in order to 
provide insight into the adolescents’ experiences of living with HIV and having to take ARVs 
everyday of their lives. This chapter also included an understanding of the challenges that the 
adolescents grapple with in their lives, and how they try to cope, manage and overcome these 
challenges. It also illustrated the different factors that help them to manage living with HIV and 
adhering to their medication.  Within this chapter the researcher also provided a self reflexive 
review which provided an authentic observation of the adolescents experiences and how the 
researcher experienced the interview, also her understanding  and insight on a bigger scale of 
how the adolescents experience living with HIV and adhering to ARVs. 
 
 
 
 
 
 
 
 
77 
 
Chapter 6: Discussion  
 
6.1. Introduction 
The aim of this study was to examine and gain an in-depth and unique understanding of these 
South African adolescents’ experiences of living with HIV and having to adhere to ARVs. This 
chapter focuses on discussing the results of this study in relation to other research studies on this 
topic and those related to this topic; along with the theoretical implications of these results. The 
discussion consists of three sections, which are as follows: HIV positive adolescents’ 
experiences with ART adherence, the factors that help adolescents adhere to their antiretroviral 
(ARV) medication and the challenges that they experience in adhering to their ARV medication.  
 
6.2. HIV positive adolescents’ experiences with ART adherence 
The adolescents’ experiences with ART adherence is captured by the sub-themes: the importance 
of disclosure; the struggle to develop an identity; and choosing to live. This section highlights, 
from the perspective of the adolescents themselves, the importance of disclosing to a child or 
adolescent their status, especially with regard to helping them to renegotiate their identity. 
Adherence to ARVs as being an aspect of their identities that needed to be managed emerged as 
a predominant theme and included the negotiation of peer relationships.  A link between taking 
ARVs and being alive that was found in the interviews is also explored.   
 
6.2.1. The importance of disclosure 
This study found that the adolescents’ understanding of their medication included their processes 
of becoming aware of their HIV status. A strong link emerged between their understandings of 
their medications and how they were told about their status and the reasons and importance of 
their ARVs. Several studies have found that disclosure to a child or adolescent with a chronic 
illness, such as HIV, is important in improving their lives (American Academy of Paediatrics, 
1999; Kubler-Ross, 1970 & Vaz et al., 2010). This study supported these findings as disclosure 
seemed to be a turning point for the participants.  Disclosure appeared to create an expansion of 
awareness, the beginning of them acknowledging their HIV status and also an awareness of why 
they need to take their ARVs. Disclosure began a process for the participants of trying to make 
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sense of what this meant to them. This meaning making then seemed to allow for a new 
awareness and understanding, which they applied to their lives.  
 
The initial experience of disclosure brought about an array of negative emotions for the 
adolescents in this study, such as disbelief, shock and sadness. This supported the findings of a 
study undertaken by Vaz et al. (2010) which indicated that the disclosure of an HIV positive 
status to a child initially evoked feelings of sadness, relief, worry and being heartbroken. Some 
of the reasons for these emotions were specifically due to the stigmatising nature of HIV (Vas et 
al., 2010). For the participants in this study, the initial experience of finding out about their 
status, the need for taking ARVs and the importance of adhering to their ARVs also initially 
seemed to be quite overwhelming and emotionally difficult.  
 
Some of the participants described difficult experiences with their ARVs prior to disclosure.  
One of the participants described not knowing why she was continuously taking medication 
without stopping, and only through her HIV positive status being explained to her did she gain 
an understanding of the need for her to take medication continuously. Another participant also 
expressed not knowing why she was taking the medication, but instead only knowing if she did 
not, she was going to die. Thus, it appeared that not knowing was frustrating and possibly riddled 
with a fear of death for these adolescents. This highlighted the importance of disclosure, as not 
disclosing to the child or adolescent can have negative consequences.  This finding supported the 
findings of the American Academy of Paediatrics (1999), who also found that a child can 
develop inappropriate negative fantasies about their illness. The adolescents expressed how 
being disclosed to and also gaining knowledge helped them to acknowledge the importance of 
taking their ARVs correctly. This has allowed them to begin processing what it means for their 
lives to be HIV positive, what it means to be on ARVs and the importance of adherence.  Given 
time to process the implications of their status seemed to be more beneficial to the adolescents’ 
understandings and overall awareness, which is what Vaz et al. (2010) also found in their study. 
However, it is interesting to note that in this study  none of the participants knew the term 
‘adherence’  but rather referred to ‘defaulting’, referring to skipping medication or not taking the 
medication as instructed by their health care provider. 
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Disclosure seemed to be a significant issue amongst the participants and represented in their 
minds knowing their status, knowing why they were taking ARVs and also understanding the 
importance of this. This was most clearly evident in the sub-theme ‘not knowing and needing to 
know how they got HIV’. This theme really highlighted the importance of full disclosure and 
allowing the adolescent space to ask their questions about their status, as this seemed to be an 
essential part of their process of understanding and trying to come to terms with their HIV 
positive status. Other studies conducted with HIV positive adolescents have shown that delayed 
disclosure is a psychosocial problem experienced by these adolescents (Amberbir et al., 2008; 
Ferrand et al., 2009; Farley et al., 2006).  An issue that appeared with these participants was that 
of knowing how they got infected, as those who were not told how they had contracted HIV 
seemed quite preoccupied and invested with finding out this information. This was evidenced in 
how motivated the participants appeared to be with regards to seeking out information to educate 
themselves about the illness and how one can be infected. Their enquiries of how they were 
infected, however, appeared to be met with evasiveness from their parents or caregivers, which 
appeared to trouble certain of the participants. Some of the feelings that were evoked were anger, 
frustration, confusion, sadness, helplessness and possibly mistrust from the non-disclosure of 
how they were infected.  Vaz et al. (2010) found a similar process occurring in their study where 
non-direct responses from parents about the child’s status had an emotional effect on children, 
such as sadness and worry. The current study also found that the issue around how they were 
infected appeared to be an attempt to find who is to blame for him or her being infected. There 
seemed to be a sense of guilt for being HIV positive and the adolescents seemed to be trying to 
figure out if the guilt is theirs to keep. The participants conveyed a sense that if they knew where 
the HIV in their bodies had come from, that they would better be able to deal with it. For one of 
the participants, knowing how he became infected seemed to represent having greater control 
over his illness and his life. Vaz et al. (2010) also found that most children and adolescents 
wanted to know the source of their infection, confirmation of the diagnosis, about getting better 
or cured, and about AIDS being fatal. However, despite this wish to know, their study found that 
most of the participants did not ask their parents or caregivers for this information (Vaz et al., 
2010). The not knowing seemed to leave many adolescents stuck and struggling to fully process 
their HIV positive status. Knowing more about the illness seemed to bring positive effects to 
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living with the HIV. The more they know about their status and the purpose of treatment then the 
better adherence, self-management behaviours and adjustment. Vaz et al. (2010) study also 
showed that disclosure helps with improved adherence and can give a sense of peace and relief 
from finally learning what was causing their illness and their suffering so that they could now 
take care of themselves.  Adolescents who knew their status tended to have a higher self esteem 
and better coping skills as compared to those who are unaware of their status (American 
Academy of Paediatrics, 1999). This was confirmed in this study, which found that disclosure 
appeared to be important with regards to providing adolescents with a space where they can 
really open up, ask the questions they need to be ask and for these to be appropriately answered, 
so that they can continue their journey of making sense of this for themselves.  
 
6.2.2. The struggle to develop an identity 
Knowing their status and understanding why they were taking their medication also influenced 
the identities of the adolescents in this study, as was found in the sub-theme of ‘experienced 
identity’. Blos and Erikson (as cited in Balk, 1995) believe that adolescence is a time for self 
discovery and finding a purpose and interest in life which is a natural process. This sub-theme 
captured these adolescents’ processes of self discovery, and in particular, how they perceived 
themselves as HIV positive adolescents, particularly in relation to their peers, both those who are 
HIV positive and those who are HIV negative. Some of the participants expressed their concern 
and anxieties around being the only ones with HIV and having to worry about taking ARVs 
when their peers do not. There was a sense that they feel lonely, as though they are the only ones 
with HIV and taking ARVs. Being with their peers who also are HIV positive and taking ARVs 
seemed to alleviate this sense of loneliness and helped them to find a place of belonging. One of 
the participants expressed this in the following statement: “Ah I feel like, ok, it’s not, uhm I’m 
not alone. I’m with someone who has the same thing that I drink, that we have and Ja... Ja it 
helps” (Tshepo). This shared experience seemed to ease the burden and pain of loneliness as they 
felt comforted by having access to someone else who could understand their challenges and pain. 
This sense of a shared identity seemed important to maintain as it helped them feel less different, 
that they belong somewhere and that they are not completely alone. The adolescents in this study 
may have been able to have this more readily as they lived in a shelter with other HIV positive 
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adolescents, however, it seemed that it was harder for them when they were away from the 
shelter, such as at camps, at school or at their homes as they were then faced with feelings of 
loneliness and the pain of having to worry about what to do with their medication and even 
wondering if there were other adolescents like them who are on medication. Blos (as cited in 
Balk, 1995) also described adolescence as a time of vulnerability, ambivalence and conflict. He 
wrote that early adolescence is marked with a lessened identification with parents, increased 
identification with peers, intense involvement with causes, and infatuations with an opposite-sex 
peer. It seemed that this was what these participants were experiencing.  However, in their 
struggles to figure out their own identities, being HIV positive seemed to complicate this for 
them. Having HIV and having to take ARVs seemed to make it more difficult for them to 
identify with their peers,  leaving them feeling lonely, vulnerable and possibly ashamed, which 
appeared to make it more challenging for them to feel like they fit in.  
 
Most of the participants in the current study really felt like they were different from their HIV 
negative counterparts which seemed to disrupt this developmental stage of an increased 
identification with their peers. They expressed feeling different from their HIV negative 
counterparts as they are not as fit and healthy and sometimes it was difficult for them to be the 
only ones having to take medication, while their friends do not have to worry about this. Taking 
the medication seemed to remind them of their difference. It is possible that much of this 
experienced difference could be related to the stigma around HIV. While one of the participants 
was able to identify more with his HIV negative peers, as he felt that there were more similarities 
than differences; the other participants were, however, more ambivalent. There were strong 
issues around identity evident in the participants grappling with whether they belong or not and 
where they belong. Adolescents between the ages of 13-24 years of age who test positive for 
HIV are often confronted with a wide range of difficulties as they struggle with ‘‘normal’’ 
adolescent developmental issues while carrying the burden of living with a highly stigmatized 
and life-threatening illness (Hosek, Harper & Robinson, 2002).  Being HIV positive and taking 
ARVs appeared to be something integrally involved in their process of identity formation. The 
WHO (2009) reported that all adolescents, including those who are living with HIV, face 
difficulties of a personal nature such as self-awareness, defining their identity, building their peer 
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group, making plans for the future, and dealing with their sexuality. During this developmental 
stage adolescents are taking the step from childhood into adulthood and this is hard in a variety 
of ways and causes inner conflicts such as stress, confusion, and an identity crisis. HIV appeared 
to add to this developmental crisis, as they appeared to have to find a place to fit their HIV 
positive status into their identity.  
 
Erickson (1968) viewed identity formation as the critical developmental task of adolescence; and 
this was quite evident in this study. Chigier (1992, as cited in Hosek et al., 2002) found that 
identity and chronic illness may often cause a feeling of flawed identity in an adolescent. Marcia 
(1968) also spoke of different identity statuses which capture the presence of various identity 
crises and how committed the individuals are in the process of consolidating an identity. 
However, they seemed to fit into the Identity achievement status (Marcia, 1980) as they seem to 
be committed to exploring their identities. This was characterised by the presence of hope in the 
future as most of the adolescents wanted to live and have set goals for themselves instead of 
giving up on life. However, they also spoke about some of their peers who do not adhere to their 
medication, as they seem to have given up on life and see no point in committing to their ART as 
they see no hope for a future. A similar study to the current research found that HIV positive 
adolescents either fell within identity achievement or identity diffusion (Marcia, 1968), which 
appeared to influence their responses to living with HIV (Hosek et al., 2002).  For some, an HIV 
diagnosis helped to facilitate and further the identity development process, while for others the 
opposite occurred, where the possibility that their life is limited and fear of setting goals that 
might not be achieved, inhibited exploration of identity issues and promoted the avoidance of 
commitment (Hosek et al., 2002). The following quote from an adolescent in this study really 
captured and supported what Hosek et al. (2002) found in their study. Tebogo one of the 
participants said: 
  
Most of the teenagers could tell themselves ah, I’m done with life, why should I drink 
medication, I won’t reach 20 years, I won’t see 20 years in the future, I won’t see this 
HIV in the future. If they hope in their selves, and believe in their selves they might reach 
there... Some teens they don’t tell themselves, okay I can make it. They always tell 
themselves negatively, no I won’t, I won’t reach there, that’s why many teenagers who 
are HIV positive kill themselves or do something, or smoke or do drugs, or drink, cause 
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yah, cause they tell themselves I ain’t gonna reach there and if I don’t and nothing will 
stop me and stuff, ah, I will rather do this and that in order to not reach there. 
 
It seems that the adolescents’ attitudes towards what it means to be HIV positive may influence 
and be influenced by the process of identity formation.  When HIV is viewed as a death sentence 
having hope for a future or setting goals may feel pointless. It seemed that for some adolescents 
being HIV positive can lead to a loss of hope in a future, which can result in them giving up on 
their lives as they do not feel that they will live long enough to meet these goals. The participants 
in this study, however, seemed to view things more positively, particularly as they trust the ART 
and have hope for a long life in which they can meet their goals in the future.  
 
6.2.3. Choosing to live 
Despite hope for the future, the participants in this study seemed to be grappling with the 
possibility of death.  The sub-theme of ‘life and death’ was evident throughout the research 
interviews. The participants seemed to be faced with the issue of life and death every single day 
as they take their medication, as for them that is the choice they have to make when it comes to 
adhering to their medication or not adhering to their medication. The following quote really 
captured the internal debate that these adolescents have when it is time to take their ARVs:  “I 
always feel, okay sometimes I feel sad, I ask myself should I live, should I, don’t, should I, 
should I, okay I just come to a point where I stop. I drink my tablets in order to live, that’s it” 
(Tebogo). Kubler-Ross (1970) wrote that to the unconscious mind, death is not possible in regard 
to the self. However, when one has a chronic and terminal illness this dynamic changes, as one 
has to directly face the possibility of their death. This seemed to be what was found in this study 
as the adolescents spoke a lot about death both directly and indirectly. An example of how 
intrinsic the idea of death was with the participants was captured in the following quote: “They 
say, this thing, this medications, I have to drink them until I die. If I leave them, I am going to 
die... Eh, ARVs they said, if I leave them I’m going to die or I’m going to be thin. I say ok, they 
teach me about ARVs” (Sipho). This illustrated how strong life and death appeared to be 
engraved in their understanding of their ARVs. It also seemed that their caregivers and heath 
care providers used the terms ‘life’ and ‘death’ when they explained the purpose and importance 
of adhering to their medication, which may also have contributed to keeping the idea that they 
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may die prominent in their minds. Having to face and accept possible death can be challenging. 
One of the participants expressed how life was better before she found out about her status and 
the purpose of her ARVs, as having to worry about death was very frightening for her. Ridder, 
Geenen, Kuijer and Van Middendorp (2008) highlighted how one of the key factors that impacts 
one’s ability for psychological adjustment to living with a chronic illness is a negative or positive 
affect. Good psychological adjustment predicts increased participation in self-management and 
vice versa (Ridder, Geenen, Kuijer & Van Middendorp, 2008). This indicates that if patients stay 
in the doom of death this can hinder their ability to come to terms with their illness and adhere to 
their ARVs. However a positive affect and attitude to life and living makes it easier for 
psychological adjustment to living with HIV. With regards to the five stages of bereavement that 
Kubler-Ross (1970) referred to, the participants seemed to have passed through the stage of 
denial, as they all appeared to have an awareness of what it means to be HIV positive and to have 
to adhere to their ARVs. Kubler-Ross (1970) wrote that in all five stages of bereavement a hope 
always exists throughout as all that is being experienced has meaning. In this study, the 
participants’ trust in the ART and their hope that they are going to live long lives seemed to be 
an important motivator and appeared to help them get through the difficult moments. Positive 
cognitive processes, emotional regulation and engaging in self-management and self-care 
behaviour are vital to the process of psychological adjustment to living with a chronic illness 
(Ridder, Geenen, Kuijer & Van Middendorp, 2008). The participants in the current study did 
have some moments of a negative attitude and affect but the more positive attitudes and 
appreciation of life and what the ARVs were doing for their lives allowed them to engage in the 
more positive self management behaviour of adherence and helped them to come to terms with 
their status. As there are different aspects to being able to accept and live with HIV practitioners 
must encourage people to engage in pleasant activities, acknowledge the emotions they have 
about the disease, challenge the barriers for engaging in self-management, and find meaning in 
small things (Ridder, Geenen, Kuijer & Van Middendorp, 2008). Meaning making is important 
as it helps with acceptance and coming to terms with living with the illness. This may take time 
but it is possible as has been identified with the participants that took part in this study. The 
ARVs mean life for them and this has brought hope and life rather than death. 
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6.3. The challenges adolescents experience in adhering to their ARV medication 
The participants in this study indicated a number of factors that contributed to their negative 
experiences of taking and adhering to their ARVs. This was captured by the sub-themes; ‘the 
inconvenience of ARVs, the stigma and fear of ARVs, depression and loss and ARVs, ARVs 
complicating normal adolescent developmental challenges’.   
 
6.3.1. The inconvenience of ARVs 
One participant described his frustration and hate of having to wake up early every morning to 
take his ARVs. He also expressed his hate for the taste of his medication. The taste sometimes 
was so bad for him that he wished to ‘vomit’ out the medication. This seemed also to be linked to 
a wish to not have to take his ARVs or perhaps a wish in fantasy to ‘vomit’ out his HIV. Some of 
the participants complained of the side effects of the ARVs making them sick to a point where 
their ARV regime was changed. Another study identified that along with bad side effects from 
the medication, among adolescents there were other factors related to medication that influenced 
poor adherence, such as pill burden and complications of day-to-day routine (Belzer et.al, 2005). 
This was not unlike that which the current study found in that these adolescents also got 
frustrated with the taste, side effects and the fixed routine, such as having to wake up early every 
day to take their medication.  Due to having to take medication at a specific time, it sometimes 
interfered with their plans, which seemed to annoy them and perhaps felt unfair, as they 
mentioned that their peers, who are not taking ARVs, do not have to worry about any of these 
things. The following quote illustrated the inconvenience of taking ARVs: “It’s like when I get 
angry, when they say ‘medication time’, maybe I’m watching something interesting, then I got 
their attention, when they say medication, I just stop, my mind can go backwards, feel like I can 
take the time back, then I get angry, pissed- off, I feel like I can say ‘stuff medication’” (Tshepo). 
There also seemed to be a lot of anger which sometimes led to the contemplation of defaulting. 
Another participant expressed how frustrating it is to take ARVs as it never stops. They have to 
take their medication everyday continuously whether they are sick or whether they are well, 
which felt like such a burden to them. Other studies found that some patients reported skipping 
doses because of simply forgetting, feeling sick or ill (sometimes due to side effects of 
medication, being busy and running out of medication) and also lack of social support (Amberbir 
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et Al., 2008; Abreu, et al., 2008). One participant shared that once his medication had expired 
but that he had kept taking it as he was meant to, unaware that it had expired, and that when he 
went to hospital for a check up, they told him he was not adhering which was upsetting for him 
as he knew he had been. It seemed difficult for these adolescents to bear the heavy responsibility 
for taking their medication within the very strict guidelines provided by their doctors. These 
adolescents seemed to have a lot to worry about and support seemed to be important as a means 
of encouraging them, particularly on the more difficult days.  
 
The participants also shared challenges that they experienced in relation to their clinics and 
health care providers. The experience at the hospital for most of the participants seemed to be 
tedious and overwhelming. A participant expressed being overwhelmed by the amount of 
information he is given at the hospital and that he gets confused at times. He also expressed his 
frustration that just when he is getting used to one ARV regime, then it is changed and he is 
confused about this and does not understand why his health care providers do this. Again, the 
importance of keeping adolescents fully informed was highlighted. However, it also seemed to 
be important that this providing of information is done at each adolescent’s pace so that they 
fully understand what is happening and what is expected from them. There was also an issue 
around having to miss school for checkups, as they miss important things in class and there 
seemed to be a worry about falling behind at school. Missing school due to the illness causes 
larger "gaps" in their learning, and trying to make up work that they never learned and, or do not 
understand is quite overwhelming and frustrating (Fennell, Leitz & Fantauzzi, 2012). These 
findings correlate with the findings of this study that HIV has an impact on school performance 
and attendance, which could even be a hindrance for a successful and healthy future. 
Absenteeism and, or dropping out of school has been found to be a big problem and has far 
reaching implication on these children’s lives both economically and health (Fennell, Leitz & 
Fantauzzi, 2012). Belzer et al. (2005) also found that some HIV positive adolescents drop out of 
school; a factor that was linked to poor adherence. The participants in the current study seemed 
to be invested in going to school which seemed to be related to a wish to be able to go far in their 
future. However it cannot be ignored that absenteeism and dropping out of school is linked to 
living with a chronic illness an issue which needs to be addressed. Fennell, Leitz and Fantauzzi 
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(2012) noted that managing and accommodating students with chronic illnesses is a big 
challenge for both the health and educational institutions but a need for understanding and 
assistance for these children by their teachers, health and educational systems is needed. This can 
be achieved on an individual level by the students and their family taking more initiative with 
their daily schedule and study time, collecting their homework or class requirements on the days 
of their clinic visits or away from school (Fennell, Leitz & Fantauzzi, 2012). On an institutional 
level teachers and education systems can take the initiatives to understand these students' 
condition and be able to educate them according to their abilities and needs such as with brain 
based learning: a system which assesses how one’s brain learns and then allows for a variety of 
strategies to be applied (Fennell, Leitz & Fantauzzi, 2012).  Support has to be available from all 
domains so these adolescents and children’s future do not get further hindered by their illness. 
 
The participants in this study were easily able to go for their medical checkups and they also had 
access to nutritious food at the shelter. One participant, however, did express that before moving 
to the shelter he did not eat as well as he should be eating. Several studies have also found that 
components of SES play a role in poor adherence issues associated with SES, such as the 
inability to afford transport fares, and food, which results in missed medical appointments and 
malnutrition (Amberbir et al., 2008; Ferrand et al., 2009). In the current study despite the support 
offered by the shelter, there were various factors that required time and routine that negatively 
influenced the participants’ experiences of taking ARVs. 
 
6.3.2. The stigma and fear of ARVs 
The other major challenge that the participants experienced on a more social level was captured 
by this sub-theme. The issue of stigma and fear of ARVs was also strongly expressed by the 
participants. One participant expressed his dislike of going to the hospital as he is worried that 
people will find out that he is HIV positive. This seemed to indicate a fear of stigma. Another 
participant expressed the following about his fears about rejection if he was to reveal his status, 
which could also be likened to a fear of stigma.  All the participants had a fear that if they were 
to reveal their status to their friends, they would be rejected. One participant described his fear of 
taking his ARVs in front of his HIV negative peers; he fears that they will make fun of him. 
88 
 
There also seemed to be a fear of what their peers might do if they were to find out about their 
status. Some participants seemed quite ambivalent about trusting their HIV negative friends, as 
even though they implied that their friends would accept their status, they still made a choice not 
to take the risk and disclose. It seemed that there is some hope that their friends would accept 
them but the risk of stigma and rejection is too big a risk to take, so they make the choice of 
concealing this part of themselves.  
 
Some other participants were very clear about not trusting their friends enough to disclose their 
status, as they feared their friends could use that information against them. One participant was 
scared that once her friends knew about her HIV status they would ridicule her and refuse to play 
with her. This seemed to be a big concern for her: a fear of being rejected and not belonging. As 
discussed earlier due to adolescents need for identification with peers, this may feel too big. This 
fear of stigma was powerful and a real threat and in this case it correlates with the issue of 
identification for these adolescent participants. A fear of stigma does not just exist just with peers 
but also within families.  One of the participants in this study shared that some of her siblings do 
not know about her status and this supported Campbell et al.’s (2005) findings that even within 
the nuclear family secrets and non-disclosure occurs. Campbell et al. (2005) found that some 
children were also afraid to even disclose their status to their own parents as they worried they 
would be stigmatised by them. The same study also found that some families would hide away 
sick relatives, depriving them of health care and support, or they disowned dead relatives and 
refused to go claim their bodies at the mortuary.  It was also found that even sick relatives would 
not ever talk about having AIDS. Among the participants of this study, there was a lot of anxiety 
about disclosing their status to both close people and strangers and so a lot of secrets and lies 
seemed to be told to conceal the truth of their status. Secrets appeared to be an everyday part of 
their lives, as it was difficult for them to trust what others may do with the information.  This 
fear seemed to be linked to awareness that HIV is associated with a stigma. 
 
One participant made the following statement: “I take tablets for mentally something and stuff” 
(Tebogo). For this participant, it seemed that he would rather people think he has a mental 
disorder than for them to know he is HIV positive. This seemed to capture the extent of the issue 
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around shame and self stigma towards their status. A qualitative study in Uganda found that 
stigma was a barrier to ART adherence (Atuyambe et al., 2009); and internalised stigma has been 
identified as being associated with important health outcomes such as delays in pharmacy refills 
and medical care (Chirwa et al., 2008). Chirwa et al. (2008) study illustrated how if one 
experiences stigma in their immediate environment, then that can translate to how one views 
their own status, such as with self stigma. The participants in this study seemed to have 
internalised some of the stigma that they perceive exists in their communities, as they seemed not 
to trust that people such as friends or for some, even their teachers, would accept them. This 
seemed to reflect something about the participants themselves not having accepted their own 
status. Gibson and Rohleder (2005) found that the ‘self’ is continuously shaped through the 
prevailing social discourses and construction of meanings. Therefore, for an HIV positive 
person, whatever negative meanings or beliefs are adopted by their communities about HIV may 
be integrated into the construction of their self identities (Gibson & Rohleder, 2005). There 
seemed to be a real fear of rejection and along with that, a sense of shame and embarrassment 
around being HIV positive and taking ARVs, so various tactics were used by the participants to 
conceal their status and the reason for taking ARVs. One way was coming up with alternative 
reasons as to why they take medication and the other way was to hide the truth, such as not 
carrying their ARV prescriptions in their prescription bottles but rather keeping them in a neutral 
pill container so that they can continue to keep their status private. 
 
6.3.3. Depression and loss and ARVs 
One of the participants expressed his frustration with regard to going for checkups, as the doctors 
know when he is not adhering to his medication and they lecture him. This particular participant 
seemed to be really struggling with being HIV positive and taking medication. He seemed 
depressed and admitted that, at times, he does not adhere to his medication as he misses his late 
mother and sometimes he feels like he wants to stop his medication so that he can die and be 
with his mother. It was evident that in this adolescent’s case, threats of death are not an effective 
means of motivating him to adhere to his medication. Many families have experienced the severe 
impact of HIV and AIDS. This was exactly what one of the participants felt when his mother 
died when he was 5 years old and he was moved from one home to another and only once he was 
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moved to the shelter, did he find some stability. The loss of his parents seemed still to be very 
painful for him, even now at the age of 17. Another participant also lost her mother to HIV, a 
fact at which she expressed being very angry and causing her to have anger management 
problems. Studies show that due to HIV, more and more children are being left orphaned and as 
a result they are bounced from one family member to another (Smit, 2010). The issue of 
mourning and loss was prevalent in these adolescents as they appeared to be mourning for lost 
loved ones and for an HIV negative life.  The participants in this study have been infected and 
affected by HIV which is a very challenging and painful reality for them. Part of this reality was 
the challenge of being ill and having to miss school. One of the participants expressed how 
before starting her ARVs she was always sick and fell significantly behind at school, and 
although she is healthier now due to taking ARVs, she is still behind and struggling with school, 
unlike her classmates. This seemed to perpetuate her feeling that she does not fit in. There was 
also the issue of their treatment regimens being changed just as they were getting used to the 
previous regimen and this lack of stability seemed to be quite frustrating. 
 
While some challenges were on a very personal level and some at a broader level, sometimes 
these frustrations lead to a contemplation of non-adherence or defaulting. Some of the 
participants shared that sometimes they do not want to take their medication so they lie to their 
caregivers and that they know of peers who lie and say they took their medication whilst they 
have not. Some participants shared the fact that sometimes they throw away their medication or 
that they know some of their friends throw away their medication. This seemed to suggest that 
the adolescents’ moods influence their adherence to their medication; when depressed or 
preoccupied with worry, the motivation to take their ARVs seemed to decrease. This was similar 
to Belzer et al.’s (2005) finding that depression led to poor adherence. One participant expressed 
the following: “I like don’t wanna take them, you feel so disgusted when they say 
medication...for me, sometimes, I feel like, it says just run away or hide” (Tshepo). There was a 
sense that him feeling sickened by his medication may have been related to his anger and hate 
towards being HIV positive and having to take medication and a wish to escape. However the 
participants also experienced disadvantages when not adhering, as they would get into a lot of 
trouble and on a more serious level, get ill when they did not adhere to their medication, which 
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would then motivate them to get back on their regime. This section highlighted how difficult it 
can sometimes be for these adolescents and how, at times, they really struggle with living with 
HIV and having to take ARVs. There seemed to be a lot of anger, and at times, pain and 
depression due to these challenges, leading to a sense of helplessness and hopelessness, which in 
turn led to them wanting to default or, at times, actually not adhering to their ARVs. 
 
6.3.4. ARVs complicating normal adolescent developmental challenges 
The psychosocial approach indicates that there are five main sets of developmental issues during 
adolescence: identity, autonomy, intimacy, sexuality and achievement (Steinberg, 2005). While 
adolescence is normally associated with growing independence, these adolescents’ need for 
medication and having to rely on others to make decisions around their medication made striving 
for independence more difficult, which was frustrating for the participants. The participants also 
spoke about having experienced other challenges, some of which were directly linked to their 
experience of taking ARVs and some related to social challenges. The challenges they face 
appeared to be developmental and life challenges common to all adolescents, however, these 
challenges seem to be more difficult in relation to being HIV positive and taking ARVs. This 
included negative peer pressure, unstable family backgrounds and for some, mourning the loss of 
their mothers. Two of the participants described how they have been subject to peer pressure to 
drink and the difficulty associated with this due to the importance of them avoiding such 
situations. Alcohol use is been found to influence adherence (Belzer et.al, 2005). Alcohol and 
drug abuse is also quite prevalent amongst adolescents in South Africa (Peltzer & Ramlagan, 
2009; Reddy et al., 2010), but for adolescents with HIV, who have been counselled as to the 
health risks of drinking and smoking, this pressure seemed to feel more threatening. Adherence 
is a treatment process and a life style where the patient has to be an active member in that 
process; health care providers believe that it is more than taking one’s medication but that it is 
also about following a diet and, or executing lifestyle changes (WHO, 2003). This includes not 
abusing alcohol, as this does not mix well with the ART. These adolescents have to be able to 
take responsibility for their lives and choose to go against what their friends are doing despite the 
possible consequence of being rejected. Blos (as cited in Balk, 1995) stated that adolescents try 
to form new ego ideals that are separate from dependency on parents, form more heterosexual 
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relationships and develop a mature identity; and that failure to achieve these ego ideals can result 
in a permanent barrier to maturity. The forming of these ego ideals may be particularly hard for 
adolescents living with HIV because as well as trying to cope with the normal challenges of 
identity formation in adolescence and fitting in; they are also trying to find ways to cope with an 
HIV positive identity and make responsible choices instead of experimenting as their friends are. 
One of the participants even described the dangers for him to just sleep in when he does not have 
school, as there is the risk of him missing his medication. Another concern was being away from 
home, such as going away for camp and having to worry about where to hide their medication. 
Alongside this fear there seemed to be a concern around others finding out that they are on 
ARVs which aroused a fear of rejection. The challenges that these adolescents have to worry 
about suggested that they cannot be as care free as their HIV negative peers. 
 
6.4. The factors that help adolescents adhere to their antiretroviral (ARV) medication 
The participants also named a number of factors that help them to adhere to their ARVs. These 
factors are best illustrated by the sub-themes: understanding and awareness; support, practical 
strategies; emotional defence mechanisms and the process of acceptance.  
 
6.4.1. Understanding and awareness 
The process of coming to fully understand and acknowledge the purpose and importance of ART 
and having a positive attitude towards the medication and adherence seemed to play significant 
roles in the coping of these adolescents. This was illustrated in the ‘Help (good meds and trusted 
others)’ sub-theme which was identified in the analysis. Their process of meaning making and 
awareness enabled the participants to overcome the challenges that they experience with taking 
and adhering to the medication. The following quote from one of the participants really captured 
how holding on to the positive aspects of what ARVs can do helps with adherence: “Taking my 
meds is a big role in my life, cause without that medicine I’d be like okay, suffering and stuff in 
the hospitals, yah fighting for my life... What I understand is that they help you, they help you 
reach your goals, reach anywhere you want to be, because without life there is nothing” 
(Tebogo). This quote illustrated the more positive experiences with their ARVs. The participants 
appeared to have experienced for themselves that adhering to their ARVs improves their health 
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as they do not get sick often as before and instead have gained weight, and have more energy. A 
study done in Tanzania also found that patients’ confidence in ARVs after experiencing 
improvements in their health facilitates adherence. This was what the current research also 
found, as improved health seemed to give the participants some sense of normality as they can 
now properly attend school, catch up with their school work and be more like their HIV negative 
peers which is important to them. Holding onto the idea that the ARVs give them life seemed to 
assist the adolescents to have hope in a future, in which they can meet their goals and have a long 
life to be with their families. One of the participants reflected a fantasy to be able to cure HIV 
and the medication seemed to be linked in his mind to a hope and sense of a future. Another 
participant reflected a positive outlook on their experience of the ARVs and holding onto the 
belief that the ARVs give life. These beliefs seemed to facilitate adherence for them, particularly 
during the difficult times when they feel angry and frustrated and do not want to adhere to their 
ARVs.  
 
6.4.2. Support 
A positive hospital experience, such as being around other children who are having similar 
experiences also appeared to help and possibly added to a sense of belonging, instead of feeling 
alone, as if they are the only ones living like this. One of the participants expressed the following 
hospital experience: “It’s like everyone is taking it just like me. Yes... It makes me feel better 
because I saw lots of people taking, fetch their ARVs” (Pule).  Another participant described that 
there is a support group for adolescents at the hospital where he is able to interact and have fun 
with other adolescents who are taking ARVs. This seemed to improve the hospital experience 
and makes it a less dreadful place. It also seemed that having a good, open, supportive and 
trustworthy relationship with their doctor really encouraged the adolescents to adhere to their 
medication. Research shows that people who have a good relationship with their health provider 
were better able to communicate and were more likely to adhere (Murphy et al., 2004). Murphy 
et al.’s (2004) study found that the more patients trusted and believed in what their health 
provider was saying, the more likely that they would listen and adhere to their medication. A 
study in Brazil presented similar findings: that adherence was associated to the relationship 
patients had with the health care workers (Abreu et al., 2008). A South African study also 
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confirmed the importance of disclosure, having social support and a strong belief in the value of 
treatment, as these were found to facilitate adherence (Dahab et al., 2008). It seemed that having 
trust in their doctor also encouraged the adolescents to believe in and trust the ARVs, as they 
described feeling a sense of security that their doctor has their best interest at heart.  
 
Along with having a good relationship with their doctor it seemed that having supportive, trusted 
others really facilitated the adolescents’ coping with taking medication and adherence. The 
participants expressed being happy to have someone they can trust and depend on who reminds 
them to take their medication and makes sure that they take their medication. One participant 
expressed feeling safe as her trusted caregivers do not only help her manage the taking of 
medication but they also keep her safe from catching infections which could jeopardise her 
health. The participants also expressed how these trusted others are also able to explain to them 
and advise them on how to take their medication. A study conducted in Los Angeles was also 
supported by the findings of the current study in that both studies found that social support and 
professional support facilitate ARV adherence (Roberts, 2000). As the participants live in a 
shelter with other adolescents who are on ARVs, they also seemed to support each other.  They 
seemed to help each other to manage their ART by waking each other up in the mornings, 
reminding each other and also following up on each other when they notice that one of them is 
not adhering to their medication. Watt et al.’s (2009) study also found that material support, such 
as food and money and emotional support from family, friends, counsellors and their health care 
providers assists with adherence. The participants in the current study seemed to indicate that 
they have lots of support adhering to their medication, both when they are at the shelter and also 
when they are away visiting their families. However they also have strategies that they employ 
themselves to remind themselves to take their medication.  
 
6.4.3. Practical strategies 
There were various strategies employed in the management of ART in this study and one of the 
participants expressed paying attention to the clock when he is at home when he knows it is 
almost medication time, which seemed to highlight the process of routinising. Watt et al. (2009) 
emphasised that routinising the taking of medication by linking it with day to day activities can 
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help individuals to remember to take their medication. Another participant shared that when she 
does not have anyone around to remind her she sets an alarm on her cellular phone as a reminder 
to her. Roberts’ (2000) research found that there are various strategies employed by HIV positive 
people to help with adherence such as making a commitment, routinising, medi-sets, alarm 
clocks, written notes and day planners, which can remove the burden of having to remember 
complex medication schedules which are common to ARV regimens. However some people are 
concerned that there may be some stigma associated with using the medi-sets (Roberts, 2000).  
This was also evident in this study, as one participant shared that he preferred to keep his 
medication in a neutral container when he is away from the shelter instead of the original ARV 
medication bottles so that people will not know what medication he is taking. There were times 
when the participants take responsibility for their medication, however, giving responsibility to 
adolescents has to be done in moderation as Farley et al.’s (2006) study identified that older 
adolescents have an increased  likelihood of non-adherence, and thus caregivers must be careful 
with regards to giving adolescents too much responsibility too early. Farley et al.’s (2006) study 
found that the responsibility of medication adherence may be premature for some adolescents, 
given that HIV infection may have caused cognitive or emotional difficulties that may influence 
their ability to function independently, unlike their HIV negative age mates.  
 
6.4.4. Emotional defence mechanisms 
Along with the participants having positive beliefs about their medication and also having 
supportive structures to help them cope and manage with the difficult task of adhering to their 
medication amidst all the challenges they face, they have also adopted various defences. These 
help them cope with the difficulties of being an HIV positive adolescent who has to take 
medication every day while their peers do not. Finding out about their HIV positive status 
seemed to be quite traumatic for the participants and some described going through a period of 
denial from the shock of finding out their HIV positive status, which appeared to be the first step 
of bereavement (Kubler-Ross, 1970). Trying to cope with their terminal diagnosis seems to have 
led the adolescents in this study to employ a more paranoid schizoid way of functioning, in 
which primitive defences, such as denial of inner and outer reality, stifling of emotions, splitting 
and projection were used (Klein, 1946). The discovery of an HIV positive status seemed to be 
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experienced as a loss and sometimes this loss was too much for the adolescents to handle and 
thus many of them appeared to use the primitive defence mechanism of denial. Although at the 
stage that this study was conducted it was clear that all of the participants had passed through the 
stage of denial, it was clear that many of the participants were still engaged in a mourning 
process, attempting to come to terms with their diagnosis. The different stages of bereavement 
are negotiated for differing times by various individuals, and they can also follow one after the 
other or coincide (Kubler-Ross, 1970). The participants in this study seemed to describe 
experiences in which sometimes they get very frustrated and angry about being HIV positive and 
having to take medication and worry about adhering to medication, however, they also described 
at other times being in a state of depression. They seemed to move in between these two states. 
While these two stages appear to resemble Kubler-Ross’ (1970) stages of anger and depression, 
it is, however, also important to note that in adolescence depression can be masked by anger 
(Sadock & Sadock, 2007). This means that depression would present with more irritability and 
frustration rather than a depressed mood.  
 
The use of manic defences was also evident in the participants in this study.  The following 
extract illustrated the use of a manic defence (Lemma, 2003), where instead of the seriousness of 
not adhering to ones medication being acknowledged, it was avoided and instead humour was 
used: “Yah I feel safe because he is the only one who knows and stuff, he not gonna do like, 
okay, you gonna die by HIV and stuff. Okay we all make jokes, yah we all make jokes but you 
must drink your medication. I tell him why? It’s obvious you already know, why you asking and 
we laugh and laugh and you drink” (Tebogo). In this instance there seemed to be some avoidance 
of talking about the more serious implications of not taking ARVs, but instead the frustrations 
and worry was engaged with in a more playful way. Manic defences are also primitive defences 
which aim to deny depressive anxiety and guilt (Lemma, 2003), which was illustrated by the 
participant. The participants seemed to also be using splitting as a defence mechanism.  This was 
evident in their descriptions of times when they feel that the medication is all bad and other times 
when they feel that the medication is all good.  There also seemed to be a splitting of people in 
their lives: those whom they can trust with their status and those whom they cannot trust. Even 
during the interview there seemed to be a process of splitting.  There were notable 
97 
 
inconsistencies and contradictions in their accounts of their experiences, as at times they would 
report everything being fine but as they elaborated further it became clear that they also 
experience a lot of challenges and adversities around being HIV positive and adhering to 
medication. This defence is a way of splitting off knowledge about one part of the personality or 
experience under the pressure of anxiety and guilt; and is most often used in order to keep two 
usually opposing feelings or thoughts separate (Klein, 1946; Lemma, 2003). It seemed that the 
participants’ need to split off the parts of themselves and their experience that they find 
intolerable, such as the parts of themselves that do not want to adhere to their medication and 
parts of themselves that actually do not adhere. This seemed to allow them to be able to cope 
with their anxieties of not adhering to their medication or the contemplation to do so, particularly 
as they are very aware of what not adhering to their medication means. This illustrated the use of 
primitive defence mechanisms being used by the participants as a way of coping and managing 
with the difficulties of having to live with HIV and take medication at a specific time, every day 
of their lives.  
 
 Although in the current study certain primitive defences were used, there were also some 
neurotic defences being used. One participant described using reaction formation. This is when 
someone transforms a disturbing idea into its opposite (Lemma, 2003). In this case one of the 
participants described feeling no different to his HIV negative peers and seemed very invested in 
maintaining this belief. It seemed that through the use of a reaction formation defence he was 
able to avoid confronting what felt different between him and his peers and what may leave him 
feeling isolated. Another example of a more neurotic defence being used was that of repression 
(Lemma, 2003), where one of the participants spoke about how when he goes to the hospital they 
sometimes find that he is not adhering well to his medication, but when he was asked how often 
this happens he said that he does not remember, which could be an indication of him repressing 
the memory as it is too anxiety provoking and difficult for him to acknowledge and hold in mind. 
It seemed that depending on where the adolescent is in the process of trying to accept their 
illness determined the defences that they employ to help them cope with the more difficult 
emotions of their experience. Pedersen and Elklit’s (1995) study, also found that their 
participants relied more on neurotic defences than the primitive defences, particularly in relation 
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to anxiety. It seems that in this study the participants were not at a place of full acceptance of 
their status, so they tended to fluctuate and adopt various defence mechanisms depending on 
what their experience provoked. 
 
6.4.5. The process of acceptance 
As discussed above, the adolescents in this study were not at a place of full acceptance. It is also 
important to acknowledge that due to their developmental stage and where they are cognitively, 
they may be unable to come to a state of full acceptance of their status and the reality that they 
have to take ARVs for the rest of their lives (Farley et al., 2006). However, it seemed that there 
was some process of acceptance occurring, which was one of the predominant themes found in 
the study. This theme highlighted the way in which the participants in this study make sense of 
being HIV positive and having to take ARVs every day for the rest of their lives. The first issue 
that was evident was the process of trying to obtain full disclosure about how they were infected, 
as the participants who did not know how they got HIV seemed much invested in finding out that 
information. It seemed that as mentioned earlier having full disclosure and being allowed the 
space to ask their questions was important. Kubler-Ross (1970) talks of the last stage of 
bereavement as that of acceptance, in which individuals do not harbour any anger or depression, 
but rather are almost void of emotion about their fate. However, Kubler-Ross (1970) studied 
individuals with terminal illnesses, all of whom did eventually die.  HIV appears to be different, 
in that although terminal, it is an illness that can be managed with ARVs for extended periods of 
time. Thus, acceptance as being devoid of emotion and resigned to the fate of death does not 
apply here. Acceptance in the case of HIV seems to mean finding a way to live with an illness 
and all its physical and emotional consequences.  The participants in this study were not at this 
point as yet; but anger, frustration and depression, particularly for those who did not know how 
they were infected with HIV, were prevalent emotions. It seemed that, that not having full 
disclosure of their status contributed to the challenges of accepting their status.  It was almost as 
if they felt there is a big piece of the puzzle of their life missing and that until the puzzle piece is 
found, it is difficult to move forward and instead there is a lot of frustration, anger, a deep 
sadness, helplessness and desperation involved in coming to terms with ones HIV positive status. 
These feelings seemed to be managed through lots of enquiry and knowledge being gained about 
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how one can get infected with HIV, which appeared to help with their understanding of the HIV 
virus. This once again highlighted the earlier point of the importance of full disclosure.  
 
There was also a process of reasoning and a need to let go of the focus on how they were 
infected, and rather focus more on the present, which was the reality that they will have to live 
with HIV for the rest of their lives. One of the participants described initially feeling resentful 
and wanting to ‘stuff HIV!’ but through his processing of these feelings and watching ‘Soul 
Budz’ (a children’s show that deals with issues of HIV and AIDS), he described learning that 
HIV is not a death sentence and that one can live with it and this understanding helped him in his 
process of trying to get used to his ARVs. Research has shown that emotional regulation is vital 
in the process of psychological adjustment which is vital for living with a chronic illness (Ridder, 
Geenen, Kuijer, Van Middendorp, 2008). Hope in a future and meeting ones dreams and having 
a purpose seemed also to have helped with the process of taking their ARVs. Some of the 
participants expressed wanting to be able to live with and help their families, which for them 
facilitated the process of acceptance and adhering to their ARVs. One of the participants 
described how seeing his ARVs as any other tablet, such as the ones he was taking before 
(possibly vitamins) helped him manage taking his ARVs, instead of viewing them as a burden. 
While this may also be an avoidance of the reality that the tablets are for his HIV, this way of 
thinking appeared to facilitate his adherence to his medication. Another participant expressed 
how focusing on the benefits of the ARVs, such as being healthy, helps with adherence. Studies 
have found that benefit finding once diagnosed with a chronic illness can help with 
psychological adjustment and living with chronic illness (Ridder, Geenen, Kuijer, Van 
Middendorp, 2008). This indicates that it can bring benefits and improvements in our attitude to 
life and the way we live our lives for the better. It also seemed that with time the participants 
have become used to taking the ARVs and have found similarities with their HIV negative peers. 
This process of identification with peers appeared to assist in the process of acceptance of being 
HIV positive and having to take ARVs. This was also linked to a process of moving away from 
shame about ones HIV status. Most of the participants illustrated various processes of meaning 
making and most of them seemed to try to focus more on the positive factors of ARVs, which 
appeared to help them accept their HIV status and a life of having to take medication every day. 
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One of the participants, however, seemed to be at the early stages of this process of acceptance, 
as she was the only one out of all the participants who had recently found out about her status 
and also had only been taking ARVs for a few months, so she was still trying to grapple with a 
lot of the raw emotion evoked by disclosure. This suggested that time is a very important 
contributing factor in how the adolescents work through the more difficult feelings and that time 
also allowed for the development of coping mechanisms. It seemed that with time they are able 
to get used to their new lifestyle of taking ARVs and some were even able to shift from a space 
of feeling alone and at risk of rejection, to being able to identify with their HIV negative 
counterparts. Chronic illness can also bring an improved appreciation of life, an enhanced sense 
of purpose, changes in life priorities, and improved personal relationships (Ridder, Geenen, 
Kuijer, Van Middendorp, 2008). However it is important to be aware that this is a process and 
can take time. It is also very important to also be aware when this process takes place as if it is 
during the earlier phase of diagnosis it may indicate denial.   
 
6.5. Conclusion  
In this chapter the discussion was focused on the HIV positive adolescents’ experiences with 
ART adherence.  It highlighted the importance of disclosure, their struggle to develop an identity 
that integrates their HIV positive status, and that taking ARVs was choosing to live. The 
challenges that these adolescents experience in adhering to their ARV medication was also 
discussed in relation to the challenges to adherence, which has also been found in other studies.  
These challenges included: the inconvenience of ARVs; the stigma and fear of ARVs; depression 
and loss and ARVs; and ARVs complicating normal adolescent developmental challenges. 
Lastly, the factors that assist these adolescents to adhere to their antiretroviral (ARV) medication 
were discussed. The importance of understanding and awareness, support, practical strategies, 
emotional defence mechanisms, and the process of acceptance were highlighted. These were also 
discussed in relation to similar studies on this and related topics. This chapter also discussed the 
research findings in relation to various developmental theories which allowed for a better 
understanding and conceptualisation of what these adolescents are experiencing daily, the 
challenges they are faced with when it comes to adherence and also the things that help them to 
adhere. 
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Chapter 7: Conclusion 
 
7.1. Summary of research findings  
The aim of this study was to examine the experiences of adolescents who are HIV positive with 
regard to their experience of adherence to their ARVs. This study focused on the experiences of 
5 South African HIV positive adolescents’ who live in a shelter for homeless HIV positive 
women and children.  Their experiences with ART adherence was explored in relation to the 
factors that help them adhere to their ARV medication and the challenges that they experience in 
adhering to their ARV medication. The researcher conducted five semi-structured interviews 
with HIV positive adolescents from two homes belonging to a shelter in Johannesburg. These 
interviews generated some rich, very informative data with regard to adolescents’ experiences 
living with HIV and having to adhere to ARVs. This research confirmed and substantiated a 
number of the findings that emerged from previous studies regarding the challenges and the 
supportive factors experienced by adolescents living with HIV and adhering to ARVs. The 
numerous factors that form part of these adolescents’ experiences of adherence are as follows: 
 
 The first issue that arose in all the interviews was that of the importance of the adolescents 
being disclosed to with regard to their HIV positive status and the reason for taking ARVs. 
Knowing their HIV status seemed to help these adolescents understand what HIV is and the 
importance of adhering to their ARVs. This also allowed them to make meaning and start a 
process of acceptance of their status and the importance of adherence.  The importance of 
disclosure was well highlighted and coincides with other studies which have highlighted the 
importance of disclosure to children (Vaz et al., 2010). 
 Disclosure of their HIV status brought awareness; however, it also necessitated a fairly 
stressful process of incorporating an HIV positive diagnosis into their developing identities. 
The formation of a stable sense of identity is a very important task of adolescence. It seemed 
that the participants struggled with this process, grappling with how to incorporate their HIV 
positive status into their still forming identities. Being HIV positive seemed to carry the 
concept of difference, which sometimes seemed to make it difficult for these adolescents to 
feel like they fit in with their HIV negative peers. Most of the participants in this study felt 
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like they were different from their HIV negative counterparts, which seemed to disrupt this 
developmental stage of an increased identification with their peers.  
 Linked to identification with peers was also the fear of stigma. This research study also found 
that adolescents are faced with the challenge that their peers will reject or make fun of them 
if they were to know of their HIV positive status. Due to this fear of stigma the participants 
in this study tended to conceal their status and hide or disguise the taking of their ARVs, 
particularly if they were away from home. They also tended to conceal the truth regarding the 
nature of their medication, whenever someone saw their ARVs. This part or their lives 
seemed to be kept secret from friends and, or family.  
 There was also a very strong theme of the issue of life or death. This study indicated that 
being HIV positive for these adolescents carried a possibility of death and adhering to 
medication meant choosing to live and fighting death. It seemed that when these adolescents 
take their medication every day, they are faced with the issue of life or death, as for them 
adherence means choosing life and not adhering means choosing death.  
 
This study also highlighted some of the challenges that these participants face daily, which 
sometimes have an influence on their levels of adherence. These challenges included the 
following issues: 
 
 The inconveniences of adherence were noted by the participants, such as: side effects from 
the medication, having to maintain strict time requirements, having to take ARVs everyday 
for the rest of their lives, waking up early to take ARVs, and disruption to their leisure time. 
 Negative experiences at the hospital when they go for their regular checkups were also 
mentioned as being a deterrent.  These included: a fear of stigma, being overwhelmed by the 
amount of information given, the burden of the ARV regime being changed, and having to 
miss school for checkups which raised the concern that they will fall behind at school. 
 Negative peer pressure from friends around drinking and smoking was also cited as a 
challenge and something that adds complications to adherence. 
 It also seemed that the participants had experienced many losses, such as the loss of loved 
ones and also the loss of being HIV negative. They seemed to experience depression around 
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these losses, which they reported as having a significant influence on their levels of non-
adherence. For the most part, it seemed that this depression and related non-adherence was 
concealed from their parents or guardians. 
 
The study also indicated factors that facilitate adherence for these adolescents, which are as 
follows: 
 
 Understanding and awareness of the purpose of ARVs seemed to facilitate adherence and this 
was linked to the issue of disclosure. 
 Having a good support system and trusting parents or guardians, peers who are HIV positive 
and their health care providers seemed to help with the burdens and challenges experienced 
with ART. 
 A positive hospital experience and a good relationship with their health care provider were 
highlighted as aiding with adherence. 
 A positive attitude towards the medication and certain emotional defence mechanisms that 
the adolescents employed seemed also to lighten the burden experienced with taking ARVs 
every day. 
 This study also highlighted that although these adolescents seem not to have reached full 
acceptance of their status, they were all in various stages of the process of acceptance.  
 
7.2. Recommendations 
The current research study had some strengths. Due to the qualitative nature of the study and the 
use of a holistic theoretical framework, the research study was able to attain a wealth of 
information about the experiences of these particular HIV positive adolescents. In particular, this 
research aimed to examine the unique experiences of adolescents on antiretroviral therapy 
(ART), in order to understand what helps them to adhere to their medication and the challenges 
that they may have with adherence. Since very little research has been done on this topic in 
South Africa, this study may provide an important starting point for future research in this area 
of study within the South African context. Future research could perhaps also include a more 
inclusive conceptualisation of adherence. The current study focused on whether the adolescents 
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are taking their medication as per advised by their health care provider. However as illustrated 
earlier adherence is also about a life style which is also about following a diet, and, or executing 
lifestyle changes (WHO, 2003), to better improve one’s health. The findings of this study may 
also contribute to informing ways in which to assist adolescents to cope with living with HIV 
and adhering to ARVs, as this seems to be quite challenging for these individuals. An 
understanding that openness with regards to disclosure and time for processing assists these 
adolescents may help caregivers to provide appropriate support. This study may also inform 
recommendations for how to work with and support adolescents in South Africa to manage the 
burdens and challenges related to ART and adherence.  
 
As identified in this study a positive experience at the hospital is facilitative for adherence, as it 
is linked to adolescents being able to communicate their challenges to their health care providers. 
Health care providers can provide a more supportive role for adolescents and their caregivers. 
They can make sure that they tailor their care and services to suit adolescents by creating a 
friendly environment that allows the adolescents to be comfortable and feel free to raise concerns 
with their health care provider. They could also modify the way in which and pace at which 
information is given, which would increase awareness and allow the adolescents to feel 
comfortable to be open and ask questions and engage in conversation about what they are 
experiencing, rather than feeling overwhelmed and, or dreading to go for follow up 
appointments. This will also provide them with the right information about their medication and 
diagnosis. It also seems from this study that full disclosure is very important as it facilitates the 
process of acceptance.  It seems to be important that this is done carefully, and perhaps health 
care providers can collaborate with caregivers to assist with this process. The health care 
providers can also provide the adolescents with psychosocial support to allow them to express 
themselves on their follow up appointments. Along with this they could also provide support 
groups where adolescents can interact with their peers and share their experiences and share their 
coping mechanisms which help them to adjust to being HIV positive and being on ARVs. Such a 
space may allow for adolescents to be able to identify with their peers instead of feeling 
different, which is an important developmental factor in adolescence.  
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In this study the theme of death was very strong and it appears that when adolescents are 
informed of the purpose of being on ART and the importance of adherence, the theme of death is 
strongly enforced. This may be psychologically harmful as the adolescents seem to then live in a 
state of fear that if they do not adhere they may die. Living in a state of continuously thinking of 
the possibility of death may have a negative effect and certain adolescents may give up on a 
belief that they can live a long life with HIV and instead lose hope and give up. It is important 
that heath care providers and caregivers promote life and are more positive in their teachings of 
the importance of adherence so that these adolescents can have a more positive outlook on their 
lives and be encouraged to adhere to their medication and be healthy, instead of feeling 
overwhelmed by a fear of death and giving up on life.  
 
7.3. Limitations 
The current study also had some limitations. The first and most important thing to note is that 
this research study was an exploratory study by nature with a limited scope given the constraints 
of the Masters year. Thus, this study had a very small sample size. This was also the result of 
difficulties finding adolescents willing to participate in the study. This prevents the research 
findings being generalisable to the rest of the population of HIV positive adolescents on ARVs in 
South Africa. Due to time constraints and practical reasons this research study only focused on 
children living in a shelter instead of a more diverse population, which also affects 
generalisability of the findings. This also is problematic as it appears that the adolescents in the 
shelter have a lot of support and monitoring when it comes to ART, making it easier for them to 
adhere to their ARVs.  This may be unlike the rest of this population of HIV positive adolescents 
on ARVs, as for adolescents living in less sheltered environments; support and monitoring may 
not always be a reality. It would thus be very important to explore further the experiences of 
adolescents who do not live in a shelter or get as much support and how they are able to cope and 
overcome their challenges. This may generate different data. Another limitation to this study is 
that it focused on one aspect of adherence which was the medical definition to adherence and this 
may have limited our scope of exploration as there are more elaborate factors which can be 
considered with adherence of ARVs which were not captured in this study, such as following 
strict dietary plans and change in life style to accommodate ART requirements for adherence.  
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Further research in this crucial area would deepen our understandings around what HIV positive 
adolescents are experiencing, so that policies can be drawn to assist and support them to increase 
and maintain adherence.  
 
7.4. Conclusion 
This study has highlighted the experiences of five HIV positive adolescents with regard to being 
on ARVs and following strict routines to ensure adherence. The participants in this study were 
very open around their experiences of adherence to ARVs and how challenging it can be for both 
themselves and their peers who are also taking ARVs. This study also confirmed that non-
adherence is a real problem. However the study also provided information as to the factors that 
assist with adherence, which have been noted above. The current study had both strengths and 
weaknesses; however a wealth of knowledge was obtained, allowing for a better understanding 
of what these particular adolescents experience in relation to adhering to ARVs. This research 
was a starting point for further research to be conducted on the experiences of HIV positive 
adolescents with regards to adherence to ARVs, which may inform policies to better assist and 
support this booming population.  
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Appendix A 
Letter to Shelter Director 
School of Human and Community Development 
Private Bag 3, Wits 2050, Johannesburg, South Africa 
Tel: (011) 717- 4500 Fax: (011) 717-4559 
        
Dear Ms. Heather Snyman 
My name is Natasha Maswikiti. I am a student at the University of the Witwatersrand studying 
Clinical psychology. I would like your permission to conduct research as part of my research 
project at a shelter in Johannesburg. I am interested in interviewing 8 adolescents between the 
ages of 12 and 16 years living with HIV on antiretroviral therapy.  If your permission to conduct 
the study at the shelter is granted, a meeting will be set up to meet the adolescents at the shelter 
and explain the aims of the research and the criteria of participants needed. The potential 
participants will be invited to participate and the individual interviews will be run on-site at the 
shelter.  In-depth interviews will be conducted and an mp3 recorder will be used to record the 
interviews. Interviews are estimated to last approximately 1 hour and regular breaks will be given 
if needed.  The interviews will be audio recorded, however only the researcher and research 
supervisor will have access to them.   The transcripts and the final report will not contain any 
identifying information of the adolescents involved in the study and as such their rights to 
confidentiality and anonymity will be respected.   Participants and their parents/ guardian will be 
asked to give their informed consent in this regard.  After the research is finished the adolescent’s 
recordings and transcripts will be kept in password-protected file on a computer for 2 years if the 
study is published or 6 years if it is not published before it is destroyed.  All participants will 
have the right not to answer any questions they may not wish to answer and to discontinue their 
participation in the study at any time.  The aim of this research project is to explore the 
experiences of adolescents on antiretroviral therapy (ART), in order to understand their thoughts, 
feelings and behaviours around ART and the challenges they may have with adherence.  
On completion of the research you will be informed of the findings through a letter.  The contact 
details of myself and my supervisor are attached to this form in the event that you may have any 
further questions or concerns. 
Kind regards 
Natasha Maswikiti     Dr Katherine bain (supervisor) 
Phone: 082 849 5326     011 717 4558 
Email: tashamas@gmail.com    Email: katherine.bain@wits.ac.za  
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Appendix B 
Participant Information Sheet - parent/guardian  
Hello. 
 
My name is Natasha Maswikiti. I am studying a Masters degree in Clinical Psychology at the University of the 
Witwatersrand. I would like your permission to conduct research as part of my degree and am inviting your 
child to take part in a research study. My project is on South African adolescents experience with antiretroviral 
treatment (ART) adherence.  The purpose of this research project is to have a better understanding of 
adolescents experience with ART adherence and possibly find ways in which to support and help them and 
their peers adhere to ART.   
Taking part in the study would mean they would be interviewed about their personal experience, 
understanding and feelings around being on ART and adhering to it. The interviews will take place at the 
shelter and would happen in a private room.   The interview will take about an hour, but the researcher will 
make sure that she/he rests if she/he gets tired.  Your child can choose not to answer any questions that she/he 
does not want to, there are no right or wrong answers and she/he may stop the interview at any time.  Choosing 
to be part of this research is up to you and your child. Being a part of the interview can help us understand 
your child and her/his peers better, but during the interview things may come up that may make your child sad. 
If this happens and your child feels like she/he needs to speak to someone after the interview, the researcher 
can arrange counselling for your child at the shelter.  
If you and your child decide to take part in the research, the interview will be tape recorded and the researcher 
and the research supervisor will know who your child is, but both of us promise to keep you and your child’s 
identity and information private.  Researcher will write up your child’s interview (transcript) and all her/his 
identifying information will be removed from it.  Then the researcher will see it together with the research 
supervisor from the University of Witwatersrand.  The audio recordings and the transcripts will be kept in a 
locked cupboard in the researcher’s office or on her computer which has a password so only she can see the 
information.  Quotes using your child’s words will be used in the report, however, no identifying information 
will be included and they will be used with quotes from other interviews. After the report is finished the 
interview recordings and transcripts will be kept in secure places for 2 years if the research is published in a 
journal or for 6 years if it is not published, before it is destroyed. General feedback will be given in the form of 
a letter to the Director of the shelter and the finished report will be seen by the public.  Feedback can also be 
given to you in the form of a letter and if you would like more feedback I will give it to you with pleasure. My 
contact details are attached to this form. 
If you do choose to participate please can you fill out the two consent forms attached and give them back to 
me; the one is consent for your child to participate and the other is consent for the audio recording. 
Please feel free to contact either me if you would like any further information, have any further questions, or 
would like to report any negative affects the study has had on your child. 
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Kind regards 
Natasha Maswikiti 
(Researcher) 
Email: tashamas@gmail.com  
 
If you would like to report any problems or complaints that you have with regard to any part of the research 
process you can also contact the University of the Witwatersrand’s Human Research Ethics Committee 
Secretary on (011) 717 1252. 
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Appendix C 
Consent Form (Interview, and research participation) – parent/guardian 
 
I _____________________________________ consent to my child/ward (child’s name) 
__________________________________being interviewed for the purposes of a research 
project looking at antiretroviral treatment adherence in adolescents in South Africa being 
conducted by Natasha Maswikiti.  I understand that:  
- Participation in this research is voluntary. 
- My child has the choice to not answer any questions she/he does not want to answer. 
- My child may stop participating at any time. 
- Direct quotes (the words my child uses) will be used in the report, however, no personal 
information that may identify my child will be included in the report, and my child’s 
responses will remain confidential. 
- During the interview your child may disclose complicated feelings around their  status 
and taking medication, if this is the case and they are at risk of harming themselves or 
others at the end of the interview we will think about other ways to explore these feelings 
- If during the research the researcher finds out something about my child which is harmful 
to them the researcher has the responsibility and my permission to report this to the 
necessary person at the centre who can help my child. 
- After the report is finished, it will be made available to the Director at the shelter.  I can 
request a summary of the findings if I am interested. 
- The transcripts will be kept safely in a password-protected file on my computer for 2 
years if the study is published or for 6 years if it is not published and then they will be 
destroyed.  
- There are no anticipated risks for my child participating in this study, but if my child 
feels upset at any time they will be referred for free counselling . 
 
Signed __________________________________________ 
Date    __________________________________________ 
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Appendix D 
Consent Form (Audio Recording)-parent/guardian 
 
I _____________________________________ consent for the interview that my child/ward 
___________________________________ will have with Natasha Maswikiti to be tape 
recorded. I understand that:  
- The tape and transcript (these are written documents which contain what has been said in 
the interview) will not be heard or seen by any people other than the researcher and her 
research supervisor, who will keep what my child said private.   
- The recordings will be heard by the researcher and the research supervisor only. 
- No personal information, such as names (yours, your child, your family etc.) or places 
(where you live, where you are from etc.) will be used in the transcripts or the report. 
- After the report is finished my interview recording and transcript will be kept in a safe 
place that only the researcher will have access to for six years if no articles are published 
or two years if an article is published. 
 
 
Signed __________________________________________ 
Date    __________________________________________ 
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Appendix E 
Participant Information Sheet - participant (12-16) 
 
Hello. 
 
My name is Natasha Maswikiti. I am studying a Masters degree in Clinical Psychology at the University of the 
Witwatersrand. I am conducting research as part of my degree and I am inviting you to take part in this research 
project. My project is on South African adolescents experience with antiretroviral treatment (ART) adherence.  
The reason for doing this research project is to help us learn more about what HIV positive adolescents are 
experiencing with adhering to ART.   
Taking part in the study would mean you would be interviewed on personal questions about what you 
understand, think, feel and experience with taking ART and adhering to it. The interview will be at the shelter 
and would happen in a private room.   The interview will take about an hour, but the researcher will make sure 
that you take a break if you get tired.  You can choose not to answer any questions that you do not want to, 
there are no right or wrong answers. You can say okay now and change your mind later. All you have to do is 
tell us you want to stop. No one will be mad at you if you don’t want to be in the study or if you join the study 
and change your mind later and stop. Being a part of the interview can help us understand you and your peers 
better, but during the interview things may come up that may make you sad. If this happens and you feel like 
you need to speak to someone after the interview, the researcher can organise counselling for you at the 
shelter.  
If you choose to take part in this research, the interview will be audio recorded and the researcher and the 
research supervisor from the University of Witwatersrand will know who you are, but both of us promise to 
keep your identity and information private.  The researcher will write up your interview (transcript) and all 
your identifying information will be removed from it.  Then the researcher will see it together with the 
research supervisor.  The audio recordings and the transcripts will be kept in a locked cupboard in the 
researcher’s office or on her computer which has a password so only she can see the information.  Quotes 
using your exact words will be used in the report, however, no identifying information will be included and 
they will be used with exact words from your peers who will be in the study. After the report is finished the 
interview recordings and transcripts will be kept in safe place for 2 years if the research is published in a 
journal or for 6 years if it is not published, before it is destroyed. General feedback will be given in the form of 
a letter to the Director of the shelter and the finished report will be seen by the public.  Feedback can also be 
given to you in the form of a letter and if you would like more feedback I will give it to you with pleasure. My 
contact details are attached to this form. 
If you do choose to participate please can you fill out the two assent forms attached and give them back to me; 
the one is assent for you to participate and the other is assent for the audio recording. 
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If you join the study please feel free to contact either me if you would like any further information, I will 
answer any questions you have, and you can ask questions at any time. Just tell the researcher that you have a 
question. 
 
Kind regards 
Natasha Maswikiti 
(Researcher) 
Email: tashamas@gmail.com  
 
If you would like to report any problems or complaints that you have with regard to any part of the research 
process you can also contact the University of the Witwatersrand’s Human Research Ethics Committee 
Secretary on (011) 717 1252. 
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Appendix F 
Assent Form (Interview, and research participation) – participant (12-16) 
 
I _____________________________________ consent to being interviewed in for the purposes 
of a research project looking at Antiretroviral treatment adherence in adolescents in South Africa 
being conducted by Natasha Maswikiti.  I understand that:  
- Participation in this research is voluntary. 
- I have the choice to not answer any questions I do not want to answer. 
- I may stop participating at any time. 
- Direct quotes will be used in the report, however, no personal information that may 
identify me will be included in the report, and my responses will remain confidential. 
- During the interview you may disclose complicated feelings around your  status and 
taking medication, if this is the case and you are at risk of harming yourself or others at 
the end of the interview we will think about other ways to explore these feelings. 
- If during the research the researcher finds out something about me which is harmful to 
me they have the responsibility and permission to report this to the necessary person at 
the centre who can help me. 
- After the report is finished, a copy will be given to the Director at the shelter.   
- The transcripts will be kept safely in a password-protected file on my computer for 2 
years if the study is published or for 6 years if it is not published and then they will be 
destroyed.  
- There are no anticipated risks for me participating in this study, but if I feel upset at any 
time I can be referred for individual counselling. 
 
Signed __________________________________________ 
Date    __________________________________________ 
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Appendix G 
Assent Form (Audio Recording) - participant (12-16) 
 
I _____________________________________ give my permission for the interview that I will 
have with Natasha Maswikiti to be audio recorded. I understand that:  
- The tape and transcript (these are written documents which contain what has been said in 
the interview) will not be heard or seen by any people other than the researcher and 
research supervisor, who will keep what I said private.   
- The recordings will be heard by the researcher and the research supervisor only. 
- No personal information, such as names (yours, your family etc.) or places (where you 
live, where you are from etc.) will be used in the transcripts or the report. 
- After the report is finished my interview recording and transcript will be kept in a safe 
place that only the researcher will have access to. 
 
 
Signed __________________________________________ 
Date    __________________________________________ 
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Appendix H 
Interview Schedule 
 
(Preamble: I would like to discuss with you your experience of taking antiretroviral (ARV) 
medication as well as your thoughts and feelings around taking ARVs. If you do not understand 
any of the questions you may ask for them to be explained differently and if there are any 
questions you do not want to answer, that is also OK, we will carry on to talk about something 
else. You can take your time in answering the questions and please try to answer in as much 
detail as possible because I would like to learn from you so that we can have a better 
understanding of adolescents experience with ARVs). 
1. When did you first learn about your HIV-positive status? How was this time for you? 
 
2. Please tell me about when you first started taking ARV?/ Please tell me about when you 
were first told about taking ARTs 
a. What do you understand of ART and its purpose? 
b. How do you feel about being on ART?  
c. How often do you take your medicine 
 
3. Who knows about your status? 
a.   How is it for you that this/these person/people know your status? 
b.   Who gives you your medication? 
c. How do you feel about this person? 
d. Does it make it easier/harder for you that this person knows your status and helps you 
with your medication? 
 
4. Can you please tell me how you feel about having to take medication every day? 
a. What do you find easy about taking ARVs? 
b. What do you find difficult about taking ARVs? 
c. Do you ever forget take your medication as you should? 
d. What helps you remember to take your medicine at the right time every day?  
e. How do you manage to take your pills when you are away from home? 
 
5. What does taking the medicine mean for you? 
 
6. Do you ever think about or dream about stopping taking your medication? 
 
7. Do you know of anyone that does not take their medication as they should? 
If yes, please elaborate as to what happens with this person. 
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8. Where do you collect your medicines?  
a. What is it like there? How do you feel going/being there? 
b. What is your relationship with your doctor/nurse like?   
 
9. What would it mean for your life if you didn’t have to take medication?  What would be 
different for you? 
 
10. What is it like being a teenager who has to take pills every day? 
 
11. Is there anything else you think may be important for me to know that we haven’t talked 
about? 
 
 
 
 
 
